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Abstract 
The use of magnesium for degradable implants can fill the need for temporary, load bearing, 
metallic orthopaedic implants without the risks and expense of further surgeries once the 
bone has healed.  Mg is non toxic and biocompatible, but the corrosion rate in the body is too 
high.  The rate will need to be moderated if these implants are to be made clinically useful.  
A review of common orthopaedic coatings found that the biomimetic calcium phosphate 
coating process meets the criteria for a good coating.  This process was designed for 
permanent implants, and its corrosion protection properties were unknown on Mg.  The 
research presented here evaluates and optimizes aspects of the corrosion protection of 
biomimetic coatings in vitro.   
To accurately identify the corrosion mechanisms of such coatings, the in vitro behaviour of 
several common simulated body fluids and buffer systems was evaluated.  
The deposition of biomimetic coatings on Mg was compared to Ti.  The effect of common 
surface treatments on the deposition, composition, and ultimate corrosion protection was 
identified in order to understand the corrosion properties of these coatings.  Following the 
results, the biomimetic method was modified to optimize the protection by reducing the 
defects.  The corrosion properties of these modified coatings were assessed in vitro.   
The limitation of the biomimetic coatings was found to be in all cases sensitive to the defects 
present in the coating.  While these could be minimized, they were not eliminated.  This led 
to unfavourable corrosion properties.  To solve this problem, a novel treatment was 
developed to give the biomimetic coatings self-healing properties.  This treatment promoted 
local repair in the coating at the defects, greatly improving the corrosion properties. 
The in vitro model was increased in complexity by adding first amino acids, then proteins.  
The corrosion behaviour of the coatings was compared in these solutions to understand the 
effects of these molecules.  The data gathered will help to build a better model of in vivo 
corrosion, and allow better prediction of the performance of biomimetic coatings for 
corrosion resistance.   
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CHAPTER 1:  Introduction 
1.1. Overview of the Problems 
Magnesium (Mg) is a promising material for a new class of biodegradable orthopedic 
implants [1]. The use of Mg for biomedical applications has been examined for over a 
century [2].  As a metal, Mg is attractive for biomaterials because it is lightweight, has good 
mechanical properties for load bearing implants. The elastic modulus of Mg is lower than that 
of other available implant metals such as stainless steels and titanium alloys, much closer to 
that of bone.  This property can reduce the effect of stress shielding.  These properties, while 
appreciated, are secondary compared to the in vivo degradability of Mg.  Unlike other metals, 
Mg has the potential to degrade in the body.  This allows it to be used for temporary implants.  
This would allow the implant to remain in the body only while needed, degrading and 
dissolving away without the need for surgical retrieval.   This eliminates the cost and 
associated tissue damage necessary for removal and it decreases the likelihood of long term 
complications associated with permanent implants [3].   
Mg is uniquely suitable for the role of biodegradable implants due to its corrosion properties 
and biocompatibility.  Mg is the fourth most abundant metal ion found in the body, is vital for 
physiological processes and found in every cell [1, 4, 5].  The requirement of Mg in the body 
means there are homeostatic mechanisms to control the amounts in the body [6, 7].  Excess 
Mg can be easily removed by the kidneys [8, 9].  The result of this is that although an upper 
limit exists [10], large amounts of Mg can be safely excreted by the body.  The implant can 
therefore degrade during and after the healing of the original bone it was designed to support.  
Moreover, most (50-60%) Mg in the body exists in bone tissue, and Mg is necessary for bone 
growth [8, 11].  These properties make Mg ideal for orthopedic use.   
The fact that Mg will degrade in vivo is what allows it to be used.  Unfortunately, this also 
presents the biggest challenge.  Mg is very active, and Mg corrodes too quickly in the body 
for it to be effectively used [2, 12, 13].  If the implant corrodes too quickly, the mechanical 
strength of the implant will decrease at a rate that is faster than the new bone growth that is 
required to take up the load.  Too much Mg
2+
 released all at once can create 
hypermagnesemia [10, 14].  Furthermore, Mg
2+
 ions are not the only by-product of the 
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corrosion reaction.  The corrosion is accompanied by the generation of hydrogen gas and an 
increase in the pH.  Rapid hydrogen evolution leads to hydrogen gas collecting in the tissue 
[15].  The rapid corrosion rate of Mg is what has kept this material from being widely used as 
an implant to date [2].  To keep these effects from becoming problems, the rate at which the 
corrosion reactions take place must be carefully controlled.  The control must slow the 
corrosion rate enough to allow the body time to mitigate the corrosion products, yet it must 
degrade eventually to retain the benefits of a degradable implant.   
Some method is therefore needed to control the corrosion rate of the Mg in vivo.  Changing 
the bulk properties of the Mg through alloying or protecting the Mg with a coating are 
methods of overcoming the corrosion rate problem [16].  Alloying is attractive because it 
changes the properties of the entire structure, and is thus an area of active research [17, 18].  
The protection thus far provided by alloying is limited by the elements that can be used.  In a 
degradable alloy, every constituent ultimately ends up free in the body, so the toxicity limits 
must be observed [10].  Of the alloying elements available, there are further limits to the 
benefits to corrosion resistance.  The formation of secondary phases and galvanic corrosion 
limits the protection provided [15].  Likewise, any coating must also follow the criteria for 
biocompatibility.  Many industrial coating systems for Mg are very corrosion resistant, e.g. 
chromate conversion coatings, but also very toxic [19].  The coating system also has another 
requirement not found for many other applications, it is not to stop corrosion completely, but 
degrade and allow the Mg to degrade in a controlled manner.     
The ideal coating should therefore be something that slows corrosion rate in physiological 
solutions, contains no elements that are not biologically safe, and enhances the 
biocompatibility.  Calcium phosphate (CaP) coatings are already well known for their 
properties improving the biocompatibility of orthopaedic implants [20].  These coatings have 
been used on stainless steel and titanium to improve the biological response.  As calcium 
phosphates are the major mineral component of bone, the coating is highly suitable for 
orthopaedic applications.  Coatings that mimic the structure of natural bone, i.e. biomimetic 
coatings will be composed of atoms and phases that are present in the body already.  Bone 
tissue is by necessity insoluble under normal physiological fluids, so CaP can protect from 
corrosion.  However, depending on the phase, these coatings have also been observed to be 
susceptible to biodegradation [21].  Therefore, these coatings are perfect for a degradable 
implant.  The calcium phosphate coating can in theory be optimized to protect the Mg 
3 
 
implant from corrosion for a period of time before degrading without leaving any toxic by-
products. 
While biomimetic CaP coatings have been shown to be biocompatible on permanent 
implants, there is a lack of data on their corrosion protection properties and optimization on 
Mg.  Biomimetic coatings have known problems with adhesion and defects that may diminish 
the corrosion protection that can be provided [20].  As such, optimization of the deposition 
and corrosion mechanisms of these coatings needs to be determined before they can be used 
clinically.  Corrosion rates and tests must be performed in order to understand the effect of 
the biological solutions on the ultimate corrosion properties of these coatings on Mg. 
The in vivo environment is complicated.  Many ion, organic molecules, and cells exist in a 
physiological solution which can affect the corrosion rate of the implant.  In order to 
understand the corrosion properties of each individual component, they will need to be 
studied individually in vitro.   This will require isolating the factors that influence the 
corrosion of Mg in vivo, and representing them effectively in an artificial environment.  Much 
of the in vitro corrosion work done to date makes assumptions about the relevance of the in 
vitro environment which may or may not be correct.  While simplifications must be made, it 
is important to validate the mechanism and rate changes that accompany the in vitro 
approximations.  For the measurement obtained to be useful, it must be an accurate 
measurement of the effect that will be present in vivo.  This is especially true when 
comparing samples that may have very different corrosion properties, such as uncoated and 
coated samples.   
The following work will evaluate the corrosion resistance of biomimetic coatings.  These 
parameters and creation of these coatings will be studied and attempted to be optimized for 
corrosion protection in vitro.  To understand the individual effects of the corrosion 
environment on these coatings, the in vitro solutions will be studied for pH changes, buffer 
capacity and performance, and ionic and organic composition to identify and compare the 
effect of each molecule.  The results will elucidate the important aspects of in vitro corrosion 
studies of coated samples, as well as advance the technology of biomimetic coating on Mg 
for corrosion resistance.   
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1.2. Outline of the Thesis 
The chapters of the thesis are summarized as follows: 
Chapter 2 provides an overview of the state of the art of reducing the corrosion rate of Mg 
for biomaterials via surface treatments and coatings.  The processes and coating types are 
described in terms of the benefits and shortcomings of the coatings based on recent 
publications.  The in vitro corrosion solutions used in these studies is also discussed, as well 
as the techniques for measuring the corrosion rate.  The variation in coating type, in vitro 
conditions, and ultimate corrosion protection factors of different coatings on Mg are 
compared.   
Chapter 3 investigates the use of buffer type on the measured corrosion rate and 
electrochemical behaviour of uncoated Mg in different simulated body fluids (SBFs).  The 
interaction between the buffer and the Mg ions in solution is measured to validate the choice 
of the buffer.  The buffer properties investigated here determine the proper in vitro solutions 
to be used for further investigations into the corrosion behaviour of the coatings.   
Chapter 4 begins the investigation of the biomimetic coating formation properties on the 
corrosion protection these coatings provide.  The deposition of the Mg is compared to the 
deposition on Ti.  The effect of the surface treatment on the final coating and the later 
corrosion rate in SBFs are measured.  The effect of the different solutions and buffers on the 
measured protection are investigated.  The limits of protection and failure mode of the 
coatings is examined.  The formation of the coatings based on pretreatment is discussed and 
the usefulness of the pretreatments is determined.   
Chapter 5 continues the investigation of the biomimetic coatings by modifying the coating 
deposition process based on the data obtained in Chapter 4.  The additional modification was 
designed to improve the corrosion properties of the coatings given the deposition properties 
on Mg.  The effect of the modification of the coating process on composition and corrosion 
rate are determined.  The mechanisms for increased protection of the modified coatings are 
discussed.   
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Chapter 6 presents a novel method for improving the properties of the biomimetic coatings 
by introducing a self-healing mechanism. This mechanism overcomes the limitation of the 
biomimetic coating corrosion protection.  The behaviour in vitro and the mechanisms of the 
increased protection were determined.   
Chapter 7 takes all of the coating types prepared earlier and investigates the individual 
effects of a more complicated in vitro environment.  The corrosion behaviour with the 
addition of amino acids, and then proteins to the solution was measured.  The effect of each 
was documented, as well as the effects of the buffer choices as determined in Chapter 3.   
Chapter 8 presents the overall conclusions of the research and the direction future work will 
need to take to bring these coatings and Mg implants to clinical applications.   
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CHAPTER 2:  Literature Review 
2.1. Introduction 
Magnesium (Mg) and magnesium alloys have the potential to be useful in creating better 
orthopedic implants [1]. Magnesium alloys can offer the strength and toughness required 
for load bearing implants where ceramics and polymers fall short. Other metals currently 
used for implants, such as stainless steels and titanium alloys, have elastic moduli that are 
much higher than natural bone, leading to unwanted stress shielding. The elastic modulus 
of magnesium and many magnesium alloys are much closer to bone [2].  Also, a second 
surgery is required to remove current metallic implants.  Magnesium shows promise as 
the material for biodegradable implants that degrade in the body without requiring 
removal. It is found in abundance in the body, and the degradation by-product Mg
2+
 ions 
have been shown to be non toxic to cells [3].  In addition, magnesium may actually serve 
to stimulate new bone growth [1]. With all of these favourable properties magnesium 
looks very promising for this application. However, there are some challenges to be 
overcome.  
Magnesium and its alloys in general have low corrosion resistance, which is important for 
metal implants given the very aggressive environment in the physiological system [4]. 
Toxic degradation products and loss of mechanical properties are the major concerns [5]. 
The low corrosion resistance of magnesium leads to loss of mechanical properties too 
quickly. It also leads to rapid hydrogen gas evolution within the body. For these reasons, 
pure unaltered magnesium metal is not an ideal implant material. Furthermore, it is 
desirable to optimize the biological response to these implants to maximize recovery. The 
biological response to the surface of the implant is important for compatibility of the 
implant with surrounding tissue [6]. Since corrosion and biocompatibility are ultimately 
surface phenomena, surface modification through treatments or coating systems will be 
needed to optimize implant properties.   
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A good coating or surface treatment will be one that will control corrosion of the implant, 
maintaining mechanical integrity for the duration the implant is required. To be effective 
on many types of implants, it will be ideal for the coating to cover complex surfaces 
completely to ensure corrosion does not occur too quickly. Also, the coating must have 
good adhesion to the metal substrate, and have acceptable wear resistance to protect the 
implant during the insertion operation and throughout the load cycles of the implant life. 
It is also of great concern that the implant be non-toxic and fully degradable itself after 
the duration required. Additionally, good cellular response and attachment is desirable 
allow the implant to become fully integrated with the biological system. A suitable 
coating that meets these criteria will allow biodegradable magnesium implants to become 
a feasible alternative to current metallic orthopaedic implants. What follows is a 
discussion of the various approaches taken to overcome the problems facing magnesium 
implants.  
 
2.1.1.  The Corrosion of Magnesium 
In order to determine how best to control the corrosion of magnesium, it is important to 
understand the mechanism of corrosion, especially in physiological environments. In 
general, magnesium metal corrodes in aqueous environments to form magnesium 
hydroxide and hydrogen gas [7]. The overall corrosion reaction of magnesium is given in 
Equation 2-1.   
Mg + 2H2O → Mg(OH)2 + H2(g) Equation 2-1 
In general, corrosion will form a surface coating of Mg(OH)2 and/or MgO [7]. This forms 
a passivation layer that will generally slow the corrosion rate. The passive layer protects 
the substrate until the oxide layer is penetrated, exposing unoxidized metal to solution. 
The corrosion is accelerated locally when this occurs. However, the corrosion 
degradation products re-passivate the surface, slowing further corrosion [8]. Galvanic 
corrosion will occur when Mg is put into contact with other metals. This can be due to 
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either external metals or internal secondary or impurity phases. Metals that have a low 
hydrogen overvoltage can cause severe galvanic corrosion. Examples are Ni, Fe, and Cu. 
The severity of galvanic corrosion is not as high for metals with lower hydrogen 
overvoltage such as Al, Zn, Cd, and Sn [7].  
Physiological environments are typically very aggressive environments for metals. 
Corrosion tests carried out in simulated body fluids (SBF), which are fluids that contain 
many of the ions commonly found in the body, give some indication of how a metal will 
perform in an actual environment. In simulated body fluid, the rapid corrosion of 
magnesium can mainly be attributed to the presence of chloride ions. The Cl
-
 replaces 
OH
-
 into the Mg(OH)2 at the surface and MgCl2 is formed. MgCl2 is quite soluble, and 
thus increases the rate of corrosion by destroying the passivation layer of magnesium 
hydroxide [9].  The effect of the Cl
-
 can be seen when corrosion is compared to a sample 
in a similar solution with a minimal amount of Cl
-
.  Pitting and surface cracking is the 
major mechanism of corrosion in SBF due to Cl
-
 ions [10, 11]. Because of the aggressive 
nature of physiological fluids on Mg corrosion, the use of Mg as a biodegradable implant 
material will need modification to slow the corrosion rate [1, 2].   
 
2.1.2.  Biocompatibility 
Increasing the biocompatibility of the implant is also important. The response of the cells 
and tissue to a foreign-body implant is critical to the performance of the implant and the 
recovery of the patient [12]. Toxicity is crucial for the purposes of a biodegradable 
implant. If the implant is to degrade in vivo, then the inclusion of toxic elements or 
compounds must be minimized or eliminated from the implants [5]. This condition 
eliminates many of the common techniques used for corrosion resistance of magnesium 
in other applications. For example, heavy metals and chromate conversion coatings that 
have been used for magnesium corrosion resistance should not be used [13]. In addition 
to toxicity, cellular response while the implant is in place is of great importance. The 
biocompatibility of titanium implants has been investigated fairly extensively for 
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orthopaedic implants [14-18]. A magnesium implant will also need to exhibit good 
biocompatibility if it is to be effective.   
 
2.2. Magnesium Alloys as Substrates 
2.2.1.  Alloying 
Alloying the magnesium with appropriate elements to overcome problems of corrosion 
and biocompatibility has been the focus of much research, and will be important to 
perfecting magnesium implants [2, 19, 20]. Alloying elements that modify the corrosion 
layers to increase the stability of the Mg(OH)2 can slow down corrosion, but often alloys 
with multiple phases exhibit microgalvanic corrosion [7].    
The scope of alloying elements and concentrations for orthopaedic magnesium is 
severely limited [21].  For biocompatibility, alloying is limited to element that will not 
cause acute toxicity or long term damage, e.g. carcinogenic metals [5, 22].  For corrosion 
protection, the elements are limited to those that are not electrochemically too far apart 
and thus promote corrosion.  The amount of alloying is also limited by the solubility limit 
of the alloying elements, as secondary phases that form will have a different 
electrochemical potential.  This leads to galvanic corrosion [7]. For most Mg alloys, the 
alpha magnesium phase is anodic to the other phases that form [23].  The rapid corrosion 
rates in multiphase alloys limit the total amounts of alloying that can be used.   
Given these constraints, the number of alloys suitable for biomedical Mg is limited.  Of 
these, which ones can be used for magnesium is further limited by the corrosion 
protection.  Unfortunately, many of the best performing elements for enhancing corrosion 
resistance are toxic or non-biological elements, e.g. aluminium and titanium.  Recently, 
Kirkland et al. surveyed a number of biocompatible alloys in the range for biocorrosion 
[19].  The results of the study showed that most safe elements offer only limited 
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corrosion protection to Mg.  A number of rare earth elements have also been suggested as 
possible candidates for biodegradable alloys [24-27].  While some of these rare earth 
elements have been tested for acute toxicity, the lack of data on the long term health 
effects of these elements means that further study will be required before they can be 
used clinically [5].   
For the corrosion testing of coated samples, many alloys have been used as substrates.  
Figure 2-1 shows the distribution of alloys used to test corrosion protective coatings in 
the reviewed literature (See Appendix A). The most popular substrate for in vitro tests is 
pure Mg, although with varying levels of purity [28-49].  The small changes to the purity 
of the Mg can have large effects on the corrosion rate, which must be accounted for when 
comparing across studies [50, 51].   
Various Mg-Al alloys have been used as well.  The commercial aluminium alloys possess 
good corrosion resistance by themselves, compared to pure Mg. AZ31 [31, 48, 52-64], 
AZ91 [29, 47-49, 65-71] and other AZ alloys [72-74] are readily available and easy to 
use for corrosion tests, but may perhaps not be the most suitable for biomedical alloys 
due to the concentrations of Al, which may cause problems once introduced to the body 
[75-77].  
Calcium as an alloying element has been used due to the compatibility of calcium with 
the body, since it is naturally regulated and removed similar to Mg. Thus, Ca containing 
alloys have also been used [57, 78-80].  Calcium does have the disadvantage of 
accelerating the corrosion rates of pure Mg due to it being an even more active metal [81, 
82].   
Zinc is also a non toxic element, if used in low concentrations [5], that has been used [20, 
78, 83, 84].  Zinc can change the corrosion properties slightly although microgalvanic 
cells may form above the solubility limit in Mg, and higher Zn content is restricted by 
toxicity issues.   
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Ternary alloys of calcium and zinc have also been studied for implant materials [85-87].  
Additionally a number of other assorted alloys have been chosen as substrates for 
biocorrosion research with other elements such as manganese [88], rare earth alloys [89], 
and others.   
The choice of the alloy for a biodegradable implant is something that will be dependent 
on the desired mechanical and corrosion properties. The substrate may or may not be 
critical to the coating, depending on the type of coating used and how it is applied.   
 
Figure 2-1: Mg alloys used in the surveyed literature for coating evaluation with 
protective coatings. 
 
2.2.2.  Bulk Metallic Glasses 
The galvanic corrosion that forms between different phases is a limitation to the amount 
of alloying that can be used in a magnesium metal implant device.  Overcoming the 
galvanic corrosion would open up a wide range of compositions for tailoring the metal 
properties.  The formation of amorphous bulk metallic glass (BMG) is one approach to 
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completely remove corrosion potential difference due to the crystal structure in the metal. 
Casting metallic glasses requires specific alloy compositions and extremely high cooling 
rates to freeze the liquid metal without the formation of crystalline grains [90]. This 
presents a problem in creating fully amorphous structures of dimensions larger than a few 
millimetres. Alloy compositions can be optimized to form BMGs. Recently MgZnCa 
alloys at compositions with good glass forming ability have been of interest for 
biomedical and other applications [91-95]. These ternary alloys do not contain highly 
toxic elements, enabling them to be used in degradable implants.  
Amorphous MgZnCa alloys have been tested in vivo to show reduced hydrogen evolution 
[95]. Amorphous alloys above 28 at. % Zn showed particularly good passivation 
properties, due to the formation of a zinc oxide layer. However, the BMG samples 
created were sheets only 0.5mm thick, so again, dimensional constraints due to the 
formation of BMGs may limit the use of fully glassy materials for larger implants. Gu et 
al. reported similar results for 2mm thick MgZnCa BMG samples, including reduced 
corrosion rate and increased response in cell culture tests [91].  Again, with larger 
implant materials, the total amount of elements such as Zn need to be controlled, and 
therefore these high Zn ternary alloys may pose biocompatibility issues.   
 
2.2.3.  Ion Implantation 
An alternative to forming bulk metallic glasses for the substrate is to make the surface 
amorphous on a crystalline material using a surface treatment technique. Ion implantation 
provides a possible route of creating a modified surface like this. Accelerating ions to 
high velocities and implanting them into the surface of the substrate can cause a collision 
cascade that destroys the long range order of crystals in the metal, leaving a glassy 
surface.  Chatterjee et al. has demonstrated such phase formation in aluminium substrates 
by ion implantation [96].  Glassy surfaces can also be formed after ion beam mixing a 
coated surface layer with the substrate [97].  
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This method of surface modification could be used to increase corrosion resistance. 
Advantages of ion implantation include modification of the existing substrate surface, 
often creating a gradual transition between the modified surface and the bulk of the 
material. This generally tends to make strong, adherent treatments that do not have the 
problems of adhesion, thermal stresses, and cracking that separate secondary coating 
phases tend to have. Plasma immersion ion implantation (PIII or PI
3
) of Al, Zr, and Ti 
has been used to create corrosion resistance on AZ91. The mechanism of corrosion 
protection is due to the introduction of elements near the surface to increases the density 
of the corresponding oxide during corrosion, resulting in a more protective passivation 
layer [98].  However, additional elements may not be desirable if they are linked to 
toxicity like Al, or do not degrade such as Ti [99].  Using a thin implanted layer at the 
surface as opposed to bulk alloying can decrease the amount of introduced toxic ions.  
Wan et al. used Zn ions due to their biocompatibility, but found Zn ion implantation in 
MgCa alloys increased the corrosion rate rather than decrease it [100]. Oxygen ion 
implantation has also been attempted but with little success against chloride solutions 
[101]. Nitrogen ion implantation has been used to improve corrosion resistance of 
magnesium.  Nakatsugawa et al. reported nitrogen ion implantation reducing the 
corrosion rate of AZ91D to 15% of the untreated metal in 5% NaCl [102].  Similarly, 
Tian et al. used PIII to improve the corrosion resistance of AZ31B [103]. With ion 
implantation, the implant energy and dosage are critical to maximizing the implant 
performance.  Ion implantation has the drawbacks of requiring line of sight to the target.  
Also, the total depth of ion penetration is limited, thus only allowing the very initial 
surface of substrate to be protected.    
Numerous attempts to improve the in vitro corrosion resistance of Mg via alloying or 
phase modification have been done, although there exists no single solution to meets all 
of the implant design criteria as of yet.  While there are many promising areas, the 
alloying method is limited fundamentally.  The type and kind of alloying element is 
limited to those that are biocompatible.  Even the compatible elements have upper limits 
on the amount that can be safely excreted by the body [5].  Of those that remain, there are 
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limits on traditional alloying to help with the corrosion rate [19], and although rare earth 
elements may seem promising, they will need to be vetted for long term biocompatibility.  
Thus, alloying of Mg does not appear to be a complete strategy for solving the corrosion 
rate problems of biodegradable Mg.  The corrosion rates will have to be mitigated by an 
additional surface treatment or coating to meet the design criteria.   
 
2.3. Coatings 
A simple but effective method to reduce corrosion is to coat the metal so as to provide a 
barrier between the metal and the environment. Corrosion resistant coatings are 
commonly used for metals in many applications.  For biodegradable Mg, the coating is 
required to keep the corrosive ions in the physiological system (especially Cl
-
) away from 
the Mg until sufficient time has passed and the bone has healed.  Once this has occurred, 
it is desirable that the coating eventually yields to the environment and degrades along 
with the magnesium, leaving no harmful traces.  Numerous corrosion resistant coating 
types and application methods have been studied for Mg (Figure 2-2).  The search for a 
biocompatible biodegradable coating that will provide the right amount of protection for 
orthopaedic purposes has covered many of these areas.   
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Figure 2-2: Reviewed corrosion protection studies for biodegradable Mg by coating type. 
2.3.1.  Conversion Coatings 
Conversion coatings are produced by directly converting the outer surface of a metal into 
a different form to provide a protective coating [104].  This uses an electrical and/or 
chemical process to convert the metal matrix into an oxidized form that is not susceptible 
to corrosion.  For magnesium, the conversion of the magnesium alloy surface into a dense 
magnesium oxide layer in an anodization process can be considered a type of conversion 
coating, as well as chemical conversion coatings including chromate, 
phosphate/permanganate, fluoride and others [13, 104].  These coatings convert the 
surface, thus creating a dense adherent coating that can often be made with few defects.  
These coatings have a proven track record in industrial corrosion protection, but many of 
them use dangerous elements, e.g. chromium, that are unsuitable for biomaterials.  
Properties of these coatings also will depend to some extent on the substrate chemistry as 
it is converted.  Thus, these coatings can vary in properties as the alloy itself changes, 
which might present difficulties if it is desirable to modify the substrate alloy for 
mechanical properties and leave the corrosion protection intact.  Overall, a significant 
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amount of research into coatings for biomedical implants has taken place using 
conversion coatings (Figure 2-2).   
 
2.3.1.1. Oxide coatings/Anodization 
A common practice is to use anodization to form a protective corrosion resistant layer on 
metals. This process represents the largest segment of the researched conversion coatings 
presented here (Figure 2-2).  Anodization uses and electrical current to form a thick, 
dense oxide layer that is more protective than the natural layer that develops. Magnesium 
oxide layers can be formed by anodizing Mg which slow short term corrosion rate in 
SBFs such as Hanks balanced salt solution (HBSS) [29, 32, 33, 43, 47, 54, 55, 65, 67, 69, 
70, 72, 74, 78, 85, 89, 105].  
Furthermore, qualities of the coating like density can be optimized by controlling the 
voltage profiles during anodization [106]. The corrosion protection of the oxide layer can 
be increased by performing the anodization in a silicate solution, creating Mg2SiO4 on the 
surface as well as MgO [47]. These additions can change the density of the layer by 
modifying the Pilling-Bedworth ratio, leading to additional corrosion protection [107].  
However, magnesium oxide layers will convert to magnesium hydroxide in aqueous 
solutions, and magnesium hydroxide is soluble in chloride solutions such as body fluid 
[108].  Further, greater anodization does not always improve the corrosion resistance. For 
example, Xue et al. found anodization greatly increased polarization resistance in a NaCl 
solution, but after longer (2 hours) treatment time the resistance decreased by a factor of 
2 [47]. Because these films are not stable in biological solutions, anodization alone is 
unlikely to produce the protective coating required for many bioapplications.  Instead, 
anodization can be used as a pretreatment to another coating system. For example, 
anodized layers can be used to control the amount and rate of calcium phosphate 
compounds precipitated on the surface in SBFs [33].  
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2.3.1.2. Fluoride Conversion Coatings 
Fluoride conversion coatings solve the MgO solubility problem of anodized coatings by 
converting the magnesium not to an oxide like MgO but rather into MgF2.  MgF2 has 
greater chemical stability due to the high electronegativity of the fluorine atom, which 
makes the ionic compound more difficult to separate.  Because of this, MgF2 is more 
stable in water than MgCl2, and negates the effect of Cl
-
 attack.  Consequently, the MgF2 
conversion coatings on commercial Mg alloys exhibit improved corrosion resistance  
[104].  Conversion coatings can be created by reacting the Mg substrate with hydrofluoric 
acid until a passive MgF2 coating forms on the surface [31, 35, 54, 56, 70].  Because HF 
is highly corrosive and dangerous to work with, research into conversion coatings using 
other fluorides such as KF has been attempted as well [46].   
Like other chemical conversion coatings this process can coat complex shapes and form 
uniform, dense coatings.  The coverage and corrosion protection of the coatings increases 
with HF concentration up to 40% HF[54].  The formation of the conversion coatings will 
involve the creation of MgF2 and Mg(OH)2 with the amount of MgF2 dependant on 
fluoride concentration [109].  This affects the created coating and thus the corrosion 
resistance [56].  Fluoride conversion coatings significantly increase the corrosion 
resistance in SBFs [31, 35, 54] as well as in vivo [25].  Fluoride coatings are not 
completely passive [70] and will dissolve with time causing attack to the substrate [25].  
Despite this, these coatings have been used to slow down in vivo corrosion in order to 
extend the life of the mechanical strength of the implants [110].  The release of fluorine 
ions is not cytotoxic [111] so the main challenge for fluoride conversion coatings is 
optimizing the corrosion rate.  
Conversion coatings of other types exist, but as stated before, are limited to those that are 
biocompatible.  Phosphate conversion coatings can be used but are poorly protective 
without additional species [104].  Rare earth (RE) conversion coatings have been 
attempted for biomedical magnesium alloys, specifically cerium is of interest [53, 74]. 
Cerium does not interact much with the body, so can be safe for implants [112].  Cui et 
al. demonstrated that the corrosion resistance of AZ31 increased the polarization 
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resistance by a factor of ~7.5 in SBF after 10 minutes of immersion [53].  However, since 
the stability of Cerium coatings is so contingent on local environment and can degrade 
after several hours [113] these coatings will need more research to determine if they will 
be viable for biomedical use.   
 
2.3.2.  Calcium Phosphates  
One of the most biocompatible coating options for orthopedics is calcium phosphate 
(CaP) coatings. Coatings of different CaPs have been researched extensively for use in 
biomedical applications [114, 115]. Several biologically important types of apatite are 
hydroxyapatite (HA), octocalcium phosphate (OCP), tricalcium phosphate (TCP), 
dicalcium phosphate dihydrate (DCPD) and amorphous calcium phosphates, often 
containing other secondary ion substitutions.  
The mineral component of bone itself is an apatite, but also contains other ions such as 
carbonate and phosphate groups. This mineral structure is built upon a collagen matrix. 
The similarity of calcium phosphate coatings to bone minerals gives them good 
biocompatibility [115].  Calcium phosphate coatings have been used to increase the 
integration of the implant to the bone [116, 117].  HA coated titanium implants have been 
found to increase cell proliferation and bone formation [118].  CaPs are perfect 
candidates for protective coatings for Mg implants because they can be fairly insoluble in 
physiological conditions and are very biocompatible.  However, the coating must be 
complete and adherent to the substrate to provide adequate corrosion protection.  The 
quality of the coating created is dependent on the process and process parameters used for 
formation [115].  Calcium phosphate coatings have been of interest for corrosion 
reduction with researchers reporting corrosion resistance of CaP coatings in vitro [34, 36-
42, 48, 57-59, 61-64, 66, 68, 71, 72, 79, 84, 86-88].   
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2.4. Coating Techniques 
2.4.1.  Plasma Spray 
The most popular commercial procedure to attach calcium phosphate coatings to a 
metallic implant is the plasma spray method. This entails using a jet of neutral gas, 
inserting the material or precursors for the material to be coated into the jet and 
plasmatizing by some means, for example via a DC arc. The plasma spray is directed 
onto the substrate where the coating forms. The process makes precise control of the 
composition by control of the feed powders and the thickness of the coating [119].  
Plasma sprayed hydroxyapatite has been used to coat implants to increase 
biocompatibility of implants [120, 121].  However, the high temperatures required for 
this process means care must be taken to avoid the presence of unwanted phases, as well 
as decomposition of the coating and/or substrate [119]. For Mg and its biocompatible 
alloys, the temperatures reached with plasma spray will be great enough to melt or 
change the substrate, making this technology difficult to apply to Mg.  Plasma spray is 
also limited by the line of sight to the substrate, making complex shapes and porous 
structures difficult to coat uniformly. Other techniques to apply calcium phosphate 
coatings to metallic substrates have been attempted to overcome problems related to 
plasma spray such as poor integrity and adhesion, low crystallinity, and mechanical 
failure of the coating [122]. Some of these methods might be more appropriate for 
magnesium based materials.  
 
2.4.2.  Solution Chemistry Coatings 
Solution chemistry methods for coating metals with calcium phosphates have a number 
of advantages. Simple and low cost setup, the ability to coat complex and porous 
materials, and the ability to use low temperatures make these coatings attractive for Mg 
substrates. For biomaterials, calcium phosphate coatings make up the majority of these 
types of coating due to their biocompatibility. The oxidation of Mg creates a local pH rise 
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which promotes calcium phosphate deposition in solutions containing calcium and 
phosphate ions [63]. This can be leveraged to easily create coatings in simple solutions.  
However, this method also has its drawbacks, as magnesium is highly reactive in aqueous 
environments it tends to corrode during the coating process. Furthermore, for calcium 
phosphate compounds, substitutions by Mg
2+
 ion in the crystal lattice of compounds like 
HA are known to promote defects, limit crystallization [123], and decrease the stability of 
the created compound [124].  Hiromoto and Yamamoto reported HA coatings created on 
Mg and alloys in single step solution treatments [48]. The ionic concentration and pH of 
the coating solution affect the coating deposited. They reported reduction in corrosion 
current density of 10
3
 to 10
4
 times lower in 3.5% NaCl than uncoated Mg using 
potentiodynamic polarization (PDP).  Hu et al. reported creation of a DCPD coating in 
solution on AZ91 alloy by titrating K2HPO4 into a Ca(NO3)2 solution [68]. The DCPD 
coating was transformed into HA over time in SBF, and the corrosion resistance of the 
coating increased to 4210 ohms from 331 on uncoated Mg. By PDP tests, corrosion 
current density dropped from 70 to 2.6 µA/cm
2
.  Tomozawa reported solution chemistry 
techniques to form HA on pure Mg in solution [39]. Increasing temperature to 333K or 
higher increased HA formation and Mg(OH)2 formation. However, by increasing Ca 
concentration HA formation could be increased without affecting Mg(OH)2 formation, 
which may be undesirable to have underneath the coating, due to its high solubility.  Xu 
et al. reported in vivo studies using calcium phosphate coatings prepared by solution 
methods on Mg Mn Zn alloys [88]. The surface properties of the coated samples 
supported cell growth and exhibit higher overall osteoconductivity compared to uncoated 
samples. Because these solution coatings can avoid using any toxic elements, the 
biocompatibility is good. However creating a dense and adherent enough coating to 
remain crack free and fully protective in solution for the required amount of time remains 
an issue.  
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2.4.3.  Biomimetic Coatings 
One particularly interesting subset of these calcium phosphate solution coatings is the 
biomimetic coating process.  The biomimetic process uses solutions similar in ionic 
composition to physiological fluids with the aim of creating a coating that is similar in 
properties to the layer that would form in vivo [125]. The similarity of a biomimetic 
coating to natural bone mineral can increase bioactivity of the surface [126]. The bone-
like layer created is intended to enhance the activity of bone cells that come into contact 
with it, thus promoting faster integration of the implant [127].  The difference here is the 
change in composition and crystal structure of the biomimetic coatings compared to pure 
crystalline calcium phosphate coatings like stoichiometric hydroxyapatite.  Substitution 
of other ions into the apatite lattice decreases the Ca/P atomic ratio from that of synthetic 
apatite closer to natural bone [128]. Common substituting ions include CO3
2-
, HPO4
2-
, 
Mg
2+
, and others [129].  The crystallinity of the apatite decreases as well due to these 
substitutions [114, 123].  It is these changes that give the biomimetic coatings their 
unique properties.   
Biomimetic coatings were originally developed to increase the bioactivity of calcium 
phosphate coatings for titanium implants [116, 118, 130, 131].  While corrosion 
protection is not a role of these coatings on Ti, the fact that these coatings are created 
stable in simulated body fluids suggests they can be useful for protecting corrosion of Mg 
substrates, as well as incorporating the biological properties.  Some initial studies of 
biomimetic calcium phosphate coatings for corrosion protection have been shown to 
reduce corrosion on Mg [34, 42] and AZ91D [68].   
Biomimetic coatings offer some key advantages for coating implants.  These include high 
biocompatibility [42] both in vitro and in vivo [88], osteogenicity [127],  and bone 
bonding ability [132].  Other advantages include possible coating of complex shaped and 
porous implants, low temperature deposition (and thus can coat low melting temperature 
substrates), simplicity of the process and low cost [133, 134].  
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Disadvantages to such coatings include the coating time. The literature reports up to 48 
hours [34, 129] or as long as 5 days [42]. The deposition of a biomimetic layer is actually 
easier on Mg than on Ti due to the pH rise that comes from the corrosion of the Mg 
substrate [63].  The Mg
2+
 ions from the corrosion reaction also affect the nucleation of 
the calcium phosphate coating on the crystal structure.  Because of this, the Mg ion 
concentration has been found to be critical to the formation and attachment of these 
coatings [135]. 
Another problem for corrosion is the method often creates cracks and other defects in the 
coating [34, 42, 136].  Sealing the coatings with NaOH is only moderately effective while 
hydrothermal treatment does not seem to help at all [42]. Defects in the coatings will 
allow the corrosion reactions to proceed on the underlying Mg substrate.  Thus, 
elimination of the defects is required if these coatings are to be used for corrosion 
protection.   
 
2.4.4.  Electrochemical Assisted Deposition (ECAD) Coatings 
Calcium phosphate coating formation can be assisted by the application of external 
potentials and currents. These processes are collectively referred to as electrodeposition. 
The setup for these methods is inexpensive and relatively simple, and the process can be 
carried out at low temperatures. The processing parameters can be easily controlled to 
optimize the coating created.  
ECAD uses the reduction of water in an aqueous solution to promote the precipitation of 
calcium phosphates on the surface of a metallic substrate. Reduction of H2O generates H2 
gas and leaves behind OH
-
 at the cathode. This leads to a local rise in pH at the surface of 
the substrate. An increase in pH decreases the solubility of calcium phosphates in 
solution, leading to precipitation at the surface.  
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The ECAD process for calcium phosphate can be controlled using a number of methods 
[115].  A constant potential can be held between the working electrode (the surface to be 
coated) and the counter electrode, typically made of an inert material such as platinum or 
graphite. Constant potential between the working and counter electrodes means the 
potential between the solution and the electrode is not directly controlled.  Potential and 
current are therefore related to aspects of the coatings such as cell geometry, solution 
composition, counter electrode material, etc. This method has been used to form coatings 
of HA on AZ91D and have been shown to reduce corrosion currents as measured by 
electrochemical methods (PDP and electrochemical impedance spectroscopy (EIS)) 
[137]. 
Alternately, the coating process can be performed potentiostatically, where the working 
electrode is held at a constant voltage relative to a reference electrode. The reference 
electrode is placed near the working substrate in order to maintain a constant potential 
difference between the solution and the coating. This is useful for keeping the potential at 
a desired level to cause reduction of H2O, without rising to levels that can reduce other 
metal ions in the solution.  In this setup, the current will decrease as the substrate 
becomes coated and the exposed area of the electrode drops. Lower OH production at the 
cathode leads to a pH drop near the working electrode, and therefore a drop in deposition 
rate. DCPD coatings have been created on Mg alloys using the potentiostatic method, and 
while the resulting coatings do reduce corrosion rates, total coverage from thick, dense 
coatings that completely protect the substrates remains an issue [57].  
To keep the hydroxide ion production constant, fixed current, or galvanostatic methods 
have been used to coat magnesium with this method.  The standard three electrode cell is 
used, but the controls are set to keep current applied between the working and counter 
electrodes constant.  Provided H2O is the only molecule undergoing oxidation and 
reduction in solution, then the rate of OH
-
 production near the surface remains constant, 
keeping the pH profile roughly equal during the process.  The voltage can spike during 
the process, especially after the substrate is partially coated. Song found the galvanostatic 
method of coating to form a calcium phosphate coating that was protective in SBFs, 
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dropping the measured corrosion current significantly over a 48 hour test [137]. Wen 
used the galvanostatic method to coat AZ31 with HA. PDP results show protective 
effects. Corrosion potential (Ecorr) was increased and corrosion current density (Icorr) 
decreased. Post treatment in an alkali solution can result in greater stability of the coating, 
resulting in a lower rate of mass loss over 30 days [138].  Calcium phosphate and 
chitosan composite coatings have also been reported on Mg alloys by Wu et al. [71].  By 
performing the deposition in a solution containing a HA suspension as well as chitosan, 
composite coatings could be formed during the deposition process.  
Finally, the voltage profile can be controlled to optimize the coatings created. Aside from 
galvanostatic and potentiostatic control, other voltage profiles used in this process include 
pulsed profiles. Ion diffusion in the coating solution can limit the rate of coating, needing 
longer than the current can source. Additionally, the reduction of water at the cathode 
produces hydrogen gas when the voltage is high. The net result of these factors can be 
loose, porous coatings [139]. Pulse duration can be modified to change properties of the 
coatings. This includes crystal size, with longer durations leading to larger crystals [124]. 
Pulsed current deposition on MgZnCa alloys has been studied, the coatings show 
improved protection and exhibit increased Ecorr and decreased Icorr [139].   
One downside of ECAD methods is the lack of complete dense adhesive coatings [57]. 
Hydrogen evolution at the surface of the metallic substrate creates gas bubbles that block 
chemical formation of the ceramic at the interface, resulting in volcano-like interfaces as 
reported by Kumar et al. [140]. Unfortunately the evolution of hydrogen gas is 
unavoidable for these type of ECAD coatings in aqueous solutions, and is indeed 
necessary to raise the pH at the surface and drive the coating process. 
For electrodeposition processes that are not based around pH solubility, it is possible to 
avoid the reduction of water by performing the reactions in non-aqueous solutions. Due 
to the need for an electrically conductive fluid, ionic liquids present themselves as an 
alternative plating medium. Bakkar and Neubert have reported successful plating of Mg 
substrates with metallic Zn to increase corrosion resistance [49]. Ionic liquid 
composition, applied current density, and substrate alloy composition was found to affect 
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the coating created.  While these types of coatings avoid the gas bubble problem, they 
rely on the reduction of a metal ion.  Therefore they share the weaknesses of any metallic 
coating.  Since any metal coating that will corrode slower than Mg will have a higher 
corrosion potential, any exposed Mg will form a galvanic cell and experience accelerated 
corrosion.   
 
2.4.5.  Sol-Gel Coatings 
The Sol-gel process is a technique for the synthesis of metal oxides and other ceramic 
materials from colloidal solutions of organic precursor molecules [141].  Sol-gel coating 
processes can create coatings on complex shapes, use low temperatures and coatings can 
be created very thin.  The process can require precise controls, and the raw materials are 
sometimes expensive [134].  The sol-gel coating process can be used for many 
biomaterial applications [142].  Hydroxyapatite can be formed by sol-gel methods [143], 
and this method has been used to improve the osteoconductivity on Ti implants [144].   
For biomedical Mg, a sol-gel coating process has been used to create titania coatings that 
slow the corrosion rate in HBSS and Kokubo‟s solution [60, 80].  Reported protection has 
been 200 [60] to 2000 times more protective [80] on AZ31 and MgCa alloys than bare 
substrates, respectively. Although Ti is not directly cytotoxic [145], The long term 
protection and biodegradation of the titania coatings may be a problem since Ti does not 
have a biological excretion pathway like Mg, and the residual titania coating after the 
degradation of the implant may become an issue [99].  Sol gel coatings of silica have also 
been tested on Mg alloy ZE41 [146].  The coatings were found to slow the corrosion rate 
in a 3.5% NaCl solution at room temperature over 168 hours by a factor of 3.  However, 
the performance in vivo is impossible to predict as the tests were performed in an 
unbuffered, non-physiological corrosion medium.  These coatings also needed to be 
sintered at 400° C, which is high enough to modify the grain structure of the underlying 
Mg alloys.   
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2.4.6.  Chemical Vapour Deposition 
Coatings can be created by chemical reactions of gaseous chemicals near a heated 
substrate. This technique is known as chemical vapour deposition. Coating with this 
method allows the production of multilayer and composite coatings as well as complex 
shapes without line of sight. [147] For example, CVD has been used as an alternative to 
plasma spray to create a stable, crystalline, bioactive hydroxyapatite coating on 316 L 
stainless steels [148].  Most CVD processes are fairly high temperature, often requiring 
the substrate to be stable at temperatures above 600° C.  These temperatures are therefore 
unsuitable for the coating of Mg.  However, there are lower temperature processes being 
explored to limit temperatures to around 180° C [13].  
 
2.4.7.  Physical Vapour Deposition 
Physical vapour deposition (PVD) is a method of forming thin film coatings. It can 
produce dense uniform coatings on flat surface, precise control over composition. It 
covers a variety of methods of processing where a vaporized form of the coating is 
produced in a vacuum environment and deposited onto the substrate.  PDV techniques are 
necessarily line of sight.  Additionally, the equipment can be expensive, the coating 
process can be time consuming, and it often produces amorphous coatings [134].  
2.4.7.1. Metal Coatings Under PVD 
Metal coatings have been used to prevent degradation of magnesium. Pure magnesium 
coating on a magnesium alloy particularly susceptible to corrosion has been show to 
decrease the corrosion. If alloying elements increase the corrosion potential, then a high 
purity deposition coating of pure magnesium on the surface will slow the corrosion [149]. 
Coatings of other metals may be achieved as well.  Physical vapour deposition coating of 
aluminium has been successfully applied to magnesium AZ31 alloy [150]. The coating 
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did corrode in a NaCl solution, however, and aluminium is not the best choice for 
biocompatibility. Still, a metal coating for corrosion resistance is a viable option for 
protection, provided the coating metal has a low toxicity. Zirconium [151] and zinc [49] 
are possible candidates in this respect. The unfortunate downside to metallic coatings on 
magnesium is galvanic corrosion when any defect in the coating is present. If the coating 
metal is more noble than the substrate, the substrate will corrode preferentially [10]. A 
gap in the coating will lead to severe localized galvanic corrosion of the substrate 
underneath, and loss of mechanical properties will follow. Since magnesium has a lower 
corrosion potential than all other engineering metals the applications of metallic coatings 
is limited.  
2.4.7.2. Pulsed Laser Deposition (PLD) 
PLD uses a laser to vaporize a target and allow the vapor to condense on the surface of 
the substrate. This method allows for greater control of the crystallinity and composition 
and thickness of the coating [115]. Pulsed laser deposition has been studied on other 
implant materials, notably titanium [122, 152-154], however their protectiveness in 
corrosive solutions on magnesium is not widely reported.  
2.4.7.3. Ion Beam Assisted Deposition (IBAD) 
IBAD can produce coatings with good adhesion and allows precise control of the coating 
chemistry, including the Ca:P ratio. Yang et al reported using IBAD to coat AZ31 [59]. 
Calcium phosphate coatings created were heat treated to transform them into HA. 
Annealing improved the mechanical properties. Coatings were tested in a 3% NaCl 
solution for corrosion properties.  Coated samples were more protective, although pitting 
did occur through cracks in the coating.  
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2.4.8.  Composite Coatings 
Multiple coating types, processes and compositions can be combined to form composite 
coatings.  For example, microarc oxidation (MAO) can be used as a precursor to other 
coating types such as electrodeposition [72], or polymer coatings such as PLGA [73], or 
PLLA [89].  The first process or coating seeks to supplement the corrosion resistance by 
enhancing the adhesion/deposition of the first layer and/or providing a secondary barrier 
to corrosion.   The use of alkali treatments on Ti is quite common to form a layer that 
supports the deposition of a subsequent CaP coating [15-17, 126, 155].  Two stage 
biomimetic coatings that provide better coverage of the initial CaP coating has also been 
used on Ti with success [129].   
MgF2 conversion coating and subsequent HA deposition have been reported by Jo et al. 
to slow the corrosion rate of Mg by a factor of 3.5, as measured by ion release in SBF 
over 70 hours [44].  PLGA on MAO layers have reduced the corrosion current 10x in 
Hanks, and had the benefit of allowing the coating to perform slow drug release as well 
[73].  Lu et al. used a secondary coating of PLLA on a MAO layer to improve the 
corrosion resistance by sealing the microcracks and micropores in the as created coating 
[89].  The use of a composite coating to resolve the problems and shortcomings of a 
single coating process can improve the overall performance of the system.    
2.5. In Vitro Corrosion Evaluation 
2.5.1.  In Vitro Corrosion Solutions 
As noted above, the corrosion of a Mg implant will be dependent on the surrounding 
environment.  The in vivo environment is a complex place with a great many individual 
biological components, chemicals, cells and processes in play.  It is a difficult 
environment to take analytical corrosion measurements in, and can be expensive to do 
trials in, thus making it undesirable for quick screening and optimization of the coatings. 
Salunke et al. have reported coatings tested in vivo but were unable to report precise 
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corrosion rates occurring in vivo, simply that the films remained intact after 48 hours of 
implantation [28].  Similarly, Wang et al. reported better biocompatibility of CaP coated 
Mg but direct corrosion measurements were performed in vitro [64].   
Also, large numbers of tests are often needed to establish statistical significance in vivo 
due to variability between animals.  Therefore, corrosion measurements in vitro can be 
used to systematically analyze coatings and corrosion rates.  In vivo, the expected 
dominant corrosion reaction will be with H2O and Cl
-
.  These will be the direct 
participants in the corrosion reaction.  In addition to these, other ions, organic molecules 
(amino acids and proteins), and cells will be present, and may also influence the 
corrosion reaction.  The immune response may encapsulate the Mg in proteins and 
prevent corrosion [156-159], although some data has shown that proteins can increase the 
corrosion rate [160].  The effect of proteins on the ultimate corrosion rate is complicated, 
and affected by the environmental conditions [161, 162].  The exact effect and 
importance on any coating will need to be investigated in vitro in order to predict and 
understand the ultimate in vivo behaviour.   
The design of an in vitro test for corrosion assessment of coatings should not aim to 
perfectly replicate the in vivo environment. It should accurately provide a standard, 
invariant system in which the conditions that dominate the corrosion behaviour in vivo 
are built into the test design.  In the aqueous solutions, chloride ions are the most 
responsible for breaking down the passive layer [10, 11].  To measure this effect, one of 
the most common corrosion solutions for in vitro is a simple NaCl solution.  The Cl
-
 ion 
concentration in human blood plasma is around 103 mM [156], or around 0.6% NaCl by 
weight.  The Na
+
 ions act as spectators without affecting the overall corrosion reaction.  
Accelerated  corrosion tests for coatings are sometimes carried out in higher 
concentrations of NaCl, such as 3.5% [37, 41, 48, 52, 61, 146] or even 5% [29].  For 
more biological significance, tests on these coatings is done in lower concentrations of 
NaCl, either near blood plasma levels of Cl- or at the slightly higher levels popular in cell 
culture SBFs such as Hanks Balanced Salt Solution near 0.9% [46, 47, 64, 67].  The 
ability of a coating to prevent the corrosion due to Cl- is easy to measure in these SBFs.  
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As the simplest and most mechanistically relevant test, NaCl solutions account for almost 
one third of reported in vitro corrosion tests on coated Mg substrates reviewed (Figure 
2-3).   
Although Cl
-
 concentration is a significant factor for the corrosion of pure Mg, and none 
of the other common ions in human blood plasma play a direct role in the corrosion 
mechanism of Mg, a simple NaCl solution might miss some important effects on 
corrosion behavior that may be relevent in vivo.  Thus, a more complicated solution that 
better approximates the physiological fluids may be desirable for coating corrosion tests.  
Calcium, carbonate and phosphate ions by themselves do not interact with the layers 
directly, but the corrosion of Mg in solution can lead to deposition of calcium phosphates 
on the surface that retards further corrosion [2, 163].  SBFs that contain the ions present 
in blood plasma are therefore useful corrosion test solutions.  Different SBFs exists with 
varying amounts of each salt depending on the intended use (e.g. cell culture) [14, 156], 
although typically differences from physiological fluids is small.  Some popular corrosion 
test solutions reported for coating evaluation are HBSS [32, 34, 35, 53-55, 57, 60, 62, 64, 
73, 79, 85, 87, 89], and other SBFs with very similar or slightly modified compositions 
[38, 43, 47, 64, 66, 68, 83, 86].  Because some of these cell culture solutions contain 
higher Cl
-
 concentrations than found in blood plasma, and other ions are perhaps less 
important, modified formulas such as those proposed by Kokubo et al. [14] are being 
used for in vitro corrosion experiments as well[36, 45, 72, 80, 84].  Solutions containing 
the ionic salts with none of the organic components of the physiological system have the 
advantages of including the other ions found in the blood to more closely resemble the 
actual target environment.  Moreover, they do not contain the cells, proteins and other 
organic material. This negates the requirment of conducting tests in a sterile, controlled 
environment to avoid culturing bacteria and other organisms that can change the 
properties of the solution.   
The next step up in complexity from ionic solutions is the addition of organic molecules 
such as amino acids.  Standard SBFs containing amino acids for cell culture and other 
biological work can be used for corrosion tests, such as Eagle‟s Minimum Essential 
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Medium (MEM) [40], Dulbecco‟s Modified MEM (DMEM) [28, 31, 42], and similar 
solutions.  Amino acids can affect the properties of the solution such as buffer capacity 
[164] and may chelate with different ions [156].   Amino acids can also adsorb onto the 
surface of Mg alloys and create an additional barrier to corrosion [165].   
Proteins add another level of complexity of the in vitro solution to more closely represent 
the physiological fluids.  Protein interaction with the surface of implants is very 
important to the biocompatibility of the implant [166].  The interaction of these 
molecules with the surfaces can influence the corrosion rates as well [28, 42].  In the 
surveyed literature, ionic solutions of simple NaCl, slightly more complicated ionic SBFs 
or both are very common.  SBFs that also contain organic molecules are much less 
widely reported (Figure 2-3).   While the simple SBFs are very useful for corrosion 
measurements, other organic molecules can affect the ultimate corrosion behaviour, so 
these tests will need to be done to validate the results before transitioning from an in vitro 
to and in vivo model.   
 
Figure 2-3: Proportion of SBFs used to evaluate corrosion properties of protective 
coatings and surface treatments in vitro in the surveyed literature. 
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2.5.2.  Buffer Systems 
pH is a critical element to the corrosion and passivation behaviour of Mg and small 
changes in pH greatly affect the corrosion rate [167].  In vivo, this is closely maintained 
at a constant range of 7.4-7.6 by the carbon dioxide/bicarbonate buffer in the blood.  
Thus, the corrosion behaviour and coating performance should be measured within this 
range.   The passivation behaviour and corrosion kinetics change drastically with pH 
[168] as the changes in pH affect the Mg(OH)2 layer that forms on the surface.  The pH 
may also affect the chemical stability of the coating applied to the layer, and further 
change the corrosion properties.  An example would be calcium phosphate coatings that 
experience a change in stability and morphology with varying pH [134].   
The problem with corrosion being pH dependant is that the corrosion reaction itself 
changes the acidity of the solution.  The process reduces water to H2 gas and OH
-
 ions 
that will increase the pH.  The problem affects the results in vitro when this is not 
maintained at a constant level by an active mechanism such as the body‟s carbonate 
buffer system. Therefore, care must be taken when setting up an in vitro corrosion test to 
minimize the effect the pH rise has on the system.  The appropriate use of a buffer will 
help minimize the pH changes that occur during corrosion.  While many buffering agents 
can be used, the ideal buffer candidates are ones that follow these criteria: (a) able to 
maintain pH close to the physiological range; (b) should not affect the corrosion 
reactions; (c) should not interfere or change the solubility of the corrosion layer or any 
coating; and (d) should not react with, bind with, or otherwise alter the constituents of the 
in vitro solution other than the hydroxide ions to control the pH [169].   
A practical choice for a buffer in vitro is to use the HCO3/CO2 buffer, such as the one 
used in the body [170].  This buffer requires the test to be conducted in an atmosphere of 
CO2, usually 5%, to maintain a physiological pH [156]. Interestingly, the CO2 buffer 
system is not as widely used as other buffer systems in the testing of coated samples in 
vitro (Figure 2-4) [28, 31, 40, 42, 88]. However, in vitro this buffer requires a high 
availability of carbonate ions.  The influence of the carbonate rich buffer has been shown 
to slow the corrosion rates of Mg [156].  The carbonate ions have been found to deposit 
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in the corrosion layers of the Mg, thus affecting the rate [162, 169].  It is therefore of 
concern that the corrosion mechanism of the implant is not changed by using this buffer.   
An important requirement of a CO2/HCO3 buffer system is that the testing atmosphere 
must be controlled.  In order to perform in vitro tests more easily, many researchers have 
used other chemical buffers that do not require a controlled atmosphere.  Chemical 
buffers like borate, phosphate, and citric acid can be used but these do not have good 
physiological relevance [51, 168, 171].  The ideal buffers are ones that have a pKa near 
7.4 for good buffer capacity at the physiological pH and do not interact with the other 
constituents of the media [172]. Tris-(hydroxymethyl)aminomethane (TRIS) has been 
used for testing the corrosion protection of coating on Mg [32, 38, 43, 83, 86].  TRIS has 
a poor buffering capacity above pH of around 7.5, and has also been known to react with 
proteins, making it a poor choice for in vitro solutions that contain proteins.   
Zwitterionic buffers have been developed for cell cultures to meet the requirements of 
good pH control and low interaction with the media. The most popular of these currently 
were first developed by Good et al. in 1966 [172].  These buffers include MES, PIPES, 
and HEPES, all zwitterions that have good buffer capacity in the physiological range and 
low interaction with the rest of the media. Of these, the most popular in Mg biocorrosion 
studies is HEPES (Figure 2-4).  HEPES has been used as a pH control for a number of 
coating performance evaluations for biodegradable implants [34, 45, 66, 84]. HEPES, 
with a pKa of 7.55, high solubility and negligible complex interaction with the other 
biological salts is a good choice for an in vitro buffer.  
All of these chemical buffers can help resist changes in pH due to corrosion over time.  
However, these only address the problem up to the buffer capacity of the solution.  For 
Mg, which corrodes very quickly, the ratio of solution to corrosion surface area, the 
frequency the solution is replaced, and the total duration of the test must be limited to 
keep the test relevant. The corrosion behaviour changes with pH rise, and corrosion 
measurements no longer mimic the physiological environment.  For immediate 
electrochemical tests a rise in local pH as the test is conducted may affect the measured 
result, and the effect can become significant over time.  An appropriate buffer is helpful 
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in mitigating the pH rise, and extending validity to the results.  Disturbingly, a large 
number of studies on the corrosion protection of coatings did not use or did not report 
using a buffer (Figure 2-4).  The corrosion mechanism and measured rates of corrosion 
will be different if the pH is allowed to rise too much, and if it goes above 11 [47, 64] it 
will passivate the Mg [7].  When the pH is not monitored, no buffer is used, and/or the 
solution to sample ratio is low/not specified, it is difficult to have confidence that the 
reported corrosion rates will remain valid in vivo, which is the entire purpose of the in 
vitro approximation.  It is important to realize that the buffer resists pH change, but does 
not hold it constant.  A buffer will extend the time the pH stays in the desired range.  pH 
can be returned to the desired level by adding an acid to the solution to neutralize the OH
-
 
released.  Of course, the addition of the acid will affect the ionic composition of the 
solution, and certain acids are more appropriate than others.  The use of HCl to adjust the 
pH as is sometimes the case [32, 38, 43] is discouraged due to the strong relationship 
between Cl
-
 ion concentration and corrosion rate of Mg.  These studies are then simply 
trading an unphysiological pH for an unphysiological amount of Cl
-
 in the corrosion 
medium.     
Alternatively, pH and ionic concentrations can be maintained by refreshing the solution.  
In addition to causing a pH change, the amount of dissolved magnesium ions in solution 
changes the solution and corrosion reaction slightly as well [23].  Therefore, changing the 
solution can restore the solution back to the bodily concentrations of Mg
2+
.  In the body, 
there are a number of mechanisms for maintaining concentration of salts at appropriate 
levels.  Allowing the Mg to build up significantly in vitro will not be representative of the 
environment in vivo.  The solution to sample surface area ratio, the duration of testing, 
and the rate of corrosion will determine how often the solution must be refreshed.  The 
solution refresh will restore the pH regardless of the buffer type used, if any.   
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Figure 2-4: Relative usage of buffer systems used in the in vitro corrosion tests of 
coatings on Mg in the reviewed literature. 
2.6. Corrosion tests 
2.6.1.  Cumulative: Mass Loss and Ion Release 
The corrosion testing falls within two categories: cumulative corrosion tests and 
instantaneous electrochemical tests.  Cumulative tests show the amount of corrosion that 
has occurred by measuring the cumulative physical changes created by the corrosion 
reaction.  The loss in mass from the magnesium substrate is one method.  Collecting and 
measuring the volume of hydrogen gas evolved allows you to indirectly measure the 
corrosion rate by the H2 by-product of the reaction.  Additionally, monitoring the 
concentration of Mg
2+
 ions in solution will indicate how much of the substrate has 
corroded.  Measuring the pH of the solution can also indicate the level of corrosion that 
has taken place overall, but is not desirable because of the effect this has on the corrosion 
rate.  These cumulative tests show quantitatively how much corrosion has occurred since 
the beginning of the test but do not tell you anything about the mechanism or nature of 
the corrosion.  For evaluating coatings in an in vitro environment cumulative tests are 
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effective for measuring the change in corrosion resistance compared with uncoated 
samples.  As with all tests, the corrosion response will vary due to the quality of coating, 
substrate alloy, SBF used, and the duration of the immersion test.  Chen et al. reported a 
reduction in corrosion by ~67 times for a hydroxyapatite coating after 48 hours [40]. 
Zhang et al. reported the mass loss on a DCPD coating on Mg 1% Ca alloy over 3 days to 
be 4 times greater on the control than the coated sample [79].  Chiu et al. reported a 
protection factor of ~3.4 over 18 days for a fluoride conversion coating [35],  and Zhu et 
al. measured a Mg(OH)2 conversion coating with a protection factor of 1.17 after 31 days 
[55].   
Mass loss is not necessarily the best choice for the corrosion measurement of coated Mg 
in SBF because the corrosion of Mg in SBF is known to precipitate additional calcium 
phosphates on the substrate [63], thus making the mass measurements difficult to do 
precisely unless the coating is removed completely.  Chromic acid is useful for calcium 
phosphate coatings as it can dissolve these ceramic coatings while leaving the substrate 
relatively uncorroded [23].  The cleaning methods will depend on the alloy, the coating, 
and the corrosion solution, so the chemistry of the coating and the underlying substrate 
must be considered before using acid removal techniques such as this.  As Zhu et al. 
found over 31 days of corrosion testing, the corrosion rate for the coated and control 
samples varied considerably [55].  This illustrates the importance of monitoring the 
corrosion rate over time for these coated samples.   
Selective ion measurement has been used to calculate the total Mg
2+
 ions released to 
solution [156]. However, this omits the Mg incorporated into the corrosion layers of 
magnesium hydroxides, carbonates or phosphates.  Also, the increase in Mg
2+
 ions if the 
solution is not periodically refreshed and allowed to remove these ions, will affect the 
corrosion potential with the solution according to the Nernst equation [173].  Mg ion 
measurement also measures the total amount of corrosion, but does not reveal details 
about the mechanisms.   
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2.6.2.  Cumulative Corrosion tests: Hydrogen Evolution 
The next most common cumulative corrosion test is the measurement of hydrogen gas 
evolved, commonly referred to as hydrogen evolution tests [174].  H2 evolution tests 
capture the gas evolved from the cathodic half of the corrosion reaction.  Because 
stoichometrically the amounts of H2 generated is linked to the amount of oxidized Mg, 
this is an indirect method for measuring the total amount of corrosion.  This measurement 
can be monitored continuously, without the need for removing the sample from the 
solution.  To perform the test, the sample is immersed in the corrosion solution. A funnel 
and burette are filled with solution, then inverted over the immersed Mg to collect the gas 
evolved.  As long as the gas is completely captured and no other sources or sinks of H2 
gas are present other than the measurement apparatus, this method can be an accurate 
corrosion measurement.  Also, since the volume of H2 generated is of concern to the 
surrounding tissue when implanted in vivo [1, 2], this method provides direct 
measurement of the hydrogen generation rates, something that will be necessary to 
optimize if these degradable implants are to be used in vivo .  H2 generation tests have the 
same limitations as other cumulative tests such as mass loss, which is they do not provide 
mechanistic data, or any information regarding where the corrosion is occurring.  Thus, 
cumulative tests must be supplemented with electrochemical methods.   
 
2.6.3.  Electrochemical corrosion tests 
Electrochemical tests can be used to examine the instantaneous rates of reaction 
electrochemically.  Methods such as potentiodynamic polarization (PDP) and 
electrochemical impedance spectroscopy (EIS) are used to estimate the electrochemical 
properties, as these are difficult to measure directly.   
 
39 
 
2.6.3.1. Potentiodynamic Polarization: 
PDP works by polarizing the sample and measuring the current of the half reactions at 
various potentials, then extrapolating to estimate the corrosion current density.  A PDP 
scan starts at a potential below the open circuit potential (OCP), forcing the cathodic half 
reaction to dominate, and scans at increasing potential until some point higher than the 
OCP.  The corrosion current density can be estimated by extrapolating from the Tafel 
slopes of each line [175].  Since the potential will be held at voltages much higher than 
OCP, the anodic reaction will be forced to occur at high currents during the test, which 
for active metals such as magnesium means the surface can become severely corroded.  
This can change the corrosion layer, surface roughness, and surrounding solution pH over 
the test.  The test is therefore considered to be destructive to the sample.   
PDP is quite popular, showing up in many of the reviewed papers on coating corrosion 
measurements (Figure 2-5).  PDP has the disadvantages of being a destructive test, since 
the test can change the substrate significantly.  PDP is also an extrapolation, and 
obtaining a corrosion current density relies on the fit of linear Tafel slopes.  If the 
behaviour is nonlinear, it is possible the estimated current density will have a great 
degree of variability.  As an example, if the literature surveyed here is limited to the 
studies using pure Mg substrates, and PDP tests in some type of SBF, we can see large 
variations across the control samples.  Measured pure Mg corrosion rates can vary from 
0.1 to 1430 µA/cm
2
.  This is a very large variation for similar materials in SBFs.  Purity, 
SBF composition and measurement parameters are responsible for the variations.  
However, some consistency should be expected if these in vitro tests are designed to 
identify corrosion rates by accurately simulating the in vivo environment.  Since testing 
parameters vary so widely, the coatings will be presented here by comparing the ratio of 
the corrosion rate of the uncoated control sample of a given alloy over the coated sample.  
This will allow a somewhat direct comparison of the quality and integrity of the coatings 
across the various tests and substrates in the literature.   
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2.6.3.2. Electrochemical Impedance Spectroscopy: 
EIS is a technique particularly suited to measuring the performance of coatings [175].  
The technique uses the same three electrode setup as PDP.  A small AC signal (on the 
order of 10mV) is used to polarize the surface and the resulting impedance of the system 
is measured.  The signal frequency is varied to obtain a frequency response curve that is 
representative of the coatings and corrosion layers of the sample.  The resulting curves 
shed light on to the behaviour of the corrosion layer, and the resistance to corrosion 
provided by the coating.  This can be related to the thickness, coverage, and porosity of 
coatings, making it very useful to identify the relative effect and mechanism of corrosion 
protection provided by different coatings and surface treatments.  EIS is also a non-
destructive technique, or more precisely minimally destructive technique.  Due to the 
small potentials applied, the impressed currents and thus the imposed oxidation of the 
substrate is much smaller than a typical PDP scan.  As such, multiple EIS scans can be 
taken on the same sample with minimal change to the sample due to the measurement.  
Therefore, multiple scans taken over intervals can be used to monitor the changes in the 
corrosion behaviour over time.  The benefits of the EIS methods for coated samples make 
it quite a useful test, which is gaining popularity for coatings aimed at Mg implants 
(Figure 2-5).    
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Figure 2-5: Relative usage of corrosion test type to evaluate coating performance in the 
literature. 
2.7. Review of Corrosion Protection Properties of Coatings 
Assessed in the Literature 
Many different coating systems have been studied to show corrosion protection in the 
literature.  These use different coating types, performed with different application 
techniques, on different substrates, tested in different corrosion solutions.  With the great 
variety of experimental techniques, it is unsurprising that the reported results vary to such 
a great extent.  To show some of the variation present amongst the experimental results 
the substrates of those using some type of pure Mg and the AZ31 alloy across the 
literature were compared. Of these tests that used PDP as a corrosion rate measurement 
technique the measured corrosion rates of the uncoated control samples are shown in 
Figure 2-6 A.  These tests were all performed in simulated body fluids, attempting to 
simulate the body, with the same alloys.  The results across the literature span two orders 
of magnitude, highlighting the variation the test parameters can create.  A similar trend of 
the resistance of pure Mg using EIS was observed (Figure 2-6 B).  The fact that even 
similar substrates across in vitro studies are so different makes comparing the provided 
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protection by the coatings quite difficult across samples.  It should not be surprising 
therefore that in vitro tests corrosion rates are so different than the rates in vivo [156, 162, 
176]. Clearly identifying the relative corrosion rates in vitro will require more 
understanding of the environment than using a standard SBF and hoping for the best.    
In spite of these variations, the comparisons can at least be estimated as a corrosion 
protection factor (CPF).  Substrates and test solutions that lead to lower corrosion rates 
will generate coating results with lower corrosion rates than those with high corrosion 
rates to begin with.  The assessment of the properties of the coating should thus be 
normalized to the control sample used.  Therefore, the protection factor is defined as the 
rate of the uncoated substrate divided by the coated sample.  Higher coating protection 
factors should in theory indicate more protective coatings, i.e. a corrosion protection 
factor of 1 indicates the coating provide no more protection than a bare sample, and a 
corrosion protection factor of 100 says the rate of corrosion is 100 times slower when the 
coating is applied.  This also solves the problem of directly comparing different test types 
by converting them numerically to a unitless value.  This is a rough comparator, as the 
effect of corrosion solutions, test types, and buffers will provide sources of error and 
inconsistency, but the CPF will indicate something about the landscape of the literature.   
Figure 2-7 shows the CPF of different coating types reported in the literature at the latest 
timepoint measured.  The majority of the tests are performed immediately or within a few 
hours, with fewer tests reported over longer durations.  The highest protection factors are 
shown initially, whereas longer timepoints show decreased CPFs.  The decrease will be 
important in identifying a coating that can last over time.  For example, anodized coatings 
have been tested with high initial CPFs, but there are few long term tests.  For an oxide 
coating, which is not stable in SBF, making sure the coating protects for the required 
amount of time will be crucial.  Fluoride conversion coatings, as well as composite 
coatings of multiple types have been shown to exhibit long term corrosion protection.  
Again, these ratings can be somewhat suspicious depending on test type. The corrosion 
solutions, buffer systems, and experimental methods vary greatly across the literature, 
making it difficult to say with confidence how relevant and related these reported factors 
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are. Other factors will be at work as well.  In order to fully understand the protection 
mechanisms of the coating, and predict its performance in vivo, understanding the 
parameters of the in vitro tests will be critical to obtaining valid corrosion data in vitro.   
 
Figure 2-6: Box plots of available control samples for in vitro evaluation of coatings by 
PDP (A) and EIS (B). 
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Figure 2-7: Coating protection factors calculated at the longest reported immersion time 
for different types of coatings. 
2.8. Research Aims 
The above review of the literature highlights some significant gaps in the knowledge and 
design process of corrosion resistant coatings and surface treatments for biomedical Mg.  
A multitude of coating types and processes has been examined by a number of different 
methods.  However, the corrosion behaviour is highly dependent on the test environment, 
which must be carefully controlled if meaningful data about the corrosion mechanisms in 
vivo is to be collected.  This means the coating protection must be studied in solutions 
where the pH, buffer system, ionic composition, and organic inclusions of amino acids 
and proteins.  These components should be looked at individually in order to understand 
the complex system as a whole.  The in vitro test environments must be kept consistent in 
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assessing the corrosion performance across multiple coating systems, alloys, and 
immersion times. This is necessary in order to properly understand the behaviour of the 
corrosion protection of the coating.  The variation in in vitro tests reported across the 
literature is large.  This is true even when using the same alloys.  With the control 
samples differing by orders of magnitude, the comparison and ultimate predictions of in 
vivo behaviour is not possible.  Hence, the first step is to construct and identify the 
parameters important in vitro for testing the corrosion resistance of the coatings.   
The corrosion protection system for Mg biomaterials must meet a number of criteria for 
biomaterials applications.  The amount of corrosion protection provided will be the key to 
optimizing Mg implants.  The coating must provide corrosion protection, but also be able 
to degrade after the implant has performed its function.  Completely or extremely 
insoluble coating products like titania or hydroxyapatite may cause problems if they 
persist after the underlying substrate has degraded.  The degradation products must also 
be fully biocompatible, as they will end up inside the bloodstream of the patient.  The 
biocompatibility and bone growth onto the implant is also important, and should be 
optimized if at all possible.  Thus, corrosion inhibitors that have not been shown to be 
biocompatible are suspect, such as aluminium, or rare earth elements that have not been 
thoroughly investigated in the longer term following implantation.   
The coating system is also important, as the properties of Mg and the implant shape will 
limit the choices of deposition.  The ideal coating must be processed at low temperatures 
and suitable environments due to the melting temperature and reactivity of Mg.  The final 
implant shape may need to be a porous or complex-shaped structure, which cannot be 
coated completely or uniformly by techniques requiring line of sight.  The use of toxic or 
non-biocompatible precursors and intermediate chemicals during the coating process is 
not inconceivable, but these must be completely removed before the device is implanted.  
If the coating process can avoid this concern it will be beneficial.   
A coating system in the literature that meets the desired criteria is the biomimetic coating.  
This coating type has been well documented recently for its biocompatible properties on 
titanium implants, but has received little attention for Mg.  It is biocompatible, imitates 
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natural bone structure, and contains no elements or structures not found in the body 
anyway.  The process is done at body temperature, and is coated in simple solutions that 
contain no elements that are not found in physiological fluids.  The solubility of the 
phases is similar to natural bone, and thus more insoluble than Mg, and thus can be 
protective under corrosion conditions, yet less insoluble than the HA used on permanent 
Ti implants.  The biocompatibility and osteogenic properties of biomimetic coatings have 
already been proven by numerous tests on Ti, which gives us confidence that it will be 
just as useful in promoting bone growth on degradable implants.  The gap in the 
knowledge is the corrosion properties, as the corrosion protection of Ti has not been a 
design requirement of the coatings.   
The work that follows will investigate the formation mechanisms of these coatings on Mg 
substrates, and examine the effects of surface conditions, process parameters and 
conditions effect on the corrosion protection properties of these coatings.  The corrosion 
performance and protection in multiple in vitro solutions will be examined to determine 
what, how and why the coatings corrode and protect Mg substrates.   
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CHAPTER 3:  Buffering in vitro Solutions for 
Corrosion Testing 
3.1. In vitro Corrosion Measurement of Mg 
Magnesium and its alloys in general have low corrosion resistance, which is important for 
metal implants given the very aggressive environment in the physiological system [1].  
Because it is difficult to measure corrosion rates precisely in vivo, in vitro methods for 
researching corrosion rates and corrosion protection methods will be required.  The challenge 
with creating an in vitro test will be to accurately simulate the relevant corrosion environment 
found in vivo.  A good in vitro approximation will be one that correctly models the 
mechanism of corrosion that will be expected in vivo as well as the rate.  The mechanism and 
the corrosion layers that form need to be able to be assessed accurately and consistently.  
Ultimately, the aim of developing an in vitro model is also to reduce the cost of screening 
new alloy and coating systems, so ideally this should be accomplished simply and easily.   
The pH is a critical factor in the corrosion and passivation mechanisms of Mg [2]. Therefore 
pH control is essential for the design of an in vitro corrosion model.  As discussed in Chapter 
2, many studies that evaluate coatings in the literature for corrosion resistance fail to control 
the pH.  The resulting corrosion data is therefore only valid for an unknown pH, which is not 
necessarily biologically relevant.  In order to accurately test some of the corrosion properties 
and resistances in vitro, the in vitro pH must be controlled.  A buffer will provide a pH 
moderator to keep these tests in the appropriate range.  While various buffer systems are 
reported for in vitro biocorrosion tests [3], it is not clear which buffers are the most 
appropriate, and what the effect of the buffer is on the corrosion rate of Mg in SBF.  Thus, a 
detailed investigation into some of the most relevant buffer systems for in vitro tests was 
conducted with the intent of elucidating the effect of the buffer properties on the corrosion 
reactions of Mg.   
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3.1.1.  The Corrosion of Mg 
The corrosion rate of any metal is dependent on the environment to which it is in contact.  
While the corrosion reaction of metallic Mg is thermodynamically favourable in body fluids, 
the corrosion rate is dependent on a number of factors.  One important aspect is the pH [2, 4, 
5]. The corrosion reactions of Mg in aqueous solutions are very dependent on pH, and are 
given in Equation 3-1 to Equation 3-3.       
Mg(s) → Mg
2+
(aq) + 2 e
-
  Equation 3-1 
2 H2O(l) + 2 e
-
 → H2(g) + 2 OH
-
(aq) Equation 3-2 
Mg
2+
(aq) + 2 OH
-
(aq) → Mg(OH)2(s) Equation 3-3 
The dissolution of Mg must be accompanied by the reduction of either H
+
 (which actually 
exists as H3O
+
 in solution) or H2O to produce H2 gas.  Reducing H
+
 takes less energy than 
reducing H2O so the pH, or total concentration of H
+
 with respect to H2O directly impacts the 
kinetics of the net corrosion reaction.  The oxidized Mg can form the relatively insoluble (in 
water) precipitate Mg(OH)2.  The layer that forms protects the substrate from further 
oxidation and reduces the corrosion rate.  However, this layer is attacked by Cl
-
 ions, thus 
preventing Mg from fully passivating in Cl
-
 solutions [6]. With the high Cl
-
 content of 
physiological fluids, the Mg(OH)2 layer does not fully protect Mg in vivo, and corrosion takes 
place. The formation and solubility of Mg(OH)2 depends on the concentration of OH
-
 in 
solution.  Therefore, when measuring the corrosion rate for estimating corrosion 
performance, the pH must be known.  If the corrosion mechanism is to be studied, the pH 
must be kept at the conditions to be investigated, otherwise the mechanism can change due to 
the relative passivation [7] or deposition of insoluble coating products [8].  If absolute 
corrosion rates are to be compared, in the instance of alloys or coatings designed to slow the 
corrosion rate, the pH must be uniform across the tests.  The measurement and control of pH 
will therefore be critical to measuring corrosion rates of Mg in in vitro solutions with 
accuracy and reproducibility.   
The pH in physiological systems is dynamically regulated, with pH in most body fluids kept 
in the range of 7.4-7.6.  Due to the chemical interactions required in vivo, it critical that the 
pH does not stray too far from these ranges.  As such, the regulatory mechanisms of the body 
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actively compensate for this [9].  This is done with the carbonic acid/bicarbonate buffer.  The 
generation of bicarbonate ions from metabolism is regulated and compensated by releasing 
this as CO2 gas in the lungs [10].  The net reaction is given in Equation 3-4: 
CO2 + H2O  H2CO3  HCO3
-
 + H
+
  Equation 3-4 
By Le Chatelier‟s principle, the removal of CO2 gas increases the pH as the equilibrium is 
restored through the removal of carbonic acid.  When CO2 is retained by the body, the 
equilibrium is shifted the other way, producing more H
+
 and lowering the pH.  This 
mechanism reacts to keep the pH fairly constant.  Thus, in vivo it is expected that the pH of 
the surrounding fluids will be within this range, and the corrosion will reflect this.  The pH 
directly at the surface of the substrate will depend on the diffusion rates of solution in the 
body.  But overall, the environment for biodegradable implants is expected to be pH 
regulated.   
Biodegradable Mg devices are intended to be used in vivo.  One may assume therefore, that 
corrosion tests should simply be carried out in vivo.  But there are a number of problems with 
this specific to Mg corrosion and coatings that arise.   
 Expense:  It is very expensive to perform surgeries necessary to implant 
devices.  Maintaining the housing and care needed for animal studies is a large 
cost.   
 Variability: Every animal will have unique properties, and slightly different 
chemistry, depending on genetic and environmental factors.  While these can 
be minimized by using genetically similar animals and doing trials over a large 
number of statistical samples, this increases the costs.   
 Environment:  Even when the proper care is taken to prevent variation from 
affecting the results, the environmental variables cannot usually be separated 
from one another.  It is not possible in vivo to study the effect of individual 
components, rather the system as a whole must be used.   
 Absolute measurements: Corrosion rate can be compared after device removal 
by mass loss. But this gives only a bulk measurement of corrosion.  In general, 
monitoring the rate over time becomes problematic.  Electrochemical tests are 
difficult to perform in vivo. 
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 Ethics:  If a new coating fails to perform, the resulting corrosion can cause 
discomfort to the animal.  Therefore, a method of screening these before hand 
is required.   
Consequently, corrosion and mechanistic studies are performed in vitro [3].  This allows the 
simplification of the environment such that effects of individual components may be 
measured.  Unfortunately, this removes the active buffer control system that is present in 
vivo.  As Mg corrodes in a finite volume of solution, this results in the generation of H2 gas 
and the production of OH
-
.  Therefore, the pH will increase [7].  The electrochemical 
behaviour of Mg is highly sensitive to alterations in pH [5].  If the pH increases outside of the 
range 7.4-7.6 the reaction kinetics and mechanisms will no longer be physiologically 
relevant.  Steps that can be taken to mitigate this may include:  (i) short immersion times; (ii) 
large solution volume to sample surface area ratio; (iii) frequent solution refreshment; (iv) the 
use of buffering agents.   
Limiting tests to short immersion times can help reduce the corrosion reaction that takes 
place, and thus the pH change that occurs, but corrosion tests should in practice have some 
time to allow the surface layers to settle and the reactions to take place [11].  Electrochemical 
tests can be done relatively quickly for Mg.  It has been reported that Mg in SBF needs 15 
minutes for the electrochemical double layer (EDL) to settle [12].  A potentiodynamic 
polarization (PDP) scan can be done in a matter of minutes, as can electrochemical 
impedance spectroscopy (EIS).  For bulk corrosion tests such as mass loss and H2 evolution, 
it is necessary that corrosion take place to an extent that it can be measured.  Thus, some 
corrosion will have to occur.  The limitation of time before the pH is out of the range 7.4-7.6 
is dependent on corrosion rate.   
The rate of pH rise will also be dependent on the ratio of sample area to solution volume.  In 
general, larger volume of solution will mean a greater amount of OH
-
 from the corrosion 
reaction can be generated before the pH moves outside of the range.  Apparatus geometry is 
often a limiting factor for solution volume.  Alternatively, replacing the solution with new 
solution is a possible method to combat pH rise.  This also can be used to replenish salts that 
have deposited due to the corrosion reactions.  However, although these methods are valuable 
for corrosion testing, a buffer system that can resist changes in pH, providing some active 
control similar to that found in the body, will be necessary as well.   
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The obvious choice to replace the control mechanism of the body‟s buffer is to use a buffer 
system in vitro as well.  A chemically similar CO2/HCO3 buffer has been used for in vitro 
tests [13-15] as well as a number of chemical buffers [16-18].  Many of the chemical buffers 
used for this type of work use or are based on the 12 Good‟s buffers formulated to have 
properties ideal for in vitro solutions [19].  These buffers are designed for use in biological 
work, and thus possess suitable properties for biological solutions.  However, use of a 
chemical buffer system in vitro is quite different to the environment in vivo.  Thus, if these 
buffers are to be used for corrosion measurement, the effect of the buffer on the corrosion 
reaction must be understood.  The effect the buffer has on the local pH level, the relative 
formation/dissociation of Mg(OH)2 in a Cl
-
 environment, and the interaction with other salts 
in the in vitro solution must be known.  To compare the performance of these buffers over 
time for analytical corrosion tests in vitro, the changes to corrosion kinetics of pure Mg 
exposed to various buffers was assessed under in vitro conditions.   
3.2. Buffer Assessment: 
  Six different buffers were chosen in this study to examine the effect that different buffers 
might have.  In the reviewed literature, the most commonly reported buffers for the corrosion 
testing of coated Mg in vitro were 2-Amino-2hydroxymethyl-propane-1,2-diol (TRIS) [17, 
20-23], carbon dioxide and bicarbonate (hereafter referred to as bicarbonate or HCO3) [15, 
24-27], and 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) [16, 18, 28, 29].  
As HEPES is one of the 12 Good‟s buffer designed for cell culture work, other Good‟s 
buffers 2-(N-morpholino)ethanesulfonic acid (MES), piperazine-N,N′-bis(2-ethanesulfonic 
acid) (PIPES), and N-(2-Hydroxy-1,1-bis(hydroxymethyl)ethyl)glycine (Tricine) were 
investigated as well [19].  The structure of the buffers is shown in Figure 3-1 and some 
relevant physical properties in Table 3-2.   
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Figure 3-1: Chemical structures of the buffers used in this study. 
3.2.1.  CO2/HCO3
-
 
The CO2/bicarbonate buffer is commonly used for in vitro cell culture work to control pH 
[13].  The buffer is prepared by adding sodium bicarbonate to the SBF and keeping it in an 
atmosphere of CO2, typically between 5 and 10%.  The carbon dioxide in the atmosphere 
affects the equilibrium reaction between carbonic acid and bicarbonate to balance the pH near 
physiological conditions according to Equation 3-4.   
This buffer system is the system that controls the pH of the blood, through controlling the 
production of carbonates through metabolism and the gas exchange through the lungs.  As it 
is chemically equivalent it provides a good choice for replicating the in vivo conditions in 
vitro.  The buffer does require the CO2 atmosphere to be controlled, necessitating the use of 
an incubator or similar equipment.  In vitro evaluation of Mg and Mg coatings often makes 
use of this system [15, 25-27].  Setting the pH of this buffer to the desired starting level 
(7.40) is done by tuning the CO2 gas level to the appropriate amount to reach the desired 
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equilibrium.  In this study ~5% CO2 was used, adjusted to reach a starting pH of 7.40 ± 0.01 
for each solution.   
3.2.2.  TRIS 
TRIS is a compound that has been widely used in biology and cell culture work due to its 
effectiveness near physiological pH.  The useful buffer range of TRIS is 7-9.  It is a primary 
amine, and will thus undergo reactions as such, for example condensation with aldehydes.  
The use of TRIS for in vitro Mg corrosion is fairly common in the literature [17, 20-23].  
Unfortunately, in these studies the acid form TRIS-HCl is often used, or the base form with 
added HCl to bring the pH down to the appropriate level (7.4).  Due to the sensitivity of Mg 
corrosion to Cl
-
, the addition of HCl to the SBF is not desirable.  For the purposes of this 
study, HNO3 was chosen to bring the pH down from the initial pH of about 10 to 7.4.  As a 
monoprotic strong acid, nitric acid will not introduce an additional pKa and change the 
buffering capacity of the solution.  Although the nitrate ion is not present in large amounts in 
biological solutions, it is a spectator ion that is not expected to interact with the corrosion 
reactions or the salts of the SBFs used here.   
Although popular for biological tests, TRIS is known to inhibit some enzymes and should be 
used with care if proteins are to be present in the SBF [30].  TRIS is reported to cause 
problems with silver chloride electrodes due to Ag precipitates clogging the junction [31].  
Thus, for this study, saturated calomel electrodes (SCE) were used.   
3.2.3.  Good’s Buffers 
The zwitterionic buffers that Good et al. presented in 1966 were designed specifically to 
overcome some of the problems with existing biological buffers.  Among the criteria used for 
these was to have pKa‟s at values where the buffering capacity is high at physiological ranges 
(i.e. between 6 and 8), should be highly soluble in water, should not cross biological 
membranes, should not interfere with, or bind to, metal ions, and should be stable under the 
conditions used.  Because zwitterions fit the criteria well, Good designed an array of 
zwitterionic buffers for biological use.  Of the 12 Good‟s buffers, HEPES seems to be the one 
most used for Mg corrosion protection evaluation [16, 18, 28, 29].  The pKa of HEPES leads 
it to be used commonly for solutions at a pH of 7.4.  In this work, HEPES and selected other 
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buffers with chemical structures similar to HEPES and TRIS were selected with slightly 
different properties in order to examine the effect of these differences on the corrosion 
reactions of pure Mg in vitro.   
3.3. Materials and Methods 
3.3.1.  Substrate Material 
Pure Mg (99.98%, Timminco, Canada) was used for all tests.  The Mg was ground with 600 
grit SiC paper, rinsed with ethanol (96%) and allowed to dry in air.   
3.3.2.  Electrochemical Tests 
Electrochemical tests performed included potentiodynamic polarization (PDP) and 
electrochemical impedance spectroscopy (EIS).  A three electrode setup was used with a Pt 
counter electrode and a saturated calomel reference electrode (SCE).  300 mL of solution was 
used for each test, and the area of the working electrode was 1 cm
2
.  The solutions, cell and 
electrodes were heated to 37° C prior to the start of each test, and held at that temperature for 
the entirety of the test.   
PDP was used to examine the corrosion kinetics.  PDP scans for all samples were carried out 
from -150 mV vs. OCP to +200mV with a current limitation of 1 mA/cm
2
.  The scan rate 
during PDP was 1mV/s.  Samples were allowed 30 min of stabilization in solution at open 
circuit for the first round of PDP tests, and allowed to freely corrode for 8 hours for the 
second round.  For each solution and time point, 5 samples were tested with PDP to identify 
the range of uncertainty associated with the solutions and the Tafel fit approximations.   
EIS was tested at a rate of once per hour starting after 2 hours of stabilization to up to 8 
hours.  A sinusoidal 10mV peak to peak signal across a frequency range from 50 kHz to 20 
mHz was used.  
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3.3.3.  Buffered Solutions 
Two solutions were used for electrochemical tests.  103 mM NaCl was used as a simple SBF 
to test only the effect of the Cl
-
 at physiological levels and the buffering agent on the 
corrosion rate of pure Mg. The second solution was a standard formulation of Hank‟s 
Balanced Salt Solution (HBSS) (Sigma-Aldrich).  The total concentration of Cl
-
 in this 
solution is higher than physiological solutions (Table 3-1).  However, this is used quite 
commonly in the literature for corrosion measurements, and is therefore a solution of interest 
[32-37].  This solution contains other inorganic salts such as found in the body, without 
proteins or cells.  In this way, only the interactions of the corroding Mg with the buffer in 
question are studied, without complications of proteins and other organic molecules which 
may affect the outcome.  For more complicated in vitro tests, such interactions should not be 
overlooked.  However, for this study these are eliminated.   
Each solution had the buffer added to the correct molar concentration, and was then balanced 
to pH of 7.40 ± 0.01 at 37° C.  For HCO3 buffered solutions this was done by calibrating the 
CO2 atmosphere (5%) to reach pH = 7.40. The remaining buffers were titrated using 
additions of either 1M NaOH (HEPES, MES, PIPES, TRICINE) or 1M HNO3 (TRIS).  
HNO3 was chosen because it is a monoprotic strong acid, and will therefore not add an 
additional pKa to interfere with the buffer capacity.   
The zwitterionic buffers are not expected to contribute to the ionic strength and conductivity 
of the solutions by themselves [38], but once protonated/deprotonated, they carry a charge 
and can affect the solution resistance.  The concentration deprotonated will be equal to the 
concentration of dissociation at the pH of 7.4 for each buffer.  Solution conductivity was 
tested with a conductivity meter at 37° C for each buffer solution. 
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Table 3-1: Composition of simulated body fluids used in this test compared to Human Plasma   
Component 
 
 
Human 
plasma 
(HP) 
NaCl 
Solution 
Hank’s 
balanced salt 
solution 
(HBSS) 
Na+ 142 103 145 
Cl- 103 103 144.6 
K+ 5.0 - 5.8 
Ca2+ 2.5 - 1.3 
Mg2+ 1.5 - 0.4 
HPO4
2- 1.0 - 0.8 
SO4
2- 0.5 - 0.4 
HCO3
- 22-30 - - 
D-Glucose 5 - 5.5 
Phenol red - 0.03 0.03 
    
All concentrations in mM  
Concentrations of inorganic blood plasma given as in 
Ref [39]. 
 
 
3.4. Results and Discussion 
3.4.1.  Theoretical Buffer Capacity 
The buffer capacity was estimated and plotted for each buffer at concentrations specified at 
pH of 7 to 8 (Figure 3-2).  A HCO3 concentration of 26.2 mM under 5% CO2 atmosphere was 
used as this is standard for cell culture work [13].  HEPES is generally used at concentrations 
of 25mM to provide a balance between pH for cell culture work without harmful effects to 
the cells.  25mM was chosen as the concentration for all other buffers for consistency.  While 
all of these buffers are used for biological conditions, the differences in pKa will result in 
different buffer capacities, which will be important for the amount of pH control over time. 
The buffer capacity is a representation of the change in pH for a given addition of strong acid 
or base and is calculated using Equation 3-5 where Kw is the dissociation constant of water, 
Ka is the acid dissociation constant of the buffer at 37˚ C, and Cbuf is the concentration of the 
buffer in solution. The physical properties and concentrations of these buffers that were used 
in the calculation are listed in Table 3-2. 
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Equation 3-5 
 
Table 3-2: Physical properties and concentrations of buffers 
Buffer Mmass 
(g/mol) 
Conc. 
(mM) 
pKa1 @ 
37° C 
pKa2 
HEPES 238.3 25 3 7.31 
MES 195.2 25 5.97  
Tricine 179.17 25 2.3 7.8 
PIPES 302.37 25 6.7  
TRIS 121.14 25 7.9  
HCO3 84.01 26.2 6.3 10.3 
 
Buffer capacity, , is greatest when the pH of the solution equals the pKa of the buffering 
agent. HEPES has the highest buffer capacity at pH of 7.4.  HCO3 overcomes only MES as 
the weakest buffer, due to the pKa1 at 6.3.  The HCO3
-
 ion, while important for the body as a 
buffering agent, is not the only mechanism that comes into play.  Within the body is an active 
regulation system that can alter the partial pressure of CO2 gas through the lungs, and can 
vary the amount of HCO3
-
 released through metabolism of organic molecules [9, 10].  Thus, 
the total carbonate at a specific body location is not static.  However, the buffer under a CO2 
atmosphere will have a mechanism for exchanging carbonate external to the corrosion cell in 
vitro as well.  Thus the total concentration of HCO3
- 
will be affected by the gas exchange 
with the atmosphere, altering the buffer capacity and pH.   
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Figure 3-2: Theoretical buffer capacity, ,  from pH 7 to 8 of each buffer used in this study at 
the given concentrations in Table 3-2.   
 
3.4.2.  Solution Resistance 
Figure 3-3 tabulates the solution resistance of each buffer once buffered to capacity.  The 
solution resistance varied with buffer choice.  This was due to the additional ions added to 
bring the pH of the solution to 7.40 at 37° C.  The solution conductivity in HBSS was higher 
than NaCl in every case due to the additional ions present in the solution. .  The total current 
between the working and counter electrodes will be affected by the solution resistance due to 
these differences in solution conductivity.  This opens the possibility that the measured 
current densities, and therefore the extrapolated iCorr calculations will have some error 
introduced when comparing across different solutions [11].  From Figure 3-3, it was 
determined that the conductivity difference between buffers was smaller than the difference 
between HBSS and NaCl.  Therefore the effect on the corrosion rate, especially with the large 
surface area for the counter electrode, should be minimal.  Therefore the differences here are 
ignored.  This is fairly good assumption as the EIS later will show that the uncompensated 
solution resistance for each buffer is small compared to the charge transfer resistance of the 
metal-solution interface.   
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Figure 3-3: Solution conductivity of buffered solutions in NaCl and HBSS at 37° C. 
3.5. Electrochemical Response 
3.5.1.  Bicarbonate Buffer 
The measured corrosion potentials (ECorr) of pure Mg with the bicarbonate buffer were lower 
in NaCl than HBSS as seen in Figure 3-4A.  The amount of the salts, particularly the Mg
2+
, 
increases the potential in HBSS from that of a simple NaCl solution.  For both solutions, ECorr 
rises over the 8 hours, in part due to the release of additional Mg
2+
 from the corrosion. The 
bicarbonate itself has a certain buffer capacity, thus as corrosion occurs the pH will rise and 
the corrosion will slow.  The corrosion current density (iCorr) of the HCO3 (Figure 3-4B) 
drops dramatically with time in NaCl.  This is due to the passive layer that forms as pH 
increases [40].  The corrosion rate compared to other buffer systems remains quite high.  
HCO3 buffered systems in NaCl have higher anodic kinetics than all other buffers at both 30 
minutes (Figure 3-5) and 8 hours (Figure 3-6).   
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Figure 3-4: Electrochemical PDP results A)  ECorr and B) iCorr for all buffered systems of NaCl 
and HBSS at 30 minutes and 8 hours. 
Figure 3-9F shows that in NaCl, from 30 min to 8 hours the cathodic kinetics are very 
similar, as the thin, nonconductive Mg(OH)2 and MgCO3 layer does not impede the charge 
transfer to form hydrogen gas.  There is also a small decrease in anodic kinetics, that is 
responsible for the decrease in iCorr.  The behaviour in HBSS showed a slight cathodic 
decrease and a large anodic decrease. Due to the nature of the solution, the protection layer 
was much more effective.  The coating impedance in NaCl shows a small two time constant 
impedance curve characteristic of a semi-protective hydroxide layer that formed after 30 
minutes (Figure 3-10A) that grew but remained similar in composition  after 8 hours of 
corrosion (Figure 3-10B).  The impedance in HBSS was quite different (Figure 3-11).  Here 
the secondary time constant is very large, indicative of a highly protective coating layer.  
Rather than the semi-soluble Mg(OH)2 and MgCO3 layers formed in NaCl, the layer is near 
complete, severely limiting the diffusion of corrosive solution to the Mg metal, and reducing 
the anodic dissolution.  The pH of the solution is just high enough that with Mg corrosion, the 
calcium in solution can form a protective layer of CaCO3 and/or CaHPO4 that further 
protected the substrate.  This accounts for the great disparity in corrosion properties between 
these two SBFs.  This greater protection in HBSS is in spite of the increased Cl
-
 content of 
the HBSS over the simple NaCl solution.   
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Figure 3-5: Polarization of Mg in buffered NaCl solutions after 30 minutes immersion. 
 
Figure 3-6: Polarization of Mg in buffered NaCl solutions after 8 hours immersion. 
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Figure 3-7: Polarization of Mg in buffered HBSS solutions after 30 minutes. 
 
Figure 3-8: Polarization of Mg in buffered HBSS solutions after 8 hours. 
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Figure 3-9: PDP over time of Mg in buffered solutions of both NaCl and HBSS with A) 
HEPES, B) MES, C) PIPES, D) Tricine, E) Tris, and F) HCO3.  
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3.5.2.  TRIS Buffer 
The next common buffer agent TRIS displayed a relatively high potential in NaCl that 
increased slightly over the 8 hour test, staying well within the error.  The initial corrosion 
current density increased from 78.7 ± 26 to 121 ± 40 µA∙cm-2.  The rise was due to the 
increase in surface area from pitting as corrosion occurred.  TRIS had one of the largest 
cathodic kinetics of any buffer in NaCl at both 30 minutes (Figure 3-5) and 8 hours (Figure 
3-6).  Similarly high cathodic kinetics were seen in HBSS (Figure 3-7, Figure 3-8).  In HBSS, 
ECorr and iCorr both changed significantly from 30 min to 8 hours.  This suggests that perhaps 
the corrosion layer has not fully settled after 30 minutes in this solution despite the open 
circuit potential (OCP) settling to a constant value.  The shift in corrosion potential was not 
accompanied by major shifts in kinetics of either reaction (Figure 3-9E).  The corrosion over 
time in the solutions is therefore not varying due to large changes in the type of reaction or 
passivation layer. The changing surface area and pH, as held by the buffer, are the cause of 
the change in potential.   
EIS results confirmed this as the resistance of the layers in the Nyquist plots show.  In NaCl 
(Figure 3-10), the corrosion layer is characterized by a low resistance Mg(OH)2 layer and a 
smaller secondary EDL layer.  This shows that the Mg(OH)2 layer is not passive due to the 
Cl
-
 attack, and the EDL in this buffer shows high charge mobility, leading to easy migration 
of Mg
2+
 away from the corrosion sites and H2O and H3O
+
 to the substrate to be reduced to 
form H2 gas.  Over 8 hours (Figure 3-10B) the magnitude and relative shape of each time 
constant remained similar. Thus the similar corrosion kinetics for both timepoints in NaCl.  In 
HBSS the layers are similar in shape, indicating similar kinetics of the passive layer, but the 
total magnitude of both the passivation layer and the EDL increases in resistance over 8 
hours, suggesting the accumulation of a more protective layer in HBSS despite increased Cl
-
 
levels.  This indicates that other ions, Ca
2+
 and PO4
3-
 were incorporating themselves into this 
layer [8, 40].   
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3.5.3.  Good Buffers – HEPES, MES, PIPES and TRICINE 
3.5.3.1. HEPES 
The HEPES buffer has the highest buffer capacity at a pH of 7.4 due to its pKa. HEPES has 
been reported to lead to faster corrosion than bicarbonate buffers in SBF [14].  Higher buffer 
capacity means that the pH will take longer to rise for an equivalent corrosion rate, delaying 
the formation of a passive layer.  At pH of 7.4 before significant corrosion can take place, the 
HEPES buffer by itself was not significantly more aggressive in NaCl solutions than 
bicarbonate and other buffers.  The corrosion potential of the HEPES-buffered NaCl was 
lower than TRIS-buffered NaCl but higher than HCO3 (Figure 3-4).  ECorr in HEPES-buffered 
HBSS was lower than HEPES-buffered NaCl, and followed the trend of both HCO3 and 
TRIS by increasing slightly over the 8 hours of immersion while the corrosion layer 
stabilized.  iCorr dropped significantly after 8 hours in NaCl, but did not change as 
significantly (within error) for HBSS with the HEPES buffer.  HEPES had lower corrosion 
rates than HCO3 in NaCl, but faster rates than in HCO3.  This is evidence of HEPES holding 
a more stable pH layer across solutions, when the corrosion is not affected by the formation 
of a carbonate layer.  HEPES exhibited very little change in cathodic kinetics over 8 hours 
(Figure 3-9A). The decrease in anodic kinetics and increase in potential is therefore 
responsible for the decreased corrosion rate over time.  In NaCl, HEPES shows the 
characteristic 2 time constant corrosion resistance of a partially protective Mg(OH)2 layer 
(Figure 3-10A).  After 8 hours, this Mg(OH)2 layer developed, increasing the protection of 
the film resistance as seen in Figure 3-10B.  This layer thus accounts for the decrease in 
corrosion current density observed in HEPES-buffered NaCl.  In HBSS, similar time 
constants are visible for HEPES (Figure 3-11) but the magnitude of the increase in Mg(OH)2 
layer protectiveness is much smaller.  This suggests that the Mg(OH)2 layer is being attacked 
at a faster rate, as one would expect due to the increased Cl
-
 content of HBSS.  The fact that 
this layer is not more pronounced further suggests that the Ca
2+
 and PO4
3-
 content have not 
begun to contribute to the protective layer while the local pH remains near 7.4.   
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3.5.3.2. MES and PIPES 
MES and PIPES, similar in chemical structure to HEPES, followed similar trends to the 
HEPES buffer but corrosion currents were much lower in either solution than HEPES, TRIS, 
or Tricine.  MES and PIPES had the lowest final anodic reaction rates in NaCl (Figure 3-6) 
and along with HCO3, the lowest in HBSS as well (Figure 3-8).  MES showed decreasing 
anodic kinetics in NaCl and a decrease in both cathodic and anodic rates in HBSS (Figure 
3-9B).  Similar trends were seen in PIPES (Figure 3-9C).  This decreasing corrosion rate can 
be linked to the low buffer capacity, leading to local pH rise and passivation of the substrate.  
Indeed, large film resistances can be seen for both MES and PIPES in NaCl (Figure 3-10), 
where increasing Mg(OH)2 film resistance matches HEPES but to a greater extent in PIPES 
and MES due to the lower buffer capacity.   This behaviour is repeated to a greater extent in 
HBSS, and the behaviour matches that of bicarbonate, suggesting that the formation of the 
film is further resistant to corrosion.  The large EDL suggests a nonconductive ceramic layer 
that may include carbonates and phosphates, similar to the data collected for bicarbonate 
buffering.  Again, the difference here is the larger pH rise that is accompanied by a similar 
amount of corrosion, leading to this passive behaviour and the low measured corrosion 
current densities.   
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Figure 3-10: Nyquist plot of Mg in NaCl A) after 2 hours and B) after 8 hours. 
3.5.3.3. TRICINE 
Once settled, iCorr in Tricine was similar to TRIS and HEPES in NaCl and HBSS, as one 
might expect due to the similar buffer capacities.  Tricine in NaCl shifted in ECorr over 8 
hours as the corrosion layer settled, resulting in a small decrease in corrosion current density.  
A similar trend was seen in HBSS. Anodic and cathodic kinetics remained relatively 
consistent for each solution over the test period (Figure 3-9D).  Although Tricine had the 
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lowest measured conductivity of the buffer set (Figure 3-3) this did not appear to significantly 
affect the measured corrosion current densities.  Tricine did show the lowest potential after 8 
hours in HBSS of all buffers (Figure 3-8).  The steady corrosion kinetics are apparent from 
the Nyquist plots, where the same 2 time constant behaviour can be seen over the corrosion 
period in NaCl (Figure 3-10).  The corrosion layer of the Mg(OH)2 and the associated EDL 
for Tricine starts out very similar to that of HEPES.  However, unlike HEPES, the coating 
layer does not change much in terms of either time constant shape or magnitude.  In HBSS, 
the layer properties were similar.  No large change in passivation behaviour was observed.  
Like TRIS and HEPES, the buffer capacity of Tricine was high enough to inhibit the 
formation of additional insoluble layers in HBSS that could otherwise slow the reaction rates.   
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Figure 3-11: Nyquist plots of Mg in HBSS after A) 2 and B) 8 hours. 
 
The relationship between the buffer capacity and measured corrosion rate is especially 
important to in vitro tests.  The goal of a suitable in vitro test will be to reliably assess the 
corrosion properties of the material.  As shown here, the actual corrosion rates can be quite 
different for different buffering agents in the same solutions using the same substrate even 
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though the measured bulk pH of the solution remains the same.  The local pH rise near the 
surface and diffusion rate has a clear effect.  The chemistry of the buffer molecule may be 
important as well, despite the design criterion for these buffering agents to have low 
interactions with the ions in body fluids [19].   
3.6. The Effect of Carbonate Concentration versus Buffer 
Capacity 
The bicarbonate/carbon dioxide buffer system that is chemically if not functionally identical 
to the in vivo buffering systems, and thus is often used for in vitro models [40].  In practice, 
the buffer system itself has a large effect on the total relationship.  The corrosion properties in 
HCO3 depend on its interactions with other salts in the SBF, as evident by the disparity 
between corrosion in simple NaCl solutions and HBSS.  The carbonate ions detected in the 
corrosion layer in HCO3 buffered solutions suggest they play a role in the reduction of the 
corrosion rate [40].  The solubility of ceramic compounds such as carbonates and phosphates 
depend on pH, and the local pH rise at the Mg surface can lead to the precipitation of 
protective layers [8].  Thus, the buffer capacity, which controls this local pH rise, can also 
affect the deposition of these layers.  The local pH rise can also be responsible for the 
passivation by Mg(OH)2.   Thus, the difference in corrosion rate between HCO3 and another 
buffer is affected by the buffer capacity as well.  As HCO3 has a poor buffer capacity on its 
own, the low measured corrosion rates might have more to do with the limitations of the in 
vitro gas exchange than the actual carbonate concentration itself.   
To investigate the relationship between buffering capacity and the deposition of protective 
carbonate layers to carbonate concentration, a further test was performed.  HBSS solutions 
buffered with HEPES and HCO3 was compared to HBSS co-buffered with 25mM HEPES 
and 25mM HCO3 in a 5% CO2 atmosphere.  Thus, the effect of the increased buffer capacity 
due to the added HEPES on the corrosion rates can be measured.   
The corrosion potential of the combined buffer solution was lower than either HEPES or 
HCO3 by itself (Figure 3-12).  Corrosion current density was high initially, but over time 
lowered to within the margin of error of that of HEPES alone.  It did not drop to the levels of 
HCO3 by itself.  The higher buffer capacity of the HEPES in the presence of HCO3 prevented 
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the formation of the protective layer that forms on the corrosion surface.  It can be inferred 
that a higher pH is required to slow the corrosion rate, and these layers will not form at 
idealized in vitro conditions.  This effect can be seen by the lack of anodic reaction shift in 
the HCO3 + HEPES buffer compared to the large shift of HCO3 alone (Figure 3-13).   
 
Figure 3-12: ECorr and iCorr as a function of buffer type and corrosion time in HBSS. 
 
Figure 3-13: Polarization in HBSS with HEPES and HCO3 compared with both individual 
buffer solutions. 
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The impedance data confirms the relationship between buffer capacity and corrosion layer 
formation.  The Nyquist plot of HBSS in HEPES + HCO3 in Figure 3-14 shows the corrosion 
behaviour was dominated by a single time constant, with very little additional impedance due 
to the formation of a passive layer.  Thus, at these Cl
-
 concentrations, and a pH held very 
close to 7.4, Mg is not passive, and undergoes active corrosion.  In HEPES alone, a small 
second time constant, due to the local pH rise improving the formation of Mg(OH)2 layer 
appears on the surface [40].  This effect is not as apparent in the co-buffer system, due to the 
total increased buffer capacity.  The large impedance of the carbonate layers in the HCO3 
buffered HBSS only forms without the extra HEPES buffering capacity.  It can be concluded 
that the reduced corrosion observed in these buffers is due to the limitation of the buffering 
capacity of the component.  Thus, the assessment of corrosion properties in vitro will be 
highly dependent on the buffering capacity and local mechanisms for the measured outcome.   
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Figure 3-14: Nyquist plot of Mg in HBSS with HCO3 and HEPES. 
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3.7. General Discussion on Buffer Choice and Corrosion 
Measurement: 
The in vitro corrosion response of pure Mg varies greatly with the selection of the buffering 
agent.  In particular, the measured corrosion rate can be significantly different across 
different buffering systems even before corrosion of the substrate can significantly change the 
bulk pH of the test solution.   
3.7.1.  Buffer Capacity 
The buffer capacity is very important in the assessment of the corrosion rate of Mg alloy 
systems, since the dissolution (namely the anodic reaction) of Mg in vitro is very sensitive to 
pH [5].  The ability of a chemical buffer to resist pH changes at the surface becomes highly 
important when attempting to accurately model and predict corrosion.  Furthermore, buffer 
systems can react differently in different in vitro corrosion media. The amount of difference 
measured in a simple Cl
-
 solution versus a more complex solution like HBSS will depend on 
the buffer agent and buffer capacity. It becomes apparent that the use of a bicarbonate buffer 
in vitro simply because it is the same chemistry as found in vivo is not necessarily a solution 
to the problem as low buffer capacity and solution dependencies can drastically alter the 
corrosion mechanisms and rates of the measured solution [14, 41].  Therefore, care must be 
taken to identify and design the parameters of buffer concentration and reaction rate to ensure 
in vitro tests are comparable to each other and to in vivo applications.  If these are not 
addressed, it would be possible for a poorly buffered in vitro system to report low corrosion 
rates for a particular alloy or coating, yet behave very differently under the active controlled 
body system at the implant site.  Chemical buffers such as TRIS and the Good buffers can be 
useful in keeping the pH constant in solutions.  The effect of these chemicals on the corrosion 
rate must be considered.  Despite the low interaction with metal ions, these buffers all have 
different pKas, and thus different capacities and properties in the presence of a corrosion 
reaction.  Therefore, it will be necessary to use care and consistency when using buffered in 
vitro solutions to model the body and investigate corrosion properties in physiological fluids.   
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3.7.2.  ECorr vs. iCorr  
An overview of all data points for each buffer is shown on a semi-log plot of ECorr vs. iCorr in 
Figure 3-15.  The global trend is increasing iCorr with decreasing ECorr.  The trend of each 
buffer family with respect to ECorr and iCorr tells us about the relationship between potential 
and the current density of the corroding sample.  HCO3 follows a fairly linear trend with little 
variation.  In contrast, a buffer such as MES has much larger errors based on each point.  
MES in particular shows little trend in ECorr over a wide range of iCorr.  This suggests a wide 
variation in corrosion rates independent of the potential driving force.  The variation suggests 
it may not be a good choice of a buffer for consistency across multiple in vitro solutions.  
This can also be said of TRIS, which shows the strange behaviour of apparently increasing 
iCorr with increasing potential, with the exception of an outlying point.  PIPES, Tricine, and 
HEPES have similar trends following a linear pattern.  The trend seems to be steeper than 
HCO3.   This means the variation in corrosion rate is more independent of variations in ECorr 
across solutions and time points, a desirable property when consistency in corrosion rate 
measurements is wanted.  Of these buffers, HEPES has the highest buffer capacity at pH 7.4.  
Therefore, if all else is equal, more pH control can be gained from HEPES per molar addition 
than any other buffer.  That, and HEPES track record and study in the literature for cell 
culture work recommend HEPES as the buffer of choice for in vitro corrosion measurements 
of Mg in simple SBFs.   
 
Figure 3-15: iCorr vs. ECorr for all buffered solutions. 
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3.8. Summary of the Electrochemical Corrosion Properties of 
Mg in Buffered Solutions 
In vitro corrosion behaviour of pure Mg strongly depends on the pH present at the 
surface of the Mg.  Chemical buffers with different buffer capacities can have large 
effects on the initial corrosion rates even when the bulk pH of the solution is the 
same. The composition of the SBF has an effect on the passivation layer that forms 
based on the buffer response.  In particular, the relationship between Cl
-
 concentration 
and local pH affects the passivation tendencies of the Mg(OH)2 layer, and therefore 
the ultimate corrosion rate.  The local pH depends on the initial corrosion rate and the 
buffer capacity.  The result is the choice of buffer influences the corrosion rate even if 
it does not directly interact with the corrosion reactions.   
 
Buffer response is also affected by the presence of other inorganic salts in the 
solution.  When pH is increased, protective phases including Ca
2+
, PO4
3-
 and CO3
2-
 
can deposit on the surface.  When buffer capacity is low enough, these phases slow 
the reaction in SBFs that contain these ions, leading to different corrosion rates than 
would be expected from simple Cl
-
 solutions.  Even though it is chemically similar to 
the body‟s in vitro buffering system, HCO3 buffers under a partial CO2 atmosphere 
have a low buffering capacity and lead to the formation of protective films that greatly 
inhibit the corrosion reaction.  The response is due to the local pH rise that occurs as a 
function of the performance of the buffer in vitro, that may or may not be expected to 
be mirrored in vivo.  When the HCO3 buffer is supplemented with additional buffering 
capacity from a zwitterionic buffer, the enhanced control of the local pH does not 
allow the protective layer to form.  The ultimate corrosion rate in vivo will therefore 
be heavily influenced by the effectiveness of the body‟s active pH control systems.  
This effect should therefore be taken into account when designing in vitro corrosion 
tests and making conclusions about the ultimate in vivo corrosion rates based on 
performance in vitro.   
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3.8.1.  The Interaction of HEPES with Mg Ions in Solution 
3.8.2.  Determining the interaction between Mg and HEPES 
For a chemical buffer such as HEPES to be used in vitro, it is important to make sure the 
interaction with the metal and the surrounding solution is kept to a minimum.  In fact, the 
ideal case is that the buffer has no interaction except to perform its function.  This is not the 
case for the HCO3 buffer, as the carbonate ions become incorporated into the passive layer 
[40, 41]. The corrosion potential differs slightly across buffered solutions.  The differences 
can be attributed to differences in the layers that form, the diffusion of ions, and if the system 
has reached steady state, and the local pH.  However, the possibility exists that the 
differences are caused by the direct interaction of the HEPES molecule with the Mg.  It could 
be the case that the HEPES directly accelerates the corrosion of Mg by participating in the 
corrosion reaction, or that HEPES changes the potential, and therefore the corrosion rate, by 
removing free Mg ions through binding to form a complex.  The original formulator of 
HEPES for use as a biological buffer tested the interaction with a number of metal ions, 
including Mg and found it negligible [19].  But the purpose of Good‟s focus was not Mg 
corrosion, where local Mg concentrations may be much higher than physiological levels.  The 
best way to confirm that HEPES is not interfering with the corrosion reaction is to measure 
the interaction between Mg and HEPES directly.  This can be examined using nuclear 
magnetic resonance spectroscopy.   
 
3.8.3.  Nuclear Magnetic Resonance Spectroscopy 
Solution-state nuclear magnetic resonance spectroscopy (NMR) was used to explore the 
potential for complexation between Mg and HEPES.  Samples were prepared by adding 
23.83 g/L of HEPES to distilled H2O to form a 100 mM HEPES solution, giving an initial pH 
of  5.31. The pH was then increased to 7.40 ± 0.01 by adding 3.4 mL of ~1 M NaOH 
solution. Varying amounts of magnesium chloride hexahydrate (99.0%, M2670, Sigma 
Aldrich) was then dissolved into the HEPES solution to give the desired Mg concentrations 
of 1, 10, 25 and 100mM MgCl2. These concentrations were chosen to evaluate the behaviour 
due to increasing Mg
2+
 concentration in solution from a level of normal blood serum (of 
1.5mM) up to high levels that could be expected at the surface of a corroding block of Mg. 
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NMR was then performed with a Varian VNMR 500 (Agilent Technologies, Lexington, MA, 
USA) at 500 MHz. A glass insert tube filled with deuterium oxide (D2O) was employed to 
provide a lock signal for the instrument and acetonitrile was used to provide a reference 
without interacting directly with the test solution. All solutions were analysed at 23°C, 
ambient temperature at the location of the instrument. The uncertainty of the NMR 
measurements was estimated at ~0.002 ppm based on the maximum fluctuation of the 
acetonitrile standard across all NMR tests.   
3.8.4.  Interaction Measurements 
NMR resolved two distinct peaks assigned to the protons in the HEPES molecule that we 
would expect to be most affected by the formation of a metal ion complex. These hydrogen 
atoms are located near the negative charge on the zwitterions and would be most affected by 
the presence of Mg
2+
 ions with a correlating shift in the field energy level at resonance. The 
proposed complex behaviour is shown in Figure 3-16 [42].  The change in chemical shift 
induced by the presence of MgCl2 is not large enough to be significant at lower 
concentrations of MgCl2, although a substantial chemical shift change was observed at the 
highest concentration (100 mM) (Figure 3-17). The change in chemical shift was larger when 
the concentration of HEPES was increased from 25 mM to 100 mM.   
 
 
Figure 3-16: Shape of the proposed Mg-HEPES complex. 
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Figure 3-17: Change in chemical shift as a function of MgCl2 concentration from the 25 mM 
HEPES reference solution. Magnitude of peak shifts in 100 mM MgCl2 versus the reference 
HEPES solutions for HEPES concentrations of 25 mM and 100 mM are also shown. 
The possible chemical interaction between Mg and HEPES was explored further with NMR 
spectroscopy, based on the „apparent‟ relationship between mass loss and hydrogen evolution 
rates [14, 40]. To support this hypothesis, a recent study by Xin et al. investigating the effect 
of a TRIS buffer on the corrosion of pure Mg found that the TRIS-HCL compound that 
formed during the buffering process lowered the corrosion potential slightly while increasing 
the corrosion rate [43]. It was suggested that TRIS-HCL consumes the OH
-
 generated by the 
corrosion process, accelerating the oxidation of Mg to Mg
2+
. They also found increased 
pitting corrosion in the early stages in the presence of the buffer [43]. Thus, it is also possible 
that the chemical structure of HEPES itself is leading to enhanced corrosion of Mg. It was 
hypothesised that part of the HEPES structure is able to react with the OH
-
 group in the 
Mg(OH)2 layer itself. This would decrease the effectiveness of the Mg(OH)2 layer in 
hindering corrosion by presenting the underlying Mg substrate to the corrosion medium. 
Alternatively, HEPES may be interfering with the spontaneous CaP precipitation process that 
is normally associated with immersion in an SBF. The EIS results in HEPES buffered 
solutions show the corrosion layer does not form as large as the HCO3, PIPES or MES 
buffered solutions. Since these are also the buffers with lower capacity, this suggests that the 
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difference is due to the local pH rather than direct interaction with the corrosion layer (Figure 
3-11).  
As an alternate mechanism for HEPES effect on the corrosion rate, it could be supposed that 
the negative charges on the deprotonated zwitterions are able to attract, and thus form 
complexes with, the Mg
2+
 in solution.  In theory, this would decrease the concentration of 
aqueous Mg
2+
 in the vicinity of the corrosion surface, with the change in ionic concentration 
thus affecting the rate of the corrosion reaction and perhaps also affecting the potential of the 
Mg
2+/Mg redox couple. One of Good‟s criteria for HEPES was to have low interaction with 
salts in the solution [19].  The Mg
2+
-HEPES complexation behaviour was examined by Good 
by looking for displacement of the titration curves when MgCl2 was added, indicating 
whether Mg complex formation was competing with H
+
. The experiment reported negligible 
binding in the case of Mg
2+
, as well as Ca
2+
, Mn
2+
 and Cu
2+
 [19].  HEPES has been found to 
form weak complexes with Pb(II) [44]. Others have reported complexation behaviour with 
HEPES and Cu(II), contrary to Good‟s original estimations [19]. 
It is assumed that if HEPES forms a significant complex with Mg
2+
 ions in solution at a pH of 
7.4, then the presence of the ion will affect the nearby protons on the HEPES molecule and 
cause a change in observed chemical shift for those protons. The change in chemical shift 
observed will be the weighted average of the complex and the free ligand.  Thus, a larger 
change is indicative of greater proportion of the HEPES complex at any given time. Based on 
the work of Sokolowska  et al. [42], the complex formation with a divalent metal ion is 
assumed to be nearest to the proton NMR peaks near 3.8 ppm. Chemical shift due to protons 
away from the coordination site remained constant with varying Mg
2+
 concentration.  This 
indicates the changes at relevant peaks are due to complex interaction. The changes in the 
chemical shifts of the relevant peaks are compared in Figure 3-17. At lower MgCl2 
concentrations (i.e. 1 to 25 mM), the trends indicate some interaction with increased MgCl2 
although the chemical shifts are small and lie within the uncertainty of the experiments. This 
observation suggests Good et al. were correct in assuming that HEPES has no significant 
interaction with Mg
2+ 
at the levels typically seen in cell cultures. However, a significantly 
larger chemical shift in the peak energy level is apparent at a MgCl2 concentration of 100 mM 
(Figure 3-17). This may be evidence of a small equilibrium constant for the complex, which 
for low concentrations of MgCl2 comparatively little complex formation exists in solution 
and is difficult to detect with NMR. However, the concentration of the complex in solution 
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will increase with increasing concentrations of Mg
2+
 in accordance with Le Chatelier's 
principle. Moreover, actively corroding Mg is not at equilibrium. As the process occurs, the 
local concentration of Mg
2+
 near the substrate of corroding Mg is expected to be much higher 
than that found in the plasma of the human body.  
The corrosion rate of magnesium in a specific medium is directly related to the type of 
passivation layer formed [6]. The passivation layer may consist of Mg(OH)2, MgCO3 or other 
compounds and will exist in equilibrium with the magnesium ion concentration in the 
medium. However, if a complex forms between Mg
2+
 and HEPES, this effectively removes 
Mg
2+
 from solution, changing the equilibrium conditions with the protective coating. 
Furthermore, the presence of the complex will affect the redox potential. As the passivation 
layer decreases, more bare metal is exposed to solution, and the corrosion rate can increase. 
The relationship is shown in Equation 3-6.  The magnesium compound MgX (where X is 
(OH)2, CO3, or other anion) equilibrium is affected by the interaction between Mg
2+
 and the 
HEPES molecule to for a complex between Mg and the deprotonated HEPES ligand (L). As 
such, the interactions with the HEPES molecules may become more important, and may no 
longer be negligible. 
MgX  X + Mg2+  + HEPES  MgL Equation 3-6 
For this study, the NMR results show shifts that qualitatively indicate a complex may be 
formed (Figure 3-17). The equilibrium constant remains unknown, although the magnitude of 
the chemical shifts and the titration experiments by Good would indicate it is quite small. 
Quantification of this effect on corrosion is difficult to separate from other factors, but since 
the interactions are small, the pH and the resulting passivation layers seem to account for the 
corrosion changes between HEPES and other buffers.  As such, if proper care is taken to 
understand the passivation layer properties, HEPES will be a suitable buffer for the 
assessment of corrosion protective coatings in vitro.   
The HEPES buffer may be used to effectively control the pH.  Compared to a carbonate 
buffer, buffer capacity is higher and calcium phosphate deposition is lower.  These lead to 
faster observed corrosion rates in HEPES [40].  Additionally, it is shown that the corrosion 
rate of Mg is higher in solutions containing these ions.  This is due to the lower local pH due 
to the effect of the buffer.  Furthermore, although at concentrations of magnesium near in 
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vivo levels the interaction between HEPES and Mg is small, higher concentrations show 
shifts in the NMR spectra than may correspond to an interaction or complex between these 
two species.  During corrosion, this may have an effect on the mechanism and rates and 
should be considered when doing experiments in this buffer solution where either very high 
concentrations of HEPES are used and/or large amounts of Mg
2+
 ions will be collected in 
solution.  For these cases, further experiments to quantify this effect may be necessary.     
3.9. Recommendations on Buffer Usage for in vitro Tests 
The results from the electrochemical tests show that a number of these buffers are suitable for 
Mg corrosion studies.  All of the buffer systems have their own properties, and therefore 
some are more desirable than others.  HCO3 stands out as the obvious choice for biocorrosion 
studies based on its in vivo analogue.  However, in practice in the lab, the characteristics of 
the buffer system vary greatly depending on the in vitro SBF choice, and the time of 
immersion.  The role of carbonate in the passive layer at elevated pH coupled with the 
relatively low buffer capacity and diffusion speed with the atmosphere inside an incubator 
lead to passivation properties that may not be analogous in vivo.  Indeed, bicarbonate 
buffered in vitro solutions have slower corrosion rates than observed in vivo [41].  More 
importantly for measuring the protective effects of a coating, the lack of consistency in the 
corrosion mechanism may make it difficult to accurately determine the absolute corrosion 
protection provided.   
The zwitterionic chemical buffers reported by Good provide a buffer system with higher 
buffer capacity than HCO3 without interacting with the corrosion layer.  Of these buffers, 
HEPES has the highest capacity per concentration at pH of 7.4.  The electrochemical data 
shows that the corrosion reactions and layers are consistent enough that there is no 
compelling reason to choose one of the other buffers over HEPES for these corrosion studies.  
The wider use of HEPES in the literature for Mg corrosion studies over the other zwitterionic 
buffers also makes cross study comparisons easier.  When the interactions of HEPES with 
Mg were measured, the complex behaviour was very small at biological concentrations of 
Mg
2+
 and 25mM HEPES.  Larger interaction was detected at high concentrations of Mg.  At 
the corrosion surface, the local ion concentration will be higher than normal.  Also, the buffer 
will keep the pH lower at the surface than HCO3.  The HEPES may therefore cause corrosion 
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reaction rates faster than what would be expected in vivo [14].  With the individual 
advantages of both HEPES and HCO3, both are appropriate buffers for in vitro corrosion 
tests.  By performing tests in both buffered solutions, the properties and differences of these 
buffers can be quantified and compared. This will effectively give lower and upper bounds 
for the expected corrosion rate in vivo, and allow greater understanding of the individual 
contributions of pH, carbonate ion reactions, and passive layer performance of Mg and 
protective coatings and surface treatments.  Therefore, the following studies will make use of 
both buffer systems for comparative purposes. 
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CHAPTER 4:  Biomimetic Calcium Phosphate 
Coatings  
4.1. Introduction 
4.1.1.  Calcium Phosphates 
The necessary requirement for using Mg as a biodegradable implant is to control the rapid 
corrosion of such an implant in the aggressive in vivo environment [1, 2]. Surface 
modifications (e.g. coatings) that are able to reduce corrosion rates to acceptable levels while 
remaining biocompatible can provide a solution. Calcium phosphates (CaP) occur naturally 
as minerals in bone tissue. For this reason, CaPs have been studied extensively for 
orthopaedic applications as coatings to increase the cellular response to titanium (Ti) implants 
[3].  Calcium phosphate coatings also help to increase the implant integration into the bone 
[4, 5].   
For magnesium, it follows that a CaP coating will be biocompatible, as they are on Ti [4-6]. 
And indeed, studies on CaP coated Mg alloys show an increase in biocompatibility and 
osteoconductivity [7]. Unlike Ti, Mg needs a coating that will also protect the subsurface 
from corrosion.  CaPs are fairly insoluble in physiological conditions [3], and are thus able to 
be used for corrosion protection. Using different CaP coatings to slow corrosion of 
magnesium is an area of active research [7-12].  
CaP can take many different forms, each with their own properties.  Some relevant calcium 
phosphate phases that can form in solution and their properties are listed in Table 4-1.  
Monocalcium phosphate (MCPM) is too water soluble to be found in bone [3]. Dicalcium 
phosphate dihydrate (DCPD) is slightly more stable, and will start to precipitate in aqueous 
solutions at pH ~4-5.5.  While it is still fairly soluble at physiological conditions, it may be 
beneficial as a bioresorbable implant because DCPD is an intermediate phase in bone 
mineralization [13].  Similarly, octacalcium phosphate (OCaP) plays a role in biomineral 
formation [14].  The mineral component of bone itself is carbonated calcium deficient apatite 
(CDA) [15].  CDA is similar in structure to hydroxyapatite (HA) but with lacunae in the 
lattice.  In bone, substitutions of carbonate and non-apatitic phosphate break up the crystal 
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structure [16, 17].  These substitutions play a vital role in increasing the activity and 
solubility of the bone for its formation and dissolution [18].  HA is the most stable and least 
soluble CaP with the exception of fluorapatite.  HA is often the choice for coating Ti 
implants, where the coating is intended to be permanent [19-21].  For bioresorbable implants 
stoichiometric HA is not necessarily desirable as the goal is to have a coating that can be 
degraded by the body to allow bone to replace the implant.   
Table 4-1: Calcium phosphate properties 
Calcium Phosphate Abbrev. Chemical Formula Ca/P Ratio Solubility 
(-log(KS)) 
Monocalcium Phosphate 
monohydrate 
 
MCPM Ca(H2PO4)2·H2O 0.5 1.14 
Monocalcium Phosphate 
anhydrous 
 
MCPA Ca(H2PO4)2 0.5 1.14 
Dicalcium phosphate 
dihydrate (brushite) 
DCPD CaHPO4·2H2O 1.0 6.59 
Dicalcium phosphate 
anhydrous (monetite) 
DCPA CaHPO4 1.0 6.90 
Octacalcium phosphate OCaP Ca8(HPO4)2(PO4)4·5H2O 1.33 96.6 
Calcium deficient apatite CDA Ca10-x[]x(HPO4)x(PO4)6-x(OH)2-x[]x 
(0<x<2) 
1.33-1.66 Variable, 
~85 
Amorphous Calcium 
Phosphate 
ACP Cax(HPO4)y(PO4)z(OH)2·nH2O 
n = 3.0-4.5 
1.2-2.2 25.7-32.7 
Hydroxyapatite HA Ca10(PO4)6(OH)2 1.67 116.8 
Values as given in [3] 
Solubility is estimated at 25° C  
[] represent vacancies in the lattice of hydroxyapatite 
 
The composition and structure of the CaP coating will affect the corrosion performance.  For 
example, the degree of crystallinity greatly influences the performance of the CaP in vivo [4, 
18].  The dissolution rate has been shown to decrease as crystallinity increases [22] and 
amorphous, glassy phases will be more susceptible to biodegradation [23].  A Mg implant 
will be expected to degrade fully, and any coating or protection provided must therefore 
degrade as well.  A calcium phosphate coating applied must therefore be soluble enough to 
degrade away.  Highly crystalline HA particles that become loose on Ti particles have been 
known to cause a foreign body response [24].  Therefore it will be desirable to have a coating 
that can be completely resorbed by the body.  However, the coating must be insoluble enough 
to provide the necessary corrosion protection.  And the coating must be able to be applied to 
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the Mg implant without damaging the substrate (e.g. exposure to high temperatures during 
plasma spraying) and without the possibility of including toxic precursors or by-products of 
the coating process.  A method for forming a coating such as this is the biomimetic method. 
4.1.1.  Biomimetic Coating Method 
Though many methods for forming coatings are available (See Chapter 2), the biomimetic 
method offers the advantages of a simple, low temperature, non-toxic and non line-of-sight 
process. Biomimetic methods have been studied extensively on Ti implants [4, 6, 15, 25-27].  
As such, the biocompatibility is well known.  The question that must be answered is whether 
this coating process can be used effectively on Mg, and how well the coatings will protect the 
substrate from corrosion.    
The biomimetic method is attractive because the simple chemistry employed optimizes the 
properties needed for the coating [15].  The coating should be just insoluble enough to be 
stable in the physiological system, without becoming so insoluble they prevent the 
degradation entirely.  Ideally, the formed coating is also similar in composition to biological 
CaP.  The biomimetic method coats the samples by simulating a supersaturated physiological 
fluid [25]. The ionic composition of this fluid contains the ions found in the body.  The 
coating is performed at body temperature of 37° C.   The coating formation is driven by 
controlling the pH of the solution.  The pH is controlled with a CO2/HCO3 buffer.  The 
choice of buffer make the use of nonphysiological chemicals unnecessary, thus representing 
the physiological process as closely as possible.  The net result is that all coating parameters 
are formulated to closely match the physiological conditions.  The coatings that form in the 
biomimetic solution will therefore be similar in properties to the CaP found in natural 
biominerals.  Importantly, if the coatings are stable in the SBF, they should also be stable in 
vivo. 
The pH rise during the coating process decreases the solubility of the calcium and phosphate 
ions in solution, leading to heterogeneous nucleation of CaP on the substrate. Figure 4-1 
shows a calculated fractional diagram for calcium phosphate formation based on pH.  
Calcium and phosphate will be dissolved and exist as ions at very low pH.  As the pH is 
increased, the solubility decreases and calcium phosphate solids become more stable, leading 
to nucleation of various phases [3].  As the pH increases, the stability of the calcium 
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phosphate phase increases as well.  The biomimetic method brings the pH up to just above 
the physiological pH of 7.4.  The final coating will not be pure HA as predicted by Figure 
4-1.  The additional ions besides Ca
2+
 and PO4
3-
 in the biomimetic coating solution will 
become incorporated into the final CaP phases that form [25].  Mg ions incorporated into the 
coating have the effect of disrupting the crystal structure, making it more amorphous [15, 28].  
Carbonate ions from the buffer has a similar effect that also increases the solubility of the 
CaP [15].  This results in the coating with good biocompatibility [29].   The question to be 
answered is can these coatings be used to coat Mg as well as Ti and can they be used to 
provide the necessary corrosion protection?   
 
 
Figure 4-1: Fractional equilibrium diagram for the formation of calcium phosphates as a 
function of pH. 
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4.2. Effect of Surface Hydroxide Pretreatment on Biomimetic 
Formation 
4.2.1.  The Role of Pretreatment on Biomimetic Calcium Phosphate 
Nucleation 
The nucleation of calcium phosphate compounds on Ti is promoted by titanium hydroxide 
groups [30].  Other studies have shown alkali pretreatments increase Ti-OH groups on the 
surface of the TiO2 layer increase the deposition of calcium phosphates due to the increase in 
surface energy [31].  Various alkali pretreatments have been developed to form this layer [32-
39]. Such treatments increase the deposition of CaP by modifying the natural titanium oxide 
passivation layer. The increase in surface energy by these treatments help promote 
heterogeneous nucleation of CaP on the metal surface [31].  
Given the role of hydroxide groups on the surface of Ti for biomimetic coating formation, 
will they also play an important role on Mg?  If so, can they be used to optimize the coating 
process for corrosion resistance?  Magnesium in aqueous solutions will readily react with 
water to form Mg(OH)2 [40]. It is hypothesized that formation of this layer via pretreatment 
will influence the deposition of the biomimetic CaP film and have a subsequent important 
effect on corrosion rates in vitro.  This study was conducted to measure the effect of a 
magnesium hydroxide pretreatment has on the formation and ultimate corrosion protection of 
biomimetic calcium phosphate coatings.   
 
4.2.2.  Experimental Methods 
4.2.2.1. Pretreatments 
Pure Mg (99.98% pure, Timminco Inc., Toronto, Canada) and pure Ti was cut into 15 × 15 × 
5 mm samples and polished to 1200 grit using successive SiC papers. Samples were 
ultrasonically cleaned in ethanol for 2 minutes and air dried. Pretreatments were done in 
distilled H2O, or NaOH solutions at 100°C.   Pretreatment samples were treated in pure H2O 
for 0, 15, or 30 minutes or 1M NaOH for 15 or 30 minutes to form a Mg(OH)2 layer. 
Following pretreatment samples were rinsed with distilled water and allowed to dry in air.   
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4.2.2.2. Biomimetic Coating 
Biomimetic coatings were performed on substrates in concentrated simulated body fluid 
(SBF). Samples were coated using a modification of the process described by Habibovic et al. 
[25].  This used two modified SBF solutions with compositions as described in Table 4-2. 
Both solutions have been modified to reduce chloride ions (Cl
-
) to prevent excessive 
corrosion of Mg during the coating process.  Each modified SBF contains ions present in 
physiological solutions but at higher concentrations to promote CaP formation.  The solutions 
are designed to form a complete, adherent coating.  Solution 1 uses a higher concentration of 
carbonate ions (CO3
2-
) to promote amorphous formation of CaP.  Solution 2 is low in Mg
2+
 
because it is known to inhibit crystalline apatite formation [28, 41].  The pH of the solution 
was controlled during the process by dissolving carbon dioxide gas (CO2) in the solution.  
One litre of Solution 1 was heated to 37 °C and CO2 (g) was bubbled through for 15 minutes 
to reach a pH of 6.  The CO2 was then removed, substrates were immersed in the solution, 
and air was bubbled through the solution for 24 hours.  The solution was stirred with a 
magnetic stirrer to ensure uniform ionic concentrations.  After 24 hours the solution pH rose 
to approximately 9.  The samples were removed and rinsed with distilled water. Solution 2 
was prepared the same way, at 37 °C and pH of 6 using CO2. The samples were immersed 
and air was bubbled through the solution for a further 24 hours. When the treatment was 
complete samples were removed from the solution, rinsed with ethanol, and allowed to dry in 
air.  
Table 4-2: Chemical composition of coating solutions 
Solution 1 g/L Solution 2 g/L 
CaCl2 1.65 CaCl2 1.65 
KH2PO4 0.3 KH2PO4 0.3 
MgSO4.7H2O 1.8 NaCl 7.0 
Na2HPO4.4H2O 0.4 Na2HPO4.4H2O 0.4 
NaHCO3 2.27 NaHCO3 0.35 
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4.2.2.3. Characterization 
To study the morphology, coated samples were analyzed with a scanning electron microscope 
(JEOL 7000F FE-SEM). Samples were sputter coated in gold to prevent charging during 
analysis.  Energy dispersive X-ray spectroscopy (EDS) was performed on separate samples 
coated with carbon to identify elements present and estimate the calcium to phosphorus ratio.   
X-ray diffraction (XRD) was performed using a low glancing angle XRD (PANalytical 
X'Pert-Pro MPD PW3040/60) to identify the crystal structure of the coating.  Fourier 
transform infrared spectroscopy (FTIR) was performed using transmittance FTIR (Perkin 
Elmer Spectrum One) by mechanically removing the coating and grinding with a mortar to 
form a mull with NUJOL mineral oil.  The mull was placed between two potassium bromide 
(KBr) plates for analysis.   
 
4.2.3.  Surface Treatment for Formation of Biomimetic CaP on Mg 
4.2.3.1. The Formation of Biomimetic Coatings on Mg 
The biomimetic coating process is designed to promote heterogeneous nucleation of CaP on 
the surface of the metal as the solution undergoes a pH rise.  The first stage of the coating is 
done to form a carbonate rich layer that covers the surface.  This then provides a platform for 
the deposition of the second layer of the coating [36].  Homogeneous nucleation of CaPs in 
solution was also observed to occur in the coating solution.   Due to the mechanism of 
deposition on Ti being accelerated by Ti-OH groups at the surface, it was hypothesized that 
the formation of a similar layer on Mg would promote biomimetic coating on Mg.  For 
biomimetic deposition on Ti, the Ti-OH has a slight negative surface charge when immersed 
in a solution with a pH of 7.4, i.e. the body [31].  These negatively charged points provide 
places for positively charged calcium ions to attach to the surface, and thus lead to formation 
of the apatite layer. This step was observed to be unnecessary for Mg. The biomimetic 
coating process deposited a CaP coating on the surface of all the Mg substrates, regardless of 
pretreatment.  Figure 4-2 A, B, C shows the formation of calcium phosphates by biomimetic 
treatment on titanium based on surface treatments.  As reported in the literature, the alkali 
heat treatment is beneficial to nucleation on the surface of the Ti [31].  Figure 4-2 A that the 
untreated Ti substrate nucleates CaP at a relatively few number of points on the surface.  
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Once nucleated, the growth of the CaP is preferred on the existing points, leading to large 
areas of uncovered Ti and a few round CaP clusters.  When treated in H2O for 15 minutes at 
100° C, Ti generates more of the surface OH groups that promote apatite deposition [42]. 
Alkali heat treatment is much more effective, 30 minutes in NaOH forms a calcium 
hydroxide layer that covers the entire surface (Figure 4-2C) [33, 35, 36].   
The biomimetic coating process designed for Ti was successfully employed to coat Mg 
substrates.  The morphology of the final coatings is shown in Figure 4-2 D, E, and F. The Mg 
samples were coated completely regardless of pretreatment.  CaP was detected over the entire 
surface of the untreated sample (Figure 4-2 D), as well as samples treated with H2O (E) and 
NaOH (F).  The Mg surface needs very little help to create a surface hydroxide layer that the 
CaP favors for nucleation in the biomimetic solutions.  Mg is very reactive, and thus will 
oxidize to form Mg(OH)2 on the surface in an aqueous environment even at low temperature 
[43].  Furthermore, in the Cl
-
 containing biomimetic solutions, the Mg substrates will 
corrode.  The corrosion of the substrate will form a local pH rise near the surface due to the 
reduction of H2O.  The elevated pH causes further super saturation of the already 
concentrated calcium solution.  The result is the formation of CaP on the Mg surface [8].   
 
Figure 4-2: Comparison of calcium phosphate nucleation via biomimetic coating on titanium 
substrates vs Mg substrates for various surface pretreatments. Ti pretreated with A) no 
treatment, B) 15 minute H2O, C) 30 minute NaOH then biomimetic coated.  Mg pretreated 
with D) no treatment, E) 15 minute H2O, F) 30 minute NaOH then biomimetic coated. 
Ti 
Ti 
CaP CaP 
CaP 
CaP 
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4.2.3.2. Effect of Surface Treatment on Coating Morphology 
Having established that biomimetic coatings can be easily formed on Mg regardless of 
pretreatment, the question becomes does pretreatment time and composition significantly 
change the properties of the created coatings?  To investigate this, the morphology of the 
surface treatments and final coatings was investigated under a SEM.  The surface of samples 
after the pretreatment step, then coating in the first biomimetic solution, and finally after the 
complete coating after both solutions was examined.  Figure 4-3 tables the results.  Untreated 
Mg after polishing is shown in Figure 4-3 A.  After 15 minutes of immersion in H2O at 100° 
C, needle-like structures of Mg(OH)2 form on the surface, as is typical in aqueous solutions 
(Figure 4-3 B) [44].  By 30 minutes immersion time, the Mg(OH)2 surface coating has 
completely covered the Mg surface.  In NaOH solutions, the coating was formed even faster.  
Complete coverage was achieved at both 15 (D) and 30 (E) minutes.  The morphology of the 
layer in NaOH was quite different compared to H2O.  Once the hydroxide layer is complete, 
this layer is passive under these conditions, meaning that the hydroxide layer protects the 
substrate from further oxidation [40].  This limits the effect that longer pretreatments will be 
able to have.  Therefore, the study was limited to 30 minutes as the full layer had formed.   
After the pretreatments, the Mg samples were immersed into the first biomimetic coating 
solution.  The composition of the solution (Table 4-2) is high in Mg
2+
 and HCO3
-
. The 
purpose of this is to promote a more amorphous coating structure that will cover the entire 
surface [26].  This first step of the coating is used on Ti to promote faster deposition of the 
second, thicker CaP layer [45].   The Mg
2+
 and HCO3
-
 inhibit crystalline growth to form a 
more soluble CaP layer.  This layer then acts as a site for nucleation of additional CaP.  
Furthermore, because it is slightly soluble, the dissolution of this layer in the second 
biomimetic solution will increase the local ion concentration near the surface and also help to 
promote the formation of the final layer.  Also, the coating solution is modified to be lower in 
Cl
-
 than reported in the literature due to the corrosive effect of chloride on Mg [46, 47]. On 
Mg, all pretreatment samples formed a CaP coating in solution 1 that covered the entire 
sample (Figure 4-3 F-J).  The layer exhibited similar morphology regardless of pretreatment, 
another indicator that the pretreatment step on Mg is nowhere near as important as it is on Ti.  
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Large plate-like crystal flakes were present on the top of this coating for all samples.  At 
certain nucleation sites, larger crystals formed at irregular intervals.   
Following the coating process in solution 1, the samples were coated in the second 
biomimetic solution for a further 24 hours to create the final biomimetic coating.  The second 
solution is low in Mg and lower in carbonate in order to lead to a more crystalline and 
therefore more stable coating.  The amount of Cl
-
 is much higher than solution 1, but the Mg 
has already been covered by a protective CaP coating that will prevent corrosion while the 
ultimate coating is formed.  The increased NaCl has been shown to increase the coating 
deposition on the surface of the implant by favouring heterogeneous nucleation at the surface 
over homogeneous nucleation in the solution [48].  When the samples are coated, the slightly 
soluble first CaP layer provides nucleation sites for additional CaP deposition [45].   
Given the similarities in morphology of the first coating, it is not surprising that the final 
morphology of the CaP coatings are similar as well (Figure 4-3 K-O). The entire surface of 
the substrates were covered with the final coating for all pretreatment levels.  The coating 
was not even in thickness, as large round and flake like CaP deposits grew from the surface 
of this layer as well.  A striking feature of the final coating morphology with pretreatment is 
the number and amount of cracks and defects present after the coating is dried.  These types 
of defects appear on other biomimetic coatings in the literature on titanium substrates [6, 15, 
38, 45].  For Ti, the corrosion resistance is not terribly important.  However, for Mg the 
corrosion resistance is the main purpose of the coating.  So although the ultimate morphology 
did not change much with pretreatment, the amount and severity of the defects varied, and 
this may become important for the corrosion resistance of this style of coating.   
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Figure 4-3: Surface morphology for Mg after A) no pretreatment, B) 15 minutes H2O, C) 30 
minutes H2O, D) 15 minutes NaOH, E) 30 minutes NaOH pretreatment.  Surface after 
biomimetic coating solution 1 applied for F) no pretreatment, G) 15 minutes H2O, H) 30 
minutes H2O, I) 15 minutes NaOH, J) 30 minutes NaOH pretreatment, and after the full 2 
step coating is applied for K) no pretreatment, L) 15 minutes H2O, M) 30 minutes H2O, N) 15 
minutes NaOH, O) 30 minutes NaOH pretreatment. 
4.2.3.3. Pretreatment Effect on Ca/P ratio by EDS 
EDS was used to estimate the Ca/P ratio of the coated samples. This was done as a quick 
method for measuring the differences in composition.  EDS is not extremely precise for 
elemental composition on 3D structures such as the surface of these coatings due to possible 
edge effects [49].  Therefore, the samples were tested at multiple locations and the averages 
of the ratios of Ca to P energy peak intensities were collected (Figure 4-4).  A more detailed 
study of the composition of the coatings and their formation is explained below in section 
4.3.  This comparison was to determine if there was a significant change in the composition 
based on pretreatment.  After the first coating step, the Ca/P ratio of the created coating was 
quite low.  The high amount of Mg
2+
 and CO3
2-
 in solution promoted deposition of a 
substituted, calcium deficient CaP structure [15, 28].   
Once the second coating was applied, the Ca/P ratio was higher.  This was as expected due to 
the nature of the solution.  Solution 2 contained no Mg and a much smaller amount of 
carbonate.  This should promote the deposition of a more insoluble calcium phosphate 
compound.  Figure 4-4 shows that after the second coating is applied, the Ca/P ratio observed 
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were within the instrument error for EDS.  It can thus be concluded that the pretreatment has 
little effect on the ultimate Ca/P ratio of the final coating.   
 
Figure 4-4: Calcium to phosphorous ratio by EDS of coated Mg samples after coating in 
biomimetic solution 1 and then solution 2.  1) No pretreatment, 2) 15 minutes H2O, 3) 30 
minutes H2O, 4) 15 minutes NaOH, 5) 30 minutes NaOH. 
4.3. Pretreatment Effect on Coating Characteristics on Mg 
To further investigate the compositional and formation effects of the coatings, the H2O 
pretreatments were subjected to further tests.  Because the composition by EDS and the 
morphology was very similar, the study was limited to Mg with no pretreatment (designated 
Mg 0), pretreated in H2O at 100° C for 15 minutes (Mg 15) and 30 minutes (Mg 30).  These 
were chosen to represent the range of no initial hydroxide layer to a fully formed layer that 
coats the entire surface (Figure 4-3 A-C).  The differences in biomimetic coatings that form 
will help determine what, if any change the pretreatment has on the composition.   
For magnesium substrates, the greatest increase in mass after the coating process was 
observed for the untreated Mg 0, and decreased with increasing pretreatment time (Figure 
4-5).  The formation of these groups is not nearly as critical on Mg as it is on Ti, as Mg is 
much more reactive, and will readily react to form Mg(OH)2 in aqueous solutions [47]. 
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Pretreatment to form this layer is therefore not necessary, and may not even be beneficial for 
coating formation.  In this case, greater final coating mass corresponded with less surface 
treatment. By observing the SEM morphology of the coating, it is clear that the coatings 
contain numerous defects, and part of the coating may be flaking off in the coating solution 
instead of remaining on the substrate.  Low adhesion is a commonly reported property of 
biomimetic coatings, but can be increased by modifying the surface roughness [15, 32].  
From SEM observation crack density and size was found to increase with longer surface 
treatment. Thus it appears that although a longer pretreatment period may promote CaP 
nucleation, it might subsequently result in a lower adhesion of the coating as a whole, 
resulting in parts of the coating flaking off in solution and a decrease in total coating mass at 
the end of the process.   
 
Figure 4-5: Mass change after biomimetic coating. 
XRD shows peaks matching calcium phosphate compounds. The structure was not a single 
phase, as detected by fitting to available powder diffraction files.  Peaks close to values for 
calcium deficient apatite were observed on samples at 2θ near 26 and 32 degrees (Figure 4-6) 
[50].  Additional peaks suggest DCPD [51], calcium magnesium carbonates [52], or other 
calcium phosphates may be present.  For uncoated Mg, the XRD scan did not detect all of the 
peaks expected from the powder diffraction file [53].  The reason for this may be that the 
sample does not necessarily meet the requirements for good powder diffraction.  Specifically, 
they may not meet the requirement for small, randomly oriented crystals [49]. The Mg 
substrate was taken from a cast ingot with fairly large grain size.  As such, the XRD of the 
pure Mg misses some of the peaks.  The limitations of this method also can apply to the 
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coated samples, as there may be some directionality to the CaP phases formed on the surface.  
Also, the wide peaks denote low crystallinity, and shifted peaks are indicative of lattice 
substitutions by other ions [15].  
 
Figure 4-6: XRD of biomimetic coated samples Mg 0, Mg 15, and Mg 30. 
The calcium to phosphate ratio, as measured by EDS, was found to be below that of the 
stoichiometric HA. As previously mentioned, this is due to substitutions in the lattice.  In the 
apatite lattice, calcium can be replaced by small amounts of magnesium and sodium, and 
phosphates can be replaced by carbonate ions [25]. During the biomimetic coating process, 
these ions were incorporated into the coating.  Mg is found to be present in significant 
quantities due to the corrosion of the substrate during the coating process.  This is mostly due 
to the Cl
-
 ions which are present in solution. The corrosion mechanism of magnesium in 
physiological fluid is strongly related to the presence of chloride ions, which destroy the 
passivation layer of Mg(OH)2 [40, 54, 55].  Removing all of the chloride ions from the 
coating solutions may help to slow the corrosion, and limit the amount of Mg that makes its 
way into the coating. Substitutions and interstitial Mg in the lattice affects the growth of the 
CaP crystal structure [15, 28].  The Mg present in the lattice inhibits the growth of crystalline 
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apatite.  FTIR results confirm carbonate in the lattice, identified by the presence of C-O 
bonds, identified at 1420 and 875 cm
-1
 (Figure 4-7) [3].  Carbonate has a similar effect of 
breaking up and distorting the crystal structure, as well as allowing possible phase additions 
of calcium carbonate (CaCO3).  From a biomimetic coating standpoint, these additions are 
desirable to simulate natural bone, which is not pure crystalline HA [15]. However, from the 
perspective of corrosion, these phases are more soluble in solution, and therefore may 
provide less protection.  The next step is therefore to measure the corrosion rate of these 
coatings in vitro.   
 
Figure 4-7: FTIR of biomimetic coated samples Mg 0, Mg 15, and Mg 30. 
4.4. Corrosion Protection vs. Pretreatment 
4.4.1.  Corrosion Testing 
4.4.1.1. Electrochemical Methods 
Electrochemical tests were carried out to measure the corrosion rate.  Experiments were 
carried out in 0.8% NaCl and Hanks‟ Balanced Salt Solution (HBSS) at 37°C ± 0.5 °C and 
pH of 7.4 ± 0.05, buffered with 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) 
(25mM).  300 mL of solution was used per test. The area of the working electrode was 1 cm
2
. 
Potentiodynamic polarization (PDP) and electrochemical impedance spectroscopy (EIS) tests 
were performed.  A three electrode setup was used with a Pt counter electrode and a saturated 
calomel reference electrode (SCE).  PDP tests were carried out after 20 minutes in solution to 
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allow the open circuit potential to stabilize.  PDP tests utilized a scan rate of 1 mV/s, and 
scanned over the range OCP – 0.100 V to Ref + 0.500 V. EIS scans were performed every 30 
min over a period of 24 hours to evaluate the change in corrosion resistance with time.  A 
10mV peak to peak signal from OCP across a frequency range from 50 kHz to 20 mHz.   
 
4.4.1.2. Corrosion Properties of the Pretreatment Alone 
When exposed to H2O, the surface of the Mg metal oxidizes to form a passive layer of 
Mg(OH)2 [43].  Pretreatment in H2O at 100°C provided a Mg(OH)2 layer for the coatings to 
form on.  The pretreatment morphology of the Mg(OH)2 on surface is shown in Figure 4-3 A 
B and C. Untreated Mg is referred to as Mg 0, treatment in H2O for 15 minutes is labelled Mg 
15, and Mg 30 is 30 minutes of treatment.  After 15 minutes in the pretreatment bath, the 
morphology of the hydroxide layer grows into a flake like structure. By 30 minutes of 
immersion, the magnesium hydroxide has grown into a dense layer covering the sample 
completely.  While this hydroxide layer is passive at high pH or low Cl
-
 levels [47], the effect 
on corrosion at physiological pH needs to be measured to determine if the pretreatment layer 
contributes to the corrosion resistance of the final biomimetic coating.   
To determine the effect of the pretreatment layer on corrosion resistance, samples were tested 
in 0.8% NaCl solution using EIS over 24 hours.  Figure 4-8 shows the total film resistance of 
each group of samples.  The error bars represent ± 1 standard deviation.  Significant 
differences in the corrosion resistance were not observed. Mg 0 and Mg 15 were very similar, 
while Mg 30 had slightly less resistance, though not significantly so, than the other samples.  
This was expected as Mg(OH)2 is very soluble in Cl
-
 containing solutions [40].  This 
demonstrated that the pretreatment layer did not itself significantly contribute to the corrosion 
resistance of the final coating.  Any differences, therefore, can be attributed to the calcium 
phosphate coating.   
   
115 
 
 
Figure 4-8: Polarization resistance of uncoated Mg samples with applied H2O treatments in 
NaCl. 
4.4.2.  Biomimetic Coatings Corrosion Protection in NaCl and HBSS 
4.4.2.1. Polarization Behaviour 
PDP displayed a decrease in corrosion current density (iCorr) for all coated samples (Figure 
4-9).  Tafel-type analysis was performed on the linear regions of the plot, using the Tafel 
slopes from between 50 and 250 mV away from the corrosion potential, to provide an 
approximation of the corrosion current density (Table 4-3).  The overall corrosion rate drops 
due to the calcium phosphate coating.  The coating decreases the available surface area 
susceptible to corrosion. The lowest corrosion current density from the Tafel-type fit was 
observed on samples with no pretreatment. These also displayed the greatest gain in mass 
after the coating process.  It therefore makes sense that initially they will provide the greatest 
corrosion protection.  The CaP phases present here should be fairly insoluble under these 
conditions [3, 15], however phases containing carbonates will be more soluble than HA for 
example, and may contribute to the decreasing corrosion protection of the coating.  More 
importantly, the corrosion reactions continue through the defects and cracks in the layer. The 
greater amount of physical defects in pretreated samples, as seen in Figure 4-3 L and M, 
show higher corrosion current densities than the sample with no pretreatment.   
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All of the biomimetic coatings reduced both the cathodic and anodic reactions of the Mg.  
The greatest reduction in the reactions was observed on Mg 0, the sample with no pre-
treatment.  Mg 15 reduced the cathodic reaction nearly as much as Mg 0, but the anodic 
reaction was considerably higher.  This is an indicator that there are defects in the coating 
that allow corrosion to occur, leading to the dissolution of the Mg.  Mg 30 had the largest 
cathodic kinetics, suggesting the coating was porous enough to allow the diffusion of water to 
the sites, but the coating provided enough coverage to slow the anodic kinetics considerably.  
The PDP can give an initial estimate of the corrosion behaviour, but does not show changes 
in behaviour over time. Anodic polarisation of the samples during PDP can cause significant 
corrosion to take place on the Mg, meaning each sample can only be accurately tested once.  
Therefore, in order to evaluate the changes in corrosion properties over time, EIS was used.  
  
 
Figure 4-9: Polarization of biomimetic coatings in HBSS. 
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Table 4-3: corrosion values obtained by electrochemical analysis 
Sample ECorr  
(V) 
iCorr HBSS 
PDP 
(µA/cm
2
) 
RP NaCl 
Initial 
(Ω·cm2) 
RP HBSS 
Initial 
(Ω·cm2) 
RP NaCl 24 h 
(Ω·cm2) 
RP HBSS 
24 h 
(Ω·cm2) 
Uncoated 
Mg 
-1.921 62.6 270 249 591 885 
Mg 0 -1.877 10.9 2961 2935 1370 2446 
Mg 15 -1.931 16.8 1952 2109 780 2502 
Mg 30 -1.835 12.7 2524 2023 845 3657 
 
4.4.2.2. Polarization Resistance 
EIS was performed in both NaCl and HBSS solution to identify the coating corrosion 
properties over a period of 24 hours.  Corrosion resistance was estimated by fitting an 
equivalent circuit to the Nyquist plots of the frequency response. The change in the corrosion 
resistance over time was then plotted in NaCl (Figure 4-10) and in HBSS (Figure 4-11).  
Representative Nyquist plots in NaCl and HBSS for 1 and 24 hours are shown in Figure 4-12. 
The morphology of the coating of each sample is compared to the damage sustained due to 
corrosion in HBSS after the 24 hour EIS tests is shown in Figure 4-13.   
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Figure 4-10: Corrosion resistance of biomimetic coated samples in NaCl. 
In NaCl, the initial corrosion resistance of the coating was high but fell as the experiment 
proceeded.  By 24 hours the corrosion resistances of all samples had fallen significantly.  
This decrease can be attributed to the formation of defects in the coating (Figure 4-13).  
Pitting occurs beneath the coating through cracks, undercutting the coating, and decreasing 
the adhesion.  This lead to the eventual failure of the coating in small sections, leaving areas 
of bare Mg completely exposed to the solution (Figure 4-13F).  Figure 4-16 A shows the 
corrosion layers at 1 hour consisted of a two time constant system that is typical of a porous 
coating layer and the EDL with the solution [56].  Over the 24 hour period, the magnitude of 
the resistance for the film time constant decreased due to the decrease in the coverage of the 
coatings as the cracks and defects formed.  The subsequent increase in area exposed to 
solution leads to the additional decrease in the EDL resistance.  EIS data in NaCl shows that 
for all time points over 24 hours, the coating with no pretreatment had the highest corrosion 
resistance.  The larger EDL time constant corresponded with the visual observation of the 
fewer, less severe defects present on the Mg 0 samples.  This also corresponded to the 
greatest mass increase in coating deposition of the tested samples.  Therefore, the 
pretreatment to form a hydroxide layer on the Mg surfaces was not beneficial for depositing a 
defect free biomimetic coating.   
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Figure 4-11: Corrosion resistance of biomimetic coated samples by EIS in HBSS over 24 
hours. 
Corrosion in HBSS was very different compared with NaCl (Figure 4-11).  After an initial 
decrease, the corrosion resistance began to increase with time. In HBSS, the coating becomes 
more protective as corrosion occurs. This can be attributed to the presence the additional ions 
in HBSS.  Corrosion between cracks creates a local pH rise, leading to additional 
precipitation of calcium phosphates on the surface of magnesium. This phenomenon has been 
documented for magnesium in SBFs [2, 57]. This pH rise occurs precisely where the coating 
is weakest, leading to increasing corrosion resistance with time.  It was observed that longest 
pretreatment time led to the highest ultimate corrosion resistance after 24 hours.  This 
suggests the Mg(OH)2 layer was beneficial overall for the nucleation of calcium phosphates 
in HBSS.  These results show that the pretreatment layer has an effect on the formation of the 
coating and the subsequent corrosion performance.  However, this effect did not occur until 
after the coating became damaged, as the corrosion resistance started off high, dropped 
quickly, then began to climb (Figure 4-11).  For Mg 0 and Mg 15, the final polarization 
resistance at 24 hours was slightly higher than the initial resistance after 1 hour.  Nyquist 
plots show the rise was due to the increase in the film resistance due to the deposition of 
additional CaP from the HBSS (Figure 4-12 B).  But the EDL film resistance remained very 
low. This means there were still plenty of defects for which solution could attack the 
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substrate through the coating.  This also explains the lack of significant cathodic protection 
observed by PDP (Figure 4-9).   
The defect problem with the coatings was clearly observed under SEM.  Figure 4-13 F shows 
that the Mg 30 sample had a particular large effect as a whole section of the coating has 
delaminated and left the underlying Mg substrate exposed.  The Mg 30 samples ultimately 
had the highest corrosion resistance in HBSS despite the obvious defects, and the poor 
performance in NaCl.  The additional protection can be explained by the deposition of CaP 
from the HBSS.  As Ca
2+
 ions are not present in the NaCl solution, this effect was not seen in 
those tests.  In HBSS, the subsequent corrosion of the Mg due to the porous coating allowed 
local pH rises to deposit the CaP necessary to improve the coating as the increased EDL 
resistance shows (Figure 4-12 B).  The drop, then subsequent rise in resistance is 
characteristic of this behaviour, which can be thought of as akin to a passivation effect.  The 
effect is not seen on the bare Mg substrate because diffusion and the buffer keep the pH low 
enough near the surface to slow the CaP nucleation.  When the pH rise happens inside of a 
crack, diffusion is retarded enough that the local pH can cause supersaturation of Ca ions, and 
thus subsequent deposition.  So while the longer pretreatment seemed to lead to the largest 
polarization resistance in HBSS after 24 hours, this was due to the coating having the most 
defects.  In NaCl, the highest corrosion resistance coating is the one most effective in 
preventing Cl
-
 attack, which was samples without pretreatment.  In HBSS the protection also 
depends on additional CaP from the in vitro solution, and pretreatment was beneficial for this 
effect.   
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Figure 4-12: Nyquist plots of impedance data for pretreated biomimetic samples in NaCl (A) 
and HBSS (B) over 24 hours. 
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Figure 4-13: Scanning electron micrographs of biomimetic samples before corrosion Mg 0 
(A), Mg 15 (B), Mg 30 (C) and after corrosion 24 hours in HBSS Mg 0 (D), Mg 15 (E) and 
Mg 30 (F). 
 
4.4.3.  Conclusion on the Pretreatment Effect on Corrosion Protection 
The effect of Mg(OH)2 pretreatments on the formation and corrosion protection of 
biomimetic calcium phosphate coatings was examined.  It was not critical to pretreat 
magnesium to nucleate a CaP coating on Mg. Instead, longer pretreatment times led to a 
greater amount of cracks and defects in the coating layer.  More defects lead to faster 
corrosion underneath the coating, which would eventually lead to pieces of coating breaking 
off in solution.  In a simple NaCl solution, this results in decreasing corrosion protection with 
time. When calcium and phosphate ions were added to the solution, the Mg(OH)2 
pretreatment layer  promoted additional nucleation of CaPs. This led to increased corrosion 
resistance during the 24 hour test.  The results of the study show that pretreatment is not 
necessary for biomimetic coating of Mg and the corrosion properties are not necessarily 
improved by pretreatment.  The increase in coating polarization resistance due to CaP 
nucleation was a surprising result.  The pretreatment in this case seemed to improve the 
deposition.  If this mechanism can be leveraged to improve the corrosion properties of the 
biomimetic coatings, it may help with the ultimate goal of providing the protection needed 
for an implant.  The amount and severity of the defects in the coating do pose significant 
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concern for the ultimate utility of biomimetic coatings.  If they cannot be improved to prevent 
localized corrosion, they will not be an acceptable protection method, despite their other 
desirable properties.  The coatings will be required to withstand corrosive environments long 
enough that the bone can heal.  The length of time the coating provides protection and 
whether or not this protection persists requires more observations past 24 hours.  Therefore, 
longer term corrosion tests will be necessary to evaluate the performance.   
 
4.5. Electrochemical Investigation of the Formation of 
Biomimetic Coatings 
Biomimetic coatings form easily on Mg.  They do not require the hydroxide pretreatment 
necessary for Ti. If we want to identify and optimize the coating process, it will be necessary 
to assess the deposition mechanics.  The formation of the biomimetic coatings takes place in 
an aqueous solution.  Therefore, electrochemical monitoring can be used to measure the 
formation of the coating.  EIS can be used to measure the film resistance as a function of 
immersion time.  This charge transfer resistance will be related to the coverage and porosity 
of the biomimetic coating as it forms.  In this way the deposition and rise in protectiveness 
can be measured with coating time.  The results will shed light on the mechanisms and 
critical stages of coating formation.     
4.5.1.1. Methods 
a Mg sample was mounted in epoxy with a copper wire connected to the back.  This left one 
metal face exposed to provide a uniform electrode for measurement in the coating solution.  
No pretreatment was applied to the sample.  A polycarbonate fixture was created to hold the 
exposed Mg face parallel to a flat Pt counter electrode.  The distance between electrodes was 
2 cm.  A saturated calomel electrode (SCE) was used as a reference and placed between the 
two electrodes.  The setup was immersed into the biomimetic coating solution and coated 
with the same process described in section 4.2.2.2.  While immersed in the coating solution, 
the potential with respect to the reference electrode was monitored continuously, and an EIS 
scan was taken once every 2 hours to assess the progress of the coating.   
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4.5.1.2. Coating Formation 
The electrochemical data for the formation of the coatings is shown in Figure 4-15.   The 
potential of the electrode with respect to the reference was fairly variable, and quite noisy.  
The noise is probably an artefact of the coating solution environment.  The bubbling of the 
gas through the solution, the oscillations of the stirrers, and the switching of the 
thermoregulator may contribute to the noise on both the working and reference electrodes.  
This is in addition to the deposition of the coating itself.   
The initial response of each solution was quite varied for the first 3 to 4 hours.  The OCP 
varied the most over theses ranges as the solution and electrodes settled.  This was also a 
period of activity in the solution, as the pH rise was quite significant early on, especially in 
solution 1 (Figure 4-14).  Once settled, the polarization resistance of the solution climbed 
linearly as the coating deposition progressed.  The rise in pH promotes the deposition of more 
and more CaP on the surface [25], thus leading to more corrosion protection.  However, the 
rise in pH will also promote slower corrosion kinetics due to the formation of the Mg(OH)2 
layer.  It is therefore necessary to attempt to decouple these effects, though they are closely 
related.  It should also not be forgotten that the polarization resistance in these solutions is not 
directly comparable to in vitro corrosion response due to the very different ionic 
compositions as well as pH.   
The Nyquist plots in solution show the time constants of the coating growing (Figure 4-16).  
In solution 1, the initial response is dominated by the single large time constant of the 
uncoated Mg.  Over the 24 hours, the coating forms and the 2 time constant behaviour 
appears.  The resulting layer deposition increases the corrosion resistance as this layer is 
deposited.  The porosity and solubility of the CaP phases formed in solution 1 limit the 
protectiveness of the overall coating.  By coating the substrate in the second biomimetic 
coating solution, the higher Ca content CaP phases deposit and form the more protective 
second layer.  The polarization resistance increases slowly with pH as the coating is 
deposited over the 24 hours.    
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Figure 4-14: pH monitored over time in biomimetic coating Solutions 1 and 2 over the 48 
hour coating process. 
 
Figure 4-15: Polarization resistance and potential of Mg during the biomimetic coating 
procedure over 48 hours in Solutions 1 and 2. 
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Figure 4-16: Nyquist plots during the formation of the coating in biomimetic Solutions 1 and 
2. 
4.6. Effect of Buffer on Measured Corrosion Rates 
As evident in Chapter 3, the electrochemical behaviour of the Mg is dependent on the buffer 
system as well as the in vitro solution.  The use of the HEPES buffer keeps the pH near the 
initial value of 7.40, has limited interaction with the corrosion reactions and the corrosion of 
the Mg at different rates will have less of an effect on the measurement error due to the 
changing pH.  However, the HEPES buffer is chemically quite different than the buffer 
mechanisms in vivo.  Indeed, the lower carbonate HEPES buffered tests typically express 
corrosion rates faster than seen in animal models [58].  The use of the bicarbonate, or HCO3 
buffer is more chemically similar to in vivo, but of course the mechanism is not quite the 
same in vitro.  The buffering of carbonate ions is increased in the body by metabolism of 
hydrocarbons [59, 60].  In simple CO2 atmospheres however, the buffer capacity is 
significantly decreased.  Therefore, the corrosion rate is usually underestimated in vitro when 
this buffer is used [61].  To determine the effect of the change in buffer system on the coated 
Mg, the corrosion behaviour in HCO3 and HEPES was compared by EIS and PDP in HBSS.   
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The total polarization resistance in each solution from 1 to 7 hours immersion of the 
biomimetic coated samples is shown in Figure 4-17.  The biomimetic coatings for this study 
were given no pretreatment.  The early corrosion behaviour was focused on, to detect the 
changes in the solution before the corrosion caused much pH rise, and before the coatings 
began to fail severely, thus altering the results.  In this way the direct effect of the different 
buffers could be observed on the samples. As with uncoated Mg, the bicarbonate buffer 
caused more rapid increases in the resistance of the corrosion layer, due to the deposition of 
the carbonates with the high pH.  This is similar to what happens over time with the Mg in 
HBSS [8], but the lower buffer capacity and the greater amount of HCO3
-
 increase the rate.  
The resistance in HBSS + HCO3 doubles over 7 hours, while the HEPES buffered solutions 
the coating resistance was fairly constant.   
 
Figure 4-17: Early stage polarization resistance of biomimetic coatings in solutions buffered 
with HEPES and HCO3. 
PDP scans for all samples are displayed in Figure 4-18.  The data supports the same 
conclusions.  HEPES buffered NaCl and HBSS solutions show little change in corrosion 
kinetics for either the anodic or cathodic reactions over 8 hours.  The HCO3 buffered solution 
shows the biomimetic coating decreases the cathodic kinetics slightly and the anodic kinetics 
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significantly.  This is consistent with the effect noted in Chapter 3.  The carbonate in calcium 
containing solutions quickly forms a layer that in this case, augments the corrosion protection 
of the biomimetic layer, hence the drop in the anodic reaction. This layer is still porous 
though, as evident by the only slight decrease in cathodic kinetics.  Overall, the measured 
corrosion rate of the coated samples is also dependant on the buffer solution, further 
affirming the need for the in vitro testing environment to be consistent and relevant to obtain 
good data.   
 
 
Figure 4-18: Polarization of biomimetic coatings in HEPES and HCO3 buffered solutions at 
30 minutes and 8 hours. 
4.7. Conclusions 
The biomimetic coatings formed easily on Mg without the need for any surface treatment.  
The coatings were able to protect from corrosion, but not completely.  The surface treatment 
compromises the integrity (in terms of corrosion resistance) of the coatings by causing the 
formation of defects and such.  The corrosion protection thus falls with time in NaCl as 
corrosion occurs beneath the coating through defects.   
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The surface treatment did seem to improve the deposition of additional CaP phases from the 
solution, thus leading to the decreasing, then increasing corrosion resistance in HBSS.  The 
mechanism for this is documented for Mg in SBF [8] and in vivo [62].  The biomimetic 
coatings help promote this mechanism, leading to increased corrosion resistance in HBSS. 
The corrosion resistance of the coatings is linked to the integrity of the coating by the amount 
of defects present.  The severity of these defects is what will limit the total effectiveness of 
the corrosion resistance.  Optimizing the initial coating creation, as well as the deposition of 
additional CaP from physiological solutions will help to bring up the total protectiveness to 
where they can be used in vivo.  The continued corrosion through the defects remains a 
problem.  If they cannot be improved to prevent localized corrosion, they will not be an 
acceptable solution, despite their other desirable properties.  The coatings will be required to 
withstand corrosive environments long enough that the bone can heal.  The 24 hour tests 
show that the corrosion occurs beneath the defects, but the rise or fall of the corrosion 
resistance depends on the environment.  These short 24 hour tests do not indicate whether or 
not this protection persists.  Therefore, longer term corrosion tests were eventually necessary 
to evaluate the performance.   
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CHAPTER 5:  Modified Biomimetic Coatings 
for Improved Protection 
5.1. Introduction 
The biomimetic coating was successfully applied to the Mg substrates, and as shown, it 
reduced the early corrosion rate in vitro.  The defects in the ceramic coating were the 
dominant cause of the failure of the biomimetic coatings.  The deposition on the surface of a 
compact, defect free coating was not improved by the hydroxide pretreatments.  The final 
coatings had more defects which led to more corrosion in NaCl solutions when pretreatment 
was used than when it was not.  The use of the pretreatment, which is so necessary on Ti 
implants, is not beneficial for Mg.  This calls into question the need for the 2 stage 
biomimetic coating phase.  This process, designed to promote deposition on Ti [1, 2] is not 
optimized for Mg.  The structure and composition of the biomimetic coatings are desirable 
for biocompatibility [3-5] and osteoconductivity [6, 7].  These are properties that should be 
retained in the coatings if possible.  The need is for the biomimetic coatings to provide more 
corrosion protection. This was not initially a design consideration for the biomimetic coating 
since Ti is very corrosion resistant. Given the defects and corrosion properties of the coatings 
in simple NaCl solutions, it is uncertain if these coatings can be made to protect the implant 
for the required duration.  Furthermore, since the deposition of biomimetic coatings on Mg is 
not nearly as difficult, the formation mechanisms and whether the first step helps or hinders 
the corrosion properties has not been investigated.  
The study presented here will investigate the formation of the biomimetic coatings using the 
first solution to create the amorphous carbonated coating followed by the higher chloride 
final coating step compared with simply using the second step of the biomimetic coating 
process to create the coating directly.  The composition and structure of the coatings will be 
examined to find out how the first stage impacts the final coating layer on Mg.  The corrosion 
properties of these coatings will be assessed over a longer term test of 14 days to investigate 
if the corrosion resistance will last in solution.   
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5.2. Materials and Methods 
5.2.1.  Coating Process 
Pure Mg substrates were cut to dimensions of 15 × 15 mm, polished to 1200 grit and rinsed 
with ethanol.  Biomimetic coatings were prepared as described in Chapter 4 will be referred 
to as Biomimetic 1.  The biomimetic coatings were formed by coating the samples in solution 
1 for 24 hours, followed by coating in solution 2 for 24 hours (Table 4-2).  The modified 
coatings (Biomimetic 2) were coated only in solution 2 for 24 hours.  The coatings created 
were examined after every process with normal and glancing angle (GA) XRD.  The glancing 
angle XRD was done with a fixed X-ray incidence angle of 5 degrees and while the detector 
was moved from 5 to 80 degrees to capture the full diffraction pattern.    
5.2.2.  Hydrogen Evolution 
Hydrogen evolution was conducted for coated samples over 14 days.  Four samples of each 
experimental group were tested.  Samples were coated with silicone sealant for H2 evolution 
tests on all faces except one to ensure only one face was exposed.  Each sample was 
immersed into 500 mL of HBSS buffered with 25mM HEPES and adjusted to pH of 7.4 at a 
temperature of 37° C.  A 50 mL glass burette was attached to a glass funnel, inverted over the 
sample and filled with solution.  Hydrogen gas collected was measured at least once per day 
for 14 days.  The solution was replaced every 72 hours to keep the pH and ionic composition 
of the fluid at the appropriate conditions.   
5.2.3.  Electrochemical tests 
Electrochemical tests were carried out to measure the corrosion rate.  Experiments were 
carried out in 103mM NaCl and Hanks‟ Balanced Salt Solution (HBSS) at 37°C ± 0.5 °C and 
pH of 7.4 ± 0.05, buffered with 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) 
(25mM).  300 mL of solution was used per test. The area of the working electrode was 1 cm
2
. 
Potentiodynamic polarization (PDP) and electrochemical impedance spectroscopy (EIS) tests 
were performed.  A three electrode setup was used with a Pt counter electrode and a saturated 
calomel reference electrode (SCE).  PDP tests were carried out after 20 minutes in solution to 
allow the open circuit potential to stabilize.  PDP tests utilized a scan rate of 1 mV/s, and 
scanned over the range OCP – 0.100 V to Ref + 0.500 V. EIS scans were performed every 30 
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min over a period of 24 hours to evaluate the change in corrosion resistance with time. It used 
a 10mV peak to peak signal from OCP across a frequency range from 50 kHz to 20 mHz.   
5.2.4.  Buffered tests 
Buffered tests were carried out in HBSS with either 25mM HEPES or 26mM HCO3 as 
described in Chapter 3.  Electrochemical tests were carried out in an incubator at 37° C.  
HCO3 buffered tests were performed with a controlled 5% CO2 atmosphere to bring the pH to 
7.4.  HEPES buffered tests were performed at ambient atmospheric CO2 levels.   
5.3. Results and Discussion 
5.3.1.  Formation of the Coating 
The biomimetic coatings formed easily in Solution 2 without the first coating in Solution 1.  
The final composition was very similar for both coatings after the final treatment as shown in 
Figure 5-1.  The glancing angle XRD proved to be very useful in determining the 
composition of the thin coatings on Mg.  The low angle maximized the intensity of the 
diffracted X-rays from the coating relative to the substrate.  The normal scans are dominated 
by the Mg peaks, and the coating is barely detectable in some cases.  This is due to the X-rays 
penetrating the coatings and the signal is therefore being dominated by the underlying 
substrate.  For the low angle scans, the composition of the coating is much more detectable. 
As with the previous samples, the mixture of phases and structure of the coatings made 
absolute crystal structure identification difficult.  After coating in the first biomimetic 
solution, no direct match to a single crystal structure was found, although EDS reveals the 
composition to be composed of a semi-crystalline carbonated CaP [8].   
After coating in the second solution, the samples matched peaks close to Mg and carbonate 
substituted dicalcium phosphate dihydrate (DCPD) [9].  The wide peaks again suggest very 
low crystallinity, and small crystallite sizes as would be expected from DCPD where the 
lattice is disrupted by substitutions [10, 11].  The coatings on both samples coated with 
solution 1 then solution 2 were very similar in crystal structure to the samples coated with 
solution 2 only.  The substituted DCPD solution is formed from the composition of the 
biomimetic coating solution [12], and should therefore not be greatly influenced by the first 
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step of the coating.  This first step was designed to provide a base for the CaP to nucleate 
onto for Ti, as Ti by itself does not otherwise distribute the biomimetic coating evenly [2].  
On Mg, the corrosion of the Mg in the Cl
-
 containing solution promotes the direct deposition 
of CaP on the surface [13].  Biomimetic solution 1 is lower in Cl
-
 content than the process 
reported by Habibovic et al. [12].  This prevents significant corrosion to the substrate in 
coating solution 1. However, some corrosion in the biomimetic solution may be desirable 
since the corrosion was found to actually accelerate the coating deposition.  As the XRD 
shows, skipping the first biomimetic coating solution had little effect on the crystal structure 
of the final coating.  Further, the observed morphology (Figure 5-3 B and C) shows that the   
coating deposited completely over the surface regardless of the first biomimetic coating.   
 
 
Figure 5-1: XRD Normal and Glancing Angle (GA) for samples after coating in biomimetic 
solution 1, then biomimetic solution 2, and samples coated with biomimetic solution 2 only. 
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5.3.2.  Corrosion Results 
5.3.2.1. The Effect of Coating Process on the Hydrogen Evolution 
The hydrogen evolution results show the difference in corrosion properties over 14 days 
(Figure 5-2).  For uncoated surfaces, the corrosion rate is quite rapid, and increases with 
greater surface roughness [14].  The hydrogen evolution rate for the polished sample in the 
early portion displays positive curvature, indicative of accelerating corrosion rate.  The cause 
of this is the nonuniform pitting of the sample that occurs, leading to greater surface area and 
thus greater corrosion [14, 15].  However, there is an inflection point in the curve, after 150 
hours the corrosion rate begins to decelerate.  This is an artefact of the calcium phosphates 
that form on the surface from dissolved salts found the in the bloodstream, and therefore also 
in these in vitro environments [13, 16]. This layer provides the protection that allows the 
corrosion to decrease in the latter stages of the test.  Unfortunately, due to the limited amount 
of calcium available, the total corrosion that must take place before this occurs is 
unacceptable for implants, as by 150 hours, already significant corrosion has taken place, 
generating 10 mL/cm
2
 H2 gas, well above the estimates of tolerable H2 evolution of ~0.01 
mL/cm
2
/day [17].   
 
Figure 5-2: Hydrogen evolution over 14 days for samples.  
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The formation of the calcium phosphate on the surface of the biomimetic coatings led to an 
eventual protective CaP coating on the surface.  EDS confirmed that the composition was 
calcium phosphate with Mg and other ions from the SBF detected in trace amounts.  The 
morphology of the coating after 14 days in SBF on the corroded Mg is shown in Figure 5-3 
D.  The coating had cracks and defects that would allow corrosion, although the corrosion 
rate dropped considerably compared to the early stages of the bare Mg.  The crystal structure 
of the corroded surface was investigated with XRD (Figure 5-4).  The CaP phases were very 
amorphous, and no real peak match could be found.  The amount of corrosion that took place 
to form the coating was considerable.  Therefore, the Mg
2+
 concentration at the surface would 
have been very high. .  All of this magnesium is likely to have limited the crystallinity of the 
coating and led to a highly amorphous calcium-magnesium phosphate deposit [10, 11].   
 
Figure 5-3: Scanning electron micrographs of uncorroded A) bare Mg, B) biomimetic 
coating, C) biomimetic 2 coating; morphology of D) bare Mg, E) biomimetic coating, F) 
biomimetic 2 coating corroded in HBSS for 14 days. 
The biomimetic coatings are a method of simulating the formation of this layer, using the 
inorganic salts at higher concentration of Ca and PO4
3-
 to promote the protective layer, while 
using low concentrations of Cl
-
 to prevent significant corrosion during the coating process.  
Instead of waiting for the layer to form in situ, the layer is applied first to provide corrosion 
protection.  As shown before, these biomimetic layers can provide corrosion protection [18-
20].  In this study both biomimetic coatings 1 and 2 protected the surface, leading to less 
corrosion and therefore less H2 generation during the early stages of the corrosion.  Despite 
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similar compositions, the biomimetic 2 coatings were more protective than the biomimetic 1 
coatings.  Biomimetic 1 coatings had low corrosion rates with little variation between 
samples until ~60 hours into the corrosion tests.  Following that, the defects in the coating 
allowed corrosion to occur, accelerating the corrosion rate [19].  The accelerating rate of 
corrosion was quite variable across samples, leading to the large variation seen in Figure 5-2.   
The corrosion continued across the remainder of the 14 day test at a relatively steady rate.   
In contrast to biomimetic 1 coatings, biomimetic 2 coatings remained much more corrosion 
resistant across the 14 days.  The low variation across samples shows that although defects 
and cracks occurred in the  coating, they did not grow or become worse as time passed in the 
solutions (Figure 5-3 C, F).  The biomimetic 2 coatings formed the same semi-crystalline, 
substituted DCPD phases as the final coatings for biomimetic 1 (Figure 5-1).  The difference 
is the layer it was formed on.  Like the pretreatments in Chapter 4, the deposition of the first 
layer of amorphous CaP was unnecessary for the formation of the coating.  However, this 
layer is more soluble than the final layer due to the high concentration of carbonates and 
lower relative amounts of Ca [8]. The solubility of this layer led to the formation of defects 
and delamination of the coating from the substrate at various points, leaving the Mg exposed 
to corrosive solution (Figure 5-3 E).  This was not observed on the biomimetic 2 coatings, 
which although some corrosion took place, the overall integrity to the coating was not 
diminished over the test (Figure 5-3 F).  When corroded, the coating underwent the 
deposition of additional CaP from the solution, and this helped to keep the effect of the 
defects from dominating the corrosion properties.  Figure 5-4 shows that after the 14 day test, 
the phase of the CaP converted itself from mainly substituted, low crystalline DCPD to 
substituted, semi-crystalline Ca deficient apatite structure [21], a thermodynamically more 
stable phase [22].  This conversion of DCPD was also seen by Hu et al. after immersion in 
SBF [20].   
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Figure 5-4: XRD after corrosion for 14 days in HBSS of uncoated Mg and biomimetic 2 
coated samples (normal and glancing angle). 
5.3.2.2. Effect of Coatings on Polarization Resistance 
The impedance properties of the coatings show the effects of the defects and overall created 
integrity of the coatings.  Figure 5-5A shows the Nyquist plots of the initial polarization of 
each coating in NaCl + HEPES and HBSS + HEPES after 1 hour in solution.  The aggressive 
NaCl solutions, which contain no Ca
2+
 or PO4
3-
 to deposit an insoluble layer, display the 
coating resistance to Cl
-
 attack, and the subsequent EDL resistance through the pores in the 
coatings.  The larger resistance of the Biomimetic 2 coatings show that the deposited coating 
has fewer defects than the biomimetic 1 coating.  This effect is also seen in HBSS.  In this 
solution, the deposition of the additional CaPs becomes important [13].  While in NaCl after 
7 hours (Figure 5-5B) the resistance of the coatings is not improved, the biomimetic 2 coating 
in HBSS shows increased resistance indicated by the increased impedance.  This growth is 
not matched by the biomimetic 1 coatings.  The deposition requires a pH rise to promote the 
nucleation [13, 23].  For Biomimetc 1 coatings with large cracks and defects, the diffusion is 
too great, and this formation is much slower.  The Biomimetic 2 coatings have smaller 
defects, and are thus diffusion limited, and this effect is seen earlier.  This helps the 
Biomimetic 2 coatings reduce the corrosion and hydrogen evolution in vitro.   
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Figure 5-5: Nyquist plots of biomimetic coating 1 and 2 in NaCl and HBSS buffered with 
HEPES at 1 and 7 hours immersion. 
5.3.3.  Effect of Buffer Type on the Corrosion Measurements  
The type of buffer used for the in vitro tests can also affect the measured corrosion rate as 
demonstrated in Chapter 3.  ECorr and iCorr for both coatings is compared to uncorroded Mg in 
NaCl and HBSS buffered with HEPES, as well as HBSS buffered with HCO3 (Figure 5-6).  
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The initial corrosion potential of all of the biomimetic 2 coatings was lower than the 
Biomimetic 1 coatings.  The better protection of these layers prevented Mg
2+
 ion formation at 
the surface, keeping the ECorr low.  The slower corrosion rate by the more complete coatings 
is also preventing the corrosion layer from stabilizing as quickly for these coatings as well.  
However, the iCorr for all Biomimetic 2 samples was lower than Biomimetic 1 samples, as 
indicated by the better coating properties.  The bicarbonate buffered solutions led to much 
lower corrosion rates than HEPES buffered samples.  This effect was seen on both 
biomimetic coatings, but the effect was particularly significant for biomimetic 2 coatings.   
 
Figure 5-6: ECorr and iCorr for biomimetic 1 and biomimetic 2 coated samples. 
PDP of the Biomimetic 2 coating reveals the origins of this effect.  Like the Mg, when the 
HCO3 buffer contains Ca ions, the passive carbonate layer that forms prevents corrosion [24].  
Figure 5-7 shows that over the first 8 hours, the anodic reaction rate is slowed due to the 
formation of these layers.  This is not seen in NaCl solutions, where the only mechanism of 
corrosion is the chloride ion attack.  In HBSS, the anodic reaction rate drops while the 
cathodic reaction remains relatively unchanged.  The HCO3 buffer enhances this effect due to 
the lower buffer capacity and the high concentration of carbonate ions available to form 
calcium carbonate phases.   
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Figure 5-7: Polarization of Biomimetic 2 coatings in HEPES and HCO3 buffered solutions.   
Thus, the resistance to corrosion of the coating goes up in the bicarbonate buffered HBSS as 
immersion time increases (Figure 5-8).  This effect is not seen in NaCl for either coating, or 
in HBSS for biomimetic 1.  Biomimetic 2 coatings improve slightly in HBSS due to the CaP 
deposition effect [13].  However, both coatings show constant improvement in HCO3 
solutions.  The difference between these two effects is shown by the Nyquist plots over 1 and 
7 hours (Figure 5-9).  The growth of the EDL time constant surpasses the coating resistance 
for both coatings over 7 hours in HCO3 solutions.  The decreased area available to corrosion 
due to the pH rise and the deposition of the carbonates accounts for the lower corrosion 
current due to the anodic shift.  Therefore, the measured corrosion and hydrogen evolution 
over 14 days in HEPES buffered solutions will likely be higher than the corrosion rate 
experienced in a HCO3 buffered solution, such as in vivo.   
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Figure 5-8: Polarization resistance over 7 hours of both biomimetic coatings in HEPES and 
HCO3 buffered solutions. 
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Figure 5-9: Nyquist plots of coated samples in HBSS buffered with HEPES or HCO3 at A) 1 
and B) 7 hours. 
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5.4. Conclusions 
The experimental data here unambiguously shows that the high Mg amorphous carbonated 
CaP first step in the coating is not required for deposition of the biomimetic coating on Mg, 
like it is on Ti [1, 2].  The availability of Mg
2+
 ions and pH rise from the corrosion of the Mg 
provides enough nucleation potential on Mg to provide a full coverage coating.  This is a 
major difference between that and Ti, where there is no corrosion and the high carbonate 
solution is needed to provide the inhibition of large crystals that the Mg
2+
 ions perform here.  
The deposition of the final biomimetic 2 coatings was similar in composition and crystal 
structure to the substituted DCPD biomimetic coatings created with the first step [8].  The 
corrosion protection was found to be much greater without this step, as the biomimetic 2 
coatings produced minimal H2 gas over the course of the 2 week immersion test in HBSS.  
This low level of H2 generation puts the coatings in range of predicted acceptable levels of H2 
generation in vivo [17].  Over the 14 day test, the phase of the calcium phosphate coatings 
changed from mostly DCPD to a calcium deficient apatite structure.  This more stable phase 
is less soluble and provides more protection than the amorphous phase that formed on 
uncoated Mg [22].  The corrosion protection provided by these coatings was still limited by 
the defects and corrosion through the coating, rather than the dissolution of the coating itself.  
The defects and the corrosion problem they present remain a challenge for the use of these 
coatings in vivo.  The biomimetic 2 coatings did show some signs that the deposition of 
additional CaP from solution helped to repair the defects and extend the protection.  If this 
mechanism can be optimized and utilized it may help provide a coating with better protection 
properties.   
The choice of buffer was shown to have an effect on both the measured rates of corrosion and 
the mechanism of corrosion that takes place.  The HEPES buffer proved to be more 
aggressive than the bicarbonate buffer due to the better control of the pH rise and the lack of 
carbonate phases contributing to the corrosion layer.  The measured corrosion rates in HEPES 
are thus expected to be faster than the HCO3 in vitro tests.  In vivo tests are more difficult to 
determine, but it seems likely that the HEPES buffer will provide the upper bound of the 
corrosion rate, as it‟s expected that the HCO3 buffer in vivo will present slower rather than 
faster corrosion [24].   
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CHAPTER 6:  Improving the in vitro Corrosion 
Resistance of Biomimetic Calcium Phosphate 
Coatings for Mg using a Calcium Hydroxide 
Layer 
Biomimetic calcium phosphate coatings have been studied to improve the corrosion 
resistance of biodegradable magnesium alloys.  The corrosion resistance of these coatings 
was found to be limited by the defects in the coating [1, 2].  A method for improving the 
corrosion response of these coatings is therefore needed if biomimetic coatings are to be used 
for corrosion protection.   In this study, a calcium hydroxide under layer was applied to 
improve the properties of these biomimetic coatings. The in vitro corrosion response was 
studied using hydrogen evolution and electrochemical techniques.  It was found that the 
calcium hydroxide layer increased the corrosion resistance of the coatings. The coatings 
created had fewer defects than the unmodified biomimetic coatings.  Over time, the calcium 
hydroxide layer also prevented the defects in the coating from growing, leading to longer 
lasting protection.  The results of this study suggest calcium hydroxide coatings can 
significantly improve the corrosion protection of a biomimetic coating system.   
6.1. Introduction 
Biomimetic coatings have been shown to be able to reduce the corrosion rate of Mg.  This, 
coupled with the biocompatibility [3-5] and osteogenic properties [6-8] of these coatings 
make them ideal candidates for corrosion protection of a degradable implant. However, as the 
previous work has shown, these coatings are often undermined by the presence of defects and 
pores that allow local corrosion to continue beneath the coating.  This results in a loss of 
mechanical strength before new bone has healed so it may carry the physiological loads. 
Moreover, the release of H2 gas at rates above which the surrounding tissue can safely 
dispose of it needs to be avoided in a clinical setting.  The degradation rate needs to remain 
very low during the initial phase of tissue recovery, then degrade completely at a rate low 
enough that hydrogen gas does not accumulate [9].  The exact rates will depend on the type 
and site of the implant, however, the corrosion protection provided by the biomimetic 
coatings must not be compromised by too many defects. While steps can be taken to reduce 
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the amounts of defects created as presented in Chapter 4 and 5, the implant needs to also be 
protected from defects that may form during or after implantation due to mechanical or 
thermal stresses.  
Recalling that magnesium is a very active metal [10], with a standard reduction potential of -
2.37 V, any Mg left exposed to an aqueous solution will oxidize at physiological conditions. 
When magnesium corrodes in water, the net reaction is Mg(s) + 2H2O → Mg(OH)2 + H2(g) 
[11, 12]. Mg(OH)2 is fairly insoluble in water.  If part of this layer dissolves, or is removed 
by mechanical means, the metallic magnesium beneath corrodes and re-passivates the 
surface, by forming additional Mg(OH)2.  This protects from further corrosion.  This 
mechanism does not serve to protect in the body because Cl
-
 acts a catalyst to speed up the 
reaction [11].  The Cl
-
 replaces OH
-
 in the layer, but is much more water soluble than 
Mg(OH)2 [13]. The high concentration of Cl
-
 in vivo means the passive layer is not protective 
in the body, leading to fast degradation rates.  A protection mechanism is required at the Mg 
substrate that will react to the solution in the same manner as a passive layer, forming an 
insoluble barrier beneath any defects that appear during processing or use. Once again taking 
a biomimetic approach, the development of a self-healing property or mechanism that 
provides the required level of protection from the corrosion medium could be envisaged in 
order to “heal” defects as they appear.   
Unfortunately, as previous chapters describe, the biomimetic coatings are fraught with 
problems.  During the coating process, adhesion of the coating to the surface and complete 
coverage are necessary to prevent internal corrosion of the implant.  Any defects can lead to 
corrosion underneath the coating, leading to lower adhesion of the coating and increasing 
corrosion rates [2].  Calcium phosphates are much more brittle than the underlying substrate. 
As such, the likelihood of defects is high for a load bearing implant.  Therefore a coating that 
is not as sensitive to defects is desirable. Furthermore, the coating process in chemical 
solutions often allows, and in some cases, partially relies on the corrosion of Mg to deposit 
the CaP [1, 18].  Magnesium corrosion releases Mg
2+
 ions in solution, and these ions can 
have a negative effect on the solution coating by inhibiting the formation of crystalline apatite 
[25], favouring more soluble phases [14].  The deposition of CaP and calcium carbonates 
from in vitro [18] and in vivo [26] are interesting phenomena, as they presents us with a 
possible mechanism for imitating passivation, using the chemistry of the surrounding fluids.  
As seen in Chapters 4 and 5, the additional nucleation of calcium compounds on the Mg can 
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increase the protection of the layer and slow corrosion.  Unfortunately, the deposition of such 
compounds is limited in the deposition rate and insolubility, due to the relatively low amount 
of Ca available in the body, with typical blood plasma containing only 2.5 mM Ca
2+
 [27].  To 
increase the protection this provides, an additional source of calcium at the defect sites is 
required.   
Calcium hydroxide (Ca(OH)2) is often used as a biomaterial in dental applications [28].  The 
application of a calcium hydroxide coating can be used to provide a pretreatment or act as a 
sublayer to a top layer of calcium phosphate.  Such a layer could possibly be used to increase 
the protective properties of the biomimetic coatings. It is hypothesised that the deposition of a 
Ca(OH)2 underlayer will encourage the formation and reformation of the biomimetic CaP 
layer. It is thought that disassociation of Ca(OH)2 should provide a ready supply of Ca
2+
 to 
form CaP, while the OH
-
 raises the pH and promotes further CaP deposition. 
Once the final CaP coating is applied and immersed in a corrosive in vitro or in vivo 
environment, a slightly soluble calcium base layer exists just below the surface. Any cracks 
that form, or defects from the original coating, will lead to corrosion of this layer.  In an in 
vivo solution, the phosphate ions present can react with the calcium ions to precipitate a new 
layer CaP at the defects.  This happens naturally on Mg in physiological solutions [18], but 
the rate of coverage and deposition was found to be too slow and hence not sufficiently 
protective of the Mg substrate (Chapter 5).  This study shows the improvement of a 
biomimetic calcium phosphate coating using an electrochemical assisted deposition (ECAD) 
coating of calcium hydroxide for corrosion protection of biomedical magnesium.    
6.2. Materials and Methods 
6.2.1.  Preparation of Calcium Hydroxide Coatings 
Pure Mg (99.98% Timminco) samples were cut to 15 × 15 mm sections and mounted in 
epoxy with a copper wire attached at the back for electrical connection, and one face exposed 
for deposition. This provided a consistent surface area for both coating deposition and 
corrosion measurement.  Samples were polished to 1200 grit with SiC.  Samples were then 
ultrasonically cleaned in ethanol for 5 minutes and allowed to dry in air.  
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6.2.2.  Calcium Hydroxide Coating 
ECAD samples were coated using a standard 3 electrode setup with a saturated calomel 
electrode (SCE) as the reference and a flat Pt plate as the counter electrode.  The sample face 
was mounted parallel to the counter electrode, at a distance of 1 cm in a 2M Ca(NO3)2 
solution.  Potentiostatic coating performed with -3.2V volts vs. the SCE reference for 10 min. 
Following deposition, samples were rinsed with ethanol and allowed to dry in air.   
6.2.3.  Biomimetic Calcium Phosphate Coating 
After ECAD coating, samples were biomimetically coated using the modified 5x 
concentrated simulated body fluid (SBF) in the process described in Chapter 5 [2]. The pH of 
the solution was controlled during the process by dissolving carbon dioxide gas (CO2) in the 
solution.  One litre of biomimetic coating solution 2 was heated to 37 °C and CO2 (g) was 
bubbled through for 15 minutes to attain a pH of 6.  The CO2 was then removed, samples 
were immersed in the solution, and air was bubbled through the solution for 24 hours.  The 
solution was stirred with a magnetic stirrer to ensure uniform ionic concentrations.  After 24 
hours the solution pH rose to approximately 8.  The samples were removed, and rinsed with 
distilled water, and allowed to dry in air at room temperature.  
6.2.4.  Characterization 
Coatings created were characterized by scanning electron microscopy (SEM) (JEOL 7000F 
FE-SEM), energy dispersive X-ray Spectroscopy (EDS) and X-Ray Diffraction Spectroscopy 
(XRD) (PANalytical X'Pert-Pro MPD PW3040/60) were used to determine composition.  
Sample preparation was carried out as described in Chapter 4. 
6.2.5.  Corrosion Testing 
Corrosion tests were carried out to measure the corrosion rate.  Experiments were carried out 
in Hanks‟ Balanced Salt Solution (HBSS) at 37 ± 0.5 °C and pH of 7.4  ± 0.05, buffered with 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (25mM).  500 mL of solution 
was used per sample for each hydrogen evolution test.  Glass burettes were used to collect the 
hydrogen gas and measure the total hydrogen evolved with a precision of ± 0.1 mL.  
Corrosion solution was refreshed every 72 hours to keep pH and ionic composition relatively 
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constant.  5 samples of each biomimetic, ECAD + biomimetic, and uncoated Mg were 
measured.  The H2 Evolution was monitored for a total of 14 days.   
Electrochemical tests were performed by potentiodynamic polarization (PDP) and 
electrochemical impedance spectroscopy (EIS).  A three electrode setup was used with a Pt 
counter electrode and a saturated calomel reference electrode (SCE).  300 mL of HBSS was 
used for each test. The area of the working electrode was 1 cm
2
. PDP tests were carried out 
after 20 minutes in solution to allow the open circuit potential to stabilize.  PDP tests utilized 
a scan rate of 1 mV/s, and scanned over the range OCP – 0.100 V to Ref + 0.500 V. EIS 
scans were performed once every hour over a period of 72 hours to evaluate the change in 
corrosion resistance with time.  An AC 10mV peak to peak signal from OCP across a 
frequency range from 50 kHz to 20 mHz was used.   
6.3. Results and Discussion: 
6.3.1.  Calcium Hydroxide Layer Formation by ECAD: 
Electrodeposition proved to be useful for depositing a calcium hydroxide coating on the 
samples.  The coating produced by ECAD in concentrated 2M Ca(NO3)2 solution was dense 
and covered the entire surface more or less uniformly (Figure 6-2A). The coating exhibited 
no areas that were not covered.   The coating consisted of Ca(OH)2 as confirmed by XRD 
(Figure 6-3) and EDS.  The ECAD process required an overvoltage to create a calcium 
hydroxide coating through the reduction of water (Figure 6-1). The surface of the magnesium 
was held at -3.2 V (vs. SCE).  The current through the cathode reduced water in the solution 
(Equation 6-1).  
2 H2O + 2 e
-
 → H2(g) + 2 OH
-
 Equation 6-1 
Ca
2+
 + 2 OH
-
 → Ca(OH)2(s) Equation 6-2 
The increase in pH had the effect of decreasing the solubility of Ca
2+
 ions in solution, 
resulting in the precipitation of solid calcium hydroxide on the surface of the substrates 
(Equation 6-2). The coating can be formed very quickly, a 10 µm thick layer formed in just 
10 minutes of deposition (Figure 6-2).  Once formed, the Ca(OH)2 acts as an electrical 
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insulator, limiting the amount of current output during the electrostatic coating process.  This 
limits the total thickness that may be achieved and longer deposition times were not found to 
significantly increase the coating thickness.  10 minutes was used to attain complete coverage 
of the surface.  The coating did cover the entire surface relatively uniformly after 10 minutes 
of treatment, and had enough adhesion that it did not readily scratch or flake away.   
 
Figure 6-1: Schematic of the ECAD process. 
 
Figure 6-2: Scanning electron microghraphs of ECAD Ca(OH)2 coating (A) and cross section 
of a bubble defect (B). 
The coating method does present a few problems.  The hydrogen gas evolved forms in 
bubbles that block Ca(OH)2 formation at the interface, resulting in volcano-like defect, as 
reported by Kumar et al. [29].  Figure 6-2B shows the cross section of such a gas bubble 
defect in the coating.  The gas bubbles can be minimized by stirring and or shaking to remove 
them more quickly from the surface.  This will also have the effect of dispersing the pH rise 
near the surface, and since the ECAD process relies on the reduction of water, there is no way 
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to eliminate the hydrogen gas bubbles completely.  As such, another method for depositing 
the calcium hydroxide layer might ultimately be found to be more suitable.   
 
6.3.2.  The Formation of the Biomimetic Coating on the Calcium 
Hydroxide Layer 
After the Ca(OH)2 layer was deposited on the magnesium, a calcium phosphate layer was 
applied to the surface.  The biomimetic coatings can be applied on top of other types of 
coatings [23], and the Ca(OH)2 served as a suitable surface for deposition.  The biomimetic 
coating created flake like structure of a calcium phosphate compound on the surface (Figure 
6-4).  According to the glancing angle XRD (Figure 6-3), the coating formed mainly 
dicalcium phosphate dihydrate, or brushite [30].  The biomimetic layer produced on the 
surface of the ECAD coated material is slightly different to the biomimetic layers produced 
on bare magnesium substrates in morphology (Figure 6-4A and B).  The difference can be 
attributed to differences in crystal growth and nucleation as well as small changes in 
composition due to the Ca rich ECAD layer.   
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Figure 6-3: GA-XRD of Ca(OH)2 coating by ECAD (A), biomimetic coating (B), and ECAD 
+ biomimetic coating (C). 
Biomimetic coatings can protect against magnesium corrosion by themselves, however the 
coatings tend to have a few problems.  The coatings are deposited in solutions similar to the 
body fluids, and therefore often include additional phases and ionic substitutions in the 
crystal lattice.  While these increase the biocompatibility compared to crystalline synthetic 
CaP [4, 7] the resulting phases also tend to increase the solubility [15], and thus decrease the 
corrosion resistance.  Substitutions in the lattice with Mg is typically high, especially on a Mg 
substrate, which tends to corrode during the process, creating a high Mg
2+
 concentration near 
the surface of the substrate.  Mg
2+
 has the effect of decreasing the crystallinity of the calcium 
phosphate [25].  For ECAD samples, the corrosion of the magnesium during the biomimetic 
coating was mitigated by the calcium hydroxide coating.  Rather than the Mg substrate 
corroding in the coating solution, the Ca(OH)2 protected it. The pH rise that helps form 
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coatings in solution due to magnesium corrosion [18] can instead be created by the 
dissolution of calcium hydroxide.  This could help to prevent so many Mg ions from getting 
into the coating. Mg ions break up the lattice [31] and this ultimately creating a more soluble 
and less protective coating.   
Additionally, The Ca(OH)2 layer provided a surface of calcium that is slightly soluble for the 
CaP layers to convert to and nucleate on. The phosphate groups in the biomimetic solution 
can replace hydroxide groups on the surface of the ECAD layer to form the more insoluble 
calcium phosphates.  CaP then provides sites for further nucleation of the biomimetic coating.  
This could account for the differences observed in the morphology (Figure 6-4) and 
composition between the two coatings (Figure 6-3).   
 
Figure 6-4: Biomimetic 1 coating before (A) and after corrosion in HBSS for 24 hours (C).  
ECAD + biomimetic coat before (B) and after corrosion in HBSS for 24 hours (D). 
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6.3.3.  The Effect on Corrosion Protection of the ECAD + Biomimetic 
Coating 
Corrosion protection of coatings was assessed in HBSS at 37 °C to simulate the chemical 
conditions found in human body fluid.  The corrosion mechanism to be studied was the 
protection against chloride ion attack as well as the deposition of calcium phosphate 
compounds on the surface from the SBF [18]. Hence, HBSS was chosen for the tests because 
it contains these salts without the complication of other compounds such as proteins.  The use 
of the HEPES buffer prevents the corrosion reaction from changing the pH of the solution 
without the need for an active pH control system such as that found in the body.  The 
corrosion solutions were used for up to 72 hours, after which the pH of the solution was kept 
within ± 0.1 for all samples by the HEPES buffer.   
 
Figure 6-5: Total hydrogen evolved over 14 days. 
The corrosion rate was monitored by hydrogen gas evolution in order to examine the longer 
term corrosion behaviour of these coatings(Figure 6-5).  The hydrogen evolution of the 
ECAD modified coatings was compared to uncoated Mg and both coatings described in 
earlier chapters.  The uncoated samples exhibited rapid corrosion. For uncoated samples, the 
curvature of the early part of the graph showed accelerating corrosion rate.  This is due to 
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local pitting of the Mg surface [32]. This effectively increased the surface area available to 
the solution, leading to an accelerating corrosion rate.  Later, this rate slowed as the calcium 
phosphate was deposited on the surface of the Mg [33].  This layer begins to protect the 
surface.  As such, beyond ~250 hours of corrosion in SBF the corrosion rate decelerates.  But 
already significant amounts of H2 gas had been generated, by 350 hours the average amount 
of gas per sample is 35.6 mL (Table 6-1). So to form this protective layer in SBF required a 
large amount of corrosion to occur. This is unacceptable for degradable implants as the 
mechanical strength of the implant needs to survive during the initial stages of healing [34].   
Table 6-1: Comparison of corrosion values 
 
 
 
 
 
Figure 6-6: Potentiodynamic polarization curves for selected samples after 72 hours 
immersion. 
Coating Icorr 
(µA·cm
-2
) 
RP  at 72 
(hours 
(Ω·cm2) 
 H2 at 14 
days 
(mL·cm
-2
) 
ECAD + 
Biomimetic 
3.4 8547  1.3 
Biomimetic 2 16.8 3280  4.7 
Uncoated Mg 34.8 1640  35.6 
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The biomimetic coatings are applied to simulate this process and create the protective coating 
before it is exposed to the solution.  The biomimetic 2 coatings protect the substrate from 
corrosion by blocking the corrosive environment from the underlying Mg.  Indeed, early in 
the life of the coating both of the biomimetic calcium phosphates provided much greater 
protection from the corrosive environment than the uncoated counterparts (Figure 6-5).  The 
PDP tests showed the biomimetic coating had a lower corrosion current density (Figure 6-6) 
than the uncoated Mg, and a corresponding higher polarization resistance (Figure 6-7).  The 
lower current density was due to the smaller portion of exposed area to the solution.  Thus, 
there was a decrease in the anodic reaction rate.  The corrosive solution cannot attack the 
magnesium where it is protected by the calcium phosphate coating.  However, there were 
cracks and defects in the coating where the corrosion could continue, as seen in Figure 6-3A.  
These cracks create an imperfect coating that allows the corrosion reaction to progress.  This 
effect can be seen by the two time constant frequency response to polarization that 
corresponds to a porous coating (Figure 6-9).  The biomimetic 2 coating exhibits a resistance 
and capacitance of the coating itself and one for the electrolytic double layer (EDL) that 
forms the interface with the metal to solution.  Contrast this to the uncoated Mg which 
exhibits a single semicircle corresponding to the EDL without significant contribution of a 
coating layer.  Thus, the corrosion rate and corresponding H2 generation is lower for 
biomimetic coated samples, but the defects in the biomimetic coating still allowed corrosion 
to occur.  
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Figure 6-7: Total coating polarization resistance over 72 hours immersion in HBSS. 
Over time, the biomimetic coating properties changed.  While the polarization resistance was 
relatively steady over the first 72 hours, the corrosion rate remained relatively low.  Later on, 
the coatings begin to fail.  The size of the defects increased, as seen in Figure 6-4C.  The 
brushite coating created were not as stable as apatite coatings, as they can partially dissolve in 
SBF [14].  Furthermore, as the substrate was attacked underneath, the coatings would 
delaminate from the surface, exposing more area for corrosion [2].  As this happened, the 
average amount of corrosion increased.  The variability of the coating increased as well, as 
coatings delaminated nonuniformly across the sample population.  Figure 6-5 shows this 
trend of increasing corrosion, although the rate is still less than the uncoated samples.  
Clearly the biomimetic coatings protect from corrosion, but the defects allow some corrosion 
to occur.  If coatings such as these are to be used for slowing the corrosion rate, this problem 
of corrosion through defects in a metastable biomimetic coating is a significant challenge.  
 
The ECAD coatings attempt to solve this problem by using the Ca(OH)2 under layer to 
enhance the corrosion resistance of the biomimetic coatings.  The Ca(OH)2 is slightly soluble 
in the biomimetic coating solutions, leading to better coverage and conversion of the coating.  
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The initial polarization resistance of the ECAD coatings are higher than the biomimetic 
coatings (Figure 6-7).  There is a corresponding decrease in the corrosion current density 
measured by PDP in Figure 6-6 as well.  Compared with the uncoated Mg, the ECAD coating 
decreases both the anodic and cathodic reaction rates.  While both coatings slow the anodic 
reaction the ECAD coating also affects the cathodic reaction, leading to the much lower H2 
formation rate. This indicates that the layer formed after the biomimetic coating process, 
while similar in composition leaves a smaller area of defects though which to continue the 
corrosion reaction.  The polarization resistance over the first 72 hours displayed an interesting 
trend.  The ECAD coated samples actually increased in polarization resistance as time passed 
in the corrosion solution.  This indicates that as the samples were immersed, the protective 
qualities of the coating actually increased.   
 
Figure 6-8: Schematic of the proposed self-healing process that occurs with the introduction 
of a Ca(OH)2 coating via ECAD. 
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The mechanism of this can be explained by the high concentration of calcium in the layer 
under the biomimetic coating (Figure 6-8).  As the calcium hydroxide dissolves, the ions 
combine with phosphate ions in solution to form insoluble calcium phosphate phases at the 
corrosion sites.  This effectively blocks corrosion and preserves the integrity of the coating, 
which exhibits much less damage after exposure to the solution (Figure 6-4D).  Contrast this 
with the corrosion of the Mg substrate on the biomimetic only coated samples.  The 
subsequent release of free Mg
2+
 ions inhibited the formation of calcium phosphates [25] and 
does not repassivate the defects (Figure 6-4C).  This benefit was very pronounced over the 14 
days of corrosion.  While H2 generation is large for the other samples, the ECAD coatings 
preserve their integrity and only allow a small amount of corrosion, only evolving an average 
of 1.3 mL of H2 over the test period (Table 6-1).  The improvement in the coating properties 
over time allowed this coating to remain intact and protective for a much longer period of 
time than the biomimetic coating by itself.   
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Figure 6-9: Nyquist plots of impedance data for representative samples at 7 and 72 hours 
immersion in HBSS. 
 
The ECAD coating polarization resistance showed the typical 2 time constant porous coating 
behaviour in the early stages (Figure 6-9A). Over time, a single time constant grew to 
   
165 
 
dominate the corrosion behaviour (Figure 6-9B).  The decreased amount of defects made the 
coating resistance dominant and the corresponding effect of the EDL less prevalent.  At low 
frequencies, the uncertainty on the ECAD coatings was relatively large, which may have 
obscured the secondary time constant that the coating was expected to exhibit.  From the 
polarization behaviour over time (Figure 6-7), it can be seen that the ECAD coatings are quite 
variable in performance compared to the biomimetic coatings.  This suggests that the coatings 
are very sensitive to the coating parameters.  The volcano shaped defects due to the ECAD 
process may have left areas of lower calcium hydroxide coverage that adversely affected the 
performance of the coatings.  Further investigations into controlling the properties of this 
layer are therefore needed.  However, the effect on the stability and corrosion protection of 
the biomimetic coatings suggest this coating method is promising as a step toward 
overcoming the barriers to using biomimetic coatings for corrosion protection of magnesium 
implants.   
6.3.4.  Crystal Structure Changes after Corrosion of ECAD Coated 
Samples 
The proposed mechanism of the ECAD Ca(OH)2 coatings is the Ca(OH)2 dissolves and 
combines with phosphate and carbonate ions to seal the gap and defects in the outer 
biomimetic layer.  The changes in coating composition support this mechanism.  Figure 6-10 
shows the X-ray diffraction patterns for the samples after the 2 week hydrogen evolution 
tests.  As previously discussed, the uncoated Mg undergoes corrosion, raising the pH near the 
surface, and eventually depositing a magnesium calcium carbonate phosphate layer.  This 
layer is very amorphous, as seen by the very wide hump in the diffraction pattern.  Whereas 
highly crystalline structures have sharp, well defined peaks, this layer has little long range 
order in the structure [35].  The biomimetic coatings, composed mostly of DCPD [30] began 
showing peaks of apatites [36], converting the existing structure to a more stable phase.  
However, this coating did not repair the defects, leaving large gaps for corrosion to occur 
(Figure 6-4).   
The ECAD layer below the biomimetic coating did not significantly alter the phases present, 
as these samples also displayed peaks of semi-crystalline DCPD.  In addition to these peaks, 
peaks matching calcium magnesium carbonate appeared (Figure 6-10) [37].  The coating also 
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showed the formation of amorphous structures at low angles similar to that of uncoated Mg.    
This is evidence of very small crystal sizes of the newly deposited calcium compounds [35].   
 
Figure 6-10: GA-XRD of uncoated Mg, Biomimetic 2 coatings, and ECAD + Biomimetic 2 
coatings in HBSS + HEPES at 14 days immersion time. 
6.4. Effect of Buffer Choice on Corrosion of ECAD + 
Biomimetic Coated Samples 
Corrosion of ECAD coated samples in HCO3 was not vastly different compared with other 
types of biomimetic coatings in the HCO3 buffer system.  The early corrosion properties of 
the ECAD coated samples in all solutions were very similar in ECorr and iCorr to the 
Biomimetic 2 samples (Figure 6-11).  The polarization in NaCl and HBSS over the first 8 
hours was nearly identical in HEPES buffered solutions for all of the ECAD samples (Figure 
6-12).  This is evidence that the early corrosion behaviour is more related to the initial 
condition of the coating.  The difference in the corrosion reactions do not take place until 
after the samples have been corroding long enough for the self healing properties of the 
ECAD layer to alter the corrosion behaviour as shown in Figure 6-6.  However, the lower 
buffer capacity and high carbonate content of the HCO3 buffered HBSS shows the large 
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anodic protection for the ECAD coated samples after 8 hours, and the polarization resistance 
of the layer has the steepest increase as well (Figure 6-13).   
 
Figure 6-11: ECorr and iCorr of uncoated Mg, biomimetic coatings 1 and 2, and ECAD + 
biomimetic 2 coatings in solutions buffered with HEPES and HCO3. 
Overall, the fact that the HCO3 buffers react similarly to all of these coatings gives us 
confidence that the corrosion reaction in vitro will be similar with the carbonate buffer, and 
therefore similar to the actual carbonate buffer presented in vivo.  It is expected that the self 
healing properties of the coating will continue to repair the defects that are present for any of 
these solutions, provided phosphate and carbonate are present, both of which are plentiful in 
vivo.  Of course, this will need to be tested with more complicated in vitro solutions to make 
sure the properties are the same, such as with the addition of amino acids and proteins.  
Finally, the coatings will need to actually be tested in vivo to make sure they will perform as 
expected.  However, the corrosion properties in vitro remain very promising to solve the 
mechanical problems that arise from defective biomimetic coatings.   
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Figure 6-12: PDP of ECAD + Biomimetic 2 coated samples in solutions buffered with 
HEPES and HCO3. 
 
Figure 6-13: Early stage polarization resistance of Biomimetic 2 and ECAD + Biomimetic 2 
coatings in solutions buffered with HEPES and HBSS. 
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6.5. Conclusions 
ECAD of calcium hydroxide can increase the corrosion protection of the biomimetic coating. 
The ECAD coating provides a more resistant biomimetic coating with fewer defects. The 
corrosion protection did not degrade over time for the ECAD coatings as it did for the 
biomimetic coatings.  The ECAD method for deposition of the Ca(OH)2 was found to be 
effective with very short deposition times.  However, volcano shaped defects and bubbles in 
the coating were observed, which may decrease the overall protectiveness of the coatings.  
The biomimetic coating was deposited onto the ECAD layer, and this layer did not 
significantly change the final composition or structure of the layer.  The amount of defects in 
the final layer was lower, leading to higher initial corrosion resistance.  It was concluded that 
the Ca(OH)2 layer promotes the deposition of a complete and low defect biomimetic coating.   
The real benefit of the ECAD Ca(OH)2 was the improvement to the corrosion properties of 
the coating over time.  As corrosion progressed, the protectiveness of the ECAD coatings 
increased due to the calcium rich layer depositing additional protective calcium phosphates at 
corrosion sites.  The availability of a semisoluble calcium rich layer to deposit in the defects 
greatly improved the corrosion resistance as corrosion occurred.  This led to the coating 
remaining intact with few defects after the corrosion period, and very little H2 gas generated 
over the 14 day experiment.  This can be translated into very low corrosion of the substrate, 
and therefore the mechanical properties will be retained, and the H2 that is generated can be 
safely removed.  For a biodegradable implant application where corrosion behaviour is 
critical, a self healing coating such as the one describe here may provide much better 
corrosion properties than typical biomimetic coatings by themselves. Therefore, the calcium 
hydroxide layers are promising as a route to improving the corrosion resistance of biomimetic 
coatings.   
As with other coatings, the differences between the in vitro test with HEPES and HCO3 
buffer systems were tested. As HEPES has higher buffer capacity than HCO3 in vitro, and 
does not accurately represent the carbonate ions in the body, it could be the case that the 
mechanisms of corrosion will not be quite the same when the coating system is moved from 
in vitro to in vivo.  The performance of the ECAD + biomimetic coating in HCO3 buffered 
HBSS was actually more corrosion resistant than in HEPES.  The additional carbonate ions 
and larger pH rise led to earlier deposition of calcium compounds, further protecting the 
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substrate.  The good initial performance of the coating in HCO3 buffered solutions indicates 
that the mechanism of protection this coating provides will persist in other solutions and 
remain more protective in carbonated buffered solutions such as the body.   
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CHAPTER 7:  Effect of Amino Acids and 
Proteins on the in vitro Corrosion Rates of 
Coatings on Mg 
In vitro tests necessarily reduce the complexity of the actual in vivo environment.  The 
corrosion mechanism of Mg is influenced by the amount of Cl
-
 present, as well as the 
inorganic salts that are present in physiological fluids.  These simple test environments are 
suited to corrosion protection measurements for coatings and other surface treatments that 
seek to reduce the attack of Cl
-
 to the underlying Mg, thus limiting the corrosion rate.  This 
will be a key function if the mechanical properties of an otherwise fast degrading Mg or Mg 
alloy are to be retained in load bearing applications.  However, the actual environment faced 
does not contain only these ions, and therefore and understanding of how these coatings react 
with more complicated corrosion environments will be necessary to understand the actual 
degradation mechanisms and rates.   
Organic elements such as amino acids and proteins are present in the body.  While these do 
not necessarily react directly with the electrochemical corrosion reactions, they have been 
reported to affect the corrosion rates of degradable Mg implants in vitro [1].   The adsorption 
or adherence to the surface of biomaterials by these organic molecules can affect the 
corrosion rate of the Mg.  Therefore, understanding the influence they have on the 
mechanisms of coated samples will be necessary for optimizing and designing in vivo 
corrosion response of a coated Mg implant.   
7.1. MEM: the Addition of Amino Acids 
The cell culture medium Eagle‟s Minimum Essential Medium (MEM) is a formula containing 
ionic compounds similar to the body and other in vitro solutions as well as a number of 
amino acids to provide a suitable environment for cell cultures.  It is quite widely used for 
cell culture and has utilized in studies of Mg corrosion as well [2].   
Amino acids affect the buffer capacity of the in vitro solutions [3].  The additional buffering 
may therefore affect the corrosion rates by keeping the pH lower than it would be without 
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them.  They may also chelate with Mg and inhibit the formation of the insoluble Mg 
compounds that form the passive layer, decreasing the corrosion resistance [2].   It has also 
been reported that the amino acids can be adsorbed onto the surface Mg alloys and increase 
the corrosion resistance [4].   
The addition of the amino acids to measure corrosion rate bridges the gap between simple 
ionic solutions and more complicated protein solutions for corrosion testing.  As such, MEM 
has been used for in vitro corrosion tests. Chen et al. used MEM as a more realistic corrosion 
environment to test a hydroxyapatite coating [5].  Others have used Dulbecco's Modified 
Eagle Medium (DMEM), a version of MEM with additional amino acids present to test the 
corrosion response [6].  Proteins can be added to MEM to create a more realistic medium for 
corrosion testing [7, 8].   
Proteins can also influence the corrosion properties of metals [9].  Protein interaction is 
important to the biocompatibility of implants as well [10].  Proteins are built of chains of 
amino acids.  The structures of proteins typically have functional groups on the outside of the 
protein that can be polar, nonpolar, hydrophilic or hydrophobic, thus creating a complex 
surface.  The overall charge of which depends on the pH of the environment for a given 
protein with a given isoelectric point[10].  The charge and surface composition will affect the 
adsorption rates of the proteins on the surface.  The adsorption of these proteins can affect the 
corrosion surface and thus the interactions will be important for corrosion behaviour.  Foetal 
bovine serum (FBS) has been used to provide proteins for in vitro SBFs for corrosion tests [7, 
8, 11, 12].  FBS is taken from the blood plasma of a calf fetus.  It‟s often used for cell culture 
work for the amount of growth factors it contains as well as the low number of antibodies 
[13].  FBS contains proteins amounting to 30-45 g/L [14] with the majority of the protein 
composition made of bovine serum albumin (BSA) [15].  This is the bovine equivalent of 
human serum albumin, which accounts for about half of the blood serum protein in humans.  
BSA can be purified from bovine blood more cheaply than complete FBS can be procured.  
For the corrosion tests here for cost and simplicity, BSA was added to determine the effect of 
proteins on the corrosion properties of the coated samples.  The amount of protein added to 
the MEM for corrosion tests was 40 g/L as used by Rettig and Virtanen [16, 17], and later 
Kirkland [11], as an accurate representation of the physiological amounts of HSA in the 
body.   
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The corrosion properties of Mg and Mg alloys have been shown to be affected by the addition 
and concentration of proteins.  Studies show adding proteins have been shown to slow 
corrosion of various Mg alloys [2, 12, 18-20].  However, the effect is not always clear due to 
the complex nature of the interactions.  Mueller et al. reported corrosion rates of pure Mg in 
PBS increase when BSA is added to 0.1% but then decrease as further BSA is added (up to 
10%).  This trend depended on alloy as well, AZ31 showed very little change in corrosion 
rate across BSA concentrations, while LAE442 had steadily increasing iCorr.  Kirkland et al. 
showed that the addition of 10% FBS slowed the corrosion rate of a number of alloys as well 
as pure Mg in MEM [11].  However, increasing additions of BSA to MEM solutions from 20 
to 60 g/L led to increasing corrosion rates for pure Mg, although all were ultimately lower 
than MEM alone.  These varying trends suggest the corrosion influence of proteins is more 
complicated than the simplistic adsorption model, as proteins in solution has a complicated 
effect on the passivation layers that form [21]. In an effort to investigate the effect proteins 
have on the corrosion properties of biomimetic coated samples, the coatings were 
investigated in MEM with and without BSA.   
  
7.1.1.  Materials and Methods 
7.1.1.1. Corrosion Media 
Solutions of Eagle‟s Minimum Essential Medium (MEM) were prepared with and without 
bovine serum albumin (BSA) at 40g/L.  The solution composition is given in Table 7-1.  The 
solutions were buffered to an initial pH of 7.40 with 25mM HEPES and NaOH at a 
temperature of 37 degrees C.  Bicarbonate buffered solutions were tested in an incubator with 
a 5% CO2 atmosphere.   
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Table 7-1: Composition of corrosion media 
Component 
 
 
Human 
plasma 
(HP) 
Hank’s 
balanced salt 
solution 
(HBSS)a 
Minimum 
essential 
medium 
(MEM)c 
MEM + 
bovine serum 
albumin 
(MEM+BSA)d 
Na+ 142 145 117.4 117.4 
Cl- 103 144.6 123.5 123.5 
K+ 5.0 5.8 5.4 5.4 
Ca2+ 2.5 1.3 1.8 1.8 
Mg2+ 1.5 0.4 0.4 0.4 
HPO4
2- 1.0 0.8 1 1 
SO4
2- 0.5 0.4 0.4 0.4 
D-Glucose 5 5.5 5.5 5.5 
Bicarbonate 
(HCO3
-) 
22-30 ± 26.2 ± 26.2 ± 26.2 
HEPES - ± 25 ± 25 ± 25 
Phenol red - 0.03 0.03 0.03 
Albumin 
(g/L) 
34-54 - - 40 
All concentrations in mmol/L unless otherwise stated.   
Concentrations of inorganic blood contents given as in [22]. 
a (H1641, Sigma-Aldrich), b (E7510, Sigma-Aldrich), c (56414C, 
Sigma-Aldrich), d (MP Biomedical NZ Ltd) 
 
 
7.1.1.2. Coatings 
Pure Mg samples were prepared (Helmholtz-Zentrum Geesthacht).  Samples were polished 
up to 600 grit SiC paper and rinsed with ethanol.  Biomimetic coatings were carried out as 
described in Chapter 5.  ECAD + Biomimetic coatings were carried out as described in 
Chapter 6.   
7.1.1.3. Electrochemical Testing 
PDP was used at 30 min of settling time and at 8 hours to determine the polarization 
resistance and the change in polarization resistance for the early stages of corrosion.  5 tests 
were performed per timepoint to determine the uncertainty of both the experiments and the 
Tafel-fit extrapolations.  PDP scans went from 150 mV below OCP to 250 mV above OCP or 
to 1mA applied current.  Scans were performed at a rate of 1 mV/s.   
   
177 
 
EIS was used to measure the polarization resistance of the coating and corrosion layers.  One 
sample from each group was monitored once per hour from 1 to 7 hours immersion.  
Frequency range from 50kHz to 30 mHz was used. The amplitude of the signal was 10mV, 
and 5 measurements per frequency were averaged.   
7.2. Effect of Amino Acids on the Corrosion Properties of Mg 
7.2.1.  Uncoated Mg 
The polarization behaviour in MEM was compared to that of HBSS.  Table 7-1 shows the 
compositions of both fluids are similar, and have the same Mg
2+
 ion content.  However, 
MEM has slightly lower Cl
-
 as well as higher Ca
2+
 and PO4
3-
 concentrations.  The difference 
here might suggest slightly decreased corrosion rates and slightly increased CaP formation in 
solution.  The polarization of uncoated Mg in both solutions showed that ECorr is higher in 
MEM than in HBSS once the layer has settled (Figure 7-1).  The corrosion current density is 
initially higher in MEM than in HBSS.  This is counterintuitive given the higher ECorr, and 
lower amount of Cl
-
 in MEM.   Higher corrosion could be observed due to the increased 
buffer capacity provided by amino acids [3], as well as the proposed mechanism that amino 
acids chelate with Mg
2+
 and inhibit passive layer formation [2].   
 
Figure 7-1: Corrosion potential and current density for coated samples with and without 
amino acids and proteins. 
   
178 
 
With a similar composition of inorganic ions, and the addition of a number of amino acids 
which may act as charge carriers, the possibility exists that the higher current measurements 
were an artefact of solution conductivity.  The conductivity of the solutions was measured 
with a conductivity meter and it was determined MEM had slightly lower conductivity than 
HBSS with HEPES, showing that this was not the case (Figure 7-2).   
 
Figure 7-2: Solution Conductivity at 37° C with the HEPES buffer. 
 
7.2.2.  The effect of MEM on the Corrosion of Coated Samples 
Figure 7-3 reveals the polarization behaviour of coated samples in HBSS vs MEM.  The 
reaction kinetics displays a trend across samples.  The increase in both ECorr and iCorr in MEM 
over HBSS was primarily due to the large increase in the cathodic kinetics.  The anodic 
kinetics were similar in both solutions, possibly decreased slightly for pure Mg, although this 
was not the dominant effect.  While it has been reported that the polarization resistance of 
steel and aluminium was increased by amino acids [23, 24], polarization resistance was lower 
in MEM for uncoated Mg over the first 7 hours (Figure 7-4).  For each time point, both the 
film and EDL resistance was lowered by the presence of the amino acids.  Therefore 
adsorption of amino acids resisting corrosion is not slowing corrosion in the short term.  
Instead the opposite effect is taking place. The lower passive film resistance supports the 
findings of Yamamoto et al. [2].  Resistance increased with time, doubling after 7 hours.    
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Figure 7-3: PDP in HBSS vs. MEM buffered with HEPES at 8 hours immersion. 
Coated samples exhibit similar behaviour in the presence of amino acids.  The polarization of 
biomimetic coatings show that the cathodic reaction was again increased in MEM.  Unlike 
uncoated Mg, this shift was accompanied by a decrease in the anodic kinetics.  The anodic 
kinetics do not offset the corrosion density initially, but after 6 hours the effect is to bring the 
biomimetic coated sample in MEM below the corrosion rate in HBSS.  This behaviour is 
mirrored by the polarization resistance.  The biomimetic coated samples have lower 
resistance in MEM initially, but by 7 hours the film resistance is almost equal.  This, coupled 
with the more noble potential leads to a reduction in the corrosion rate.  The ECAD coating 
increases these differences even more dramatically.  In MEM the cathodic reaction rate is 
much higher, although not quite so high as uncoated Mg.  The large decrease in the anodic 
reaction in MEM indicates that the ECAD layer accounts for the decrease seen in the 
corrosion rate.  With the improved properties of the coating, the amino acids do not have the 
effect on the uncoated Mg.  The interference in the growth of the passivation layer does not 
affect the ECAD coating as it does the uncoated and biomimetic coated samples.   
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Figure 7-4: EIS of all samples in HBSS and MEM buffered with HEPES at 1 (A) and 7 (B) 
hours immersion. 
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7.3. The Effect of Proteins on Corrosion Properties of Coated 
Samples 
7.3.1.  Uncoated Mg 
Uncoated Mg displayed highly invariant corrosion potential in both MEM and MEM + BSA 
over the duration of the tests (Figure 7-1 A).  The proteins do not directly interact with the 
corrosion of pure Mg in solution.  For uncoated Mg, the proteins decreased the cathodic and 
anodic kinetics at 30 minutes (Figure 7-5) and 8 hours (Figure 7-6) without changing the 
corrosion potential significantly.  The effect of proteins is reported to be in the adsorption to 
form a protective layer [18, 19].  The total corrosion current density for Mg in MEM was 
initially high, over 140 µA/cm
2
 but decreased rapidly over the 8 hours of testing (Figure 
7-1B). The decrease can be attributed to the formation of the hydroxide layer, the charge 
separation, and the local pH rise with the immersion time decreasing the corrosion rate. In 
Figure 7-7A the PDP of the uncoated samples shows that over the test, there was a slight drop 
in both the anodic and cathodic branches, consistent with the formation of a the corrosion 
layer.  This is confirmed by EIS in Figure 7-8 A and B as Mg in MEM shows the 2 time 
constant system characterizing a semi-protective hydroxide layer.  After 8 hours, the total 
impedance of both the oxide layer and the EDL increased, indicating the corrosion film 
became slightly more protective as corrosion occurred and the layer formed.  Figure 7-9 
shows the slow and steady rise of this resistance.   
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Figure 7-5: PDP of all samples in MEM and MEM + BSA at 30 minutes. 
 
Figure 7-6: PDP of all samples in MEM and MEM + BSA at 8 hours. 
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When albumin is added to the solution, the ECorr does not change much, but the corrosion 
current density drops considerably.  The variation in iCorr is greater as well.  Figure 7-7 shows 
that after 30 minutes, BSA addition decreases the cathodic reaction greatly and the anodic 
reaction somewhat.  After 8 hours, it is observed that the anodic and cathodic reactions are 
suppressed by the albumin, as the anodic reaction decreases with time in the BSA solutions 
(Figure 7-7 A).  The total corrosion current density is thus fairly constant in BSA over the 8 
hours for pure Mg.  The Nyquist plots in Figure 7-8 show that the relative shape is similar to 
MEM though the resistances are increased in magnitude, and furthermore stays relatively 
constant over the test period.  The explanation for this is found in the proteins impeding 
corrosion by attaching to the surface and forming a protective layer as reported elsewhere 
[16-19].  Albumin has been shown to increase ECorr of Mg by decreasing the anodic reaction 
rate on AZ91 [18], as well as increase the anodic reaction rate on WE43 and LAE442 [25]. 
Over the time period here, both anodic and cathodic reactions decreased with addition of 
BSA as reported by Kirkland [26], and along with the EIS data the mechanism seems to be 
adsorption of proteins to the Mg surface creates a layer that partially protects by reducing the 
effective surface area available to corrosion.  The reported effect that chelating metal ions 
with the proteins would increase the corrosion rate [9] was not apparent in this study, as has 
previously been reported for pure Mg [21].   
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Figure 7-7: PDP over time in MEM and MEM + BSA for A) uncoated Mg, B) Biomimetic 
coated and C) ECAD coated samples. 
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Figure 7-8: EIS of solutions with and without proteins at 1 (A) and 7 (B) hours. 
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7.3.2.  Biomimetic Coated Mg in Protein Solutions 
The biomimetic coatings had the effect of reducing the corrosion potential in the short run, 
but this increased towards the direction of the uncoated samples in both solutions over the 8 
hours of testing (Figure 7-1). The corrosion current density behaved in a similar manner to 
what would be expected for these coated samples.  The early corrosion rates in both solutions 
are quite high, but decrease as time goes on.  The rate drops with increasingly noble 
potentials, as the corrosion layer forms and the coating reduces the corrosion rate.  Here, the 
addition of proteins provided a decrease in the corrosion rate early on, and this protection was 
improved over the 8 hour test.  Comparing the polarization behaviour in Figure 7-5, the 
protection early on due to the proteins comes from a decrease in the cathodic kinetics.  This is 
again the case with the biomimetic coatings after 8 hours (Figure 7-6) where the lower 
cathodic kinetics provides a lower corrosion current density despite an increase in anodic 
kinetics due to the more negative potential.   
In Figure 7-7B, the trend of increasing time shows that the cathodic kinetics of each solution 
remained fairly constant over the test period. The decrease in anodic kinetics therefore drives 
the reduction in corrosion current density.  The decrease in the corrosion reaction is due to 
the improvement in properties of the layers that form.  For the coated samples, BSA resulted 
in less anodic shift than MEM alone.  The corrosion layer here also exhibits the typical 2 time 
constant system of a semi-porous coating (Figure 7-8).   After an hour in solution, the 
additional proteins in the BSA solution increase the magnitude of the layer resistance, 
suggesting the proteins are adsorbing on the surface and reducing the area vulnerable to 
corrosion.  Interestingly, the size of the impedance of the biomimetic coated sample in BSA 
is comparable to the uncoated Mg at this time in BSA, which is larger than the impedance of 
the biomimetic coated sample in MEM alone.  Thus the presence of proteins in this solution 
radically changes the corrosion layer properties.  Indeed, the initial corrosion current density 
in MEM and MEM + BSA is higher and nearly equal to (within error) the corrosion rates of 
uncoated Mg in MEM + BSA.  Thus, the reduction of corrosion rate at least initially due to 
proteins is significant.  Unfortunately, the barrier to corrosion that the proteins provide does 
not appear to provide lasting protection, as the corrosion rate by impedance of the uncoated 
Mg in protein-containing solutions stays constant or rises over the test period. 
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The biomimetic coatings, which have some corrosion initially, show slightly improving rates 
over the 8 hours of testing whereby the total impedance improves as the layer on the 
biomimetic coatings approaches steady state, while the proteins alone do not provide the 
lasting protection of these calcium phosphates.  The biomimetic coating is porous [27], and 
the local pH rise inside these pores lead to decreasing corrosion rates as corrosion occurs.  
This accounts for the decrease in anodic reaction rate over time and the improvement in the 
film resistance.  When proteins are added to the solutions, the film resistance improves even 
further.  The corrosion potential is lower, leading to an increase in anodic kinetics, but despite 
this the overall corrosion current density is lowered by proteins for biomimetic coated 
samples.   
 
7.3.3.  ECAD + Biomimetic Coatings:  
The ECAD improvement to the biomimetic coatings is also apparent in the protein solutions.  
The corrosion resistance of the coatings is greatly improved over the standard biomimetic 
coatings in simple SBFs as described in Chapter 6.  The corrosion potential of ECAD coated 
samples was quite variable for these tests.  Early ECorr values are near that of uncoated Mg, 
and the potential becomes more positive as time progresses in either solution.  iCorr is initially 
much lower than other uncoated and coated samples, as a testament to the improved 
formation and composition of the coating structure.  Again, in MEM and MEM + BSA, the 
coating properties improve over time and the corrosion current density drops over the 8 hour 
test.   
In MEM + BSA, the ECAD coating iCorr is down but more variable and not lower than ECAD 
in MEM alone.  At 30 minutes, the addition of proteins to the MEM solution causes a 
decrease in the cathodic reactions, as with the other samples (Figure 7-5).   However, this is 
coupled with an increase in the anodic kinetics when proteins are added.  This trend is also 
apparent after 8 hours.  So while the proteins appear to adsorb and impede the diffusion of 
solution to the metal, slowing the production of hydrogen gas, they also prevent/slow the 
reformation of calcium phosphates on the surface of the biomimetic coating due to the ECAD 
calcium hydroxide layer [28].  As such, the total protection of these coatings takes longer to 
show up in protein solutions.  However, the phenomenon is still passive enough to provide 
   
188 
 
the most corrosion protection in protein solutions.  At 1 hour (Figure 7-8A) the total 
impedance of ECAD samples in both protein solutions is showing a large coating impedance 
and a large additional EDL impedance as the solution moves into the pores of the coating.  At 
7 hours (Figure 7-8B) the impedance has grown, and the coating resistance shows small 
capacitance, as the insulating properties of the coating resist build up of charge, and the EDL 
impedance is relatively large, as there is now very little defects and pores in the coating for 
corrosion to occur.  Again, here the proteins impede the process, and the impedance in BSA 
is lower in this solution than MEM alone.  The proteins slow the self healing mechanism of 
the ECAD coatings, leading to a larger measured corrosion rate.  However, both ECAD 
coatings in both solutions show the characteristic improvement over time that is the 
mechanism of the coating system (Figure 7-9).  Therefore, in more complicated SBFs that 
include amino acids and proteins, the ECAD layer of calcium hydroxide still provides 
increased corrosion protection for biomimetic coatings.   
 
Figure 7-9: EIS over time total polarization resistance. 
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The response of the coatings across all MEM solutions and time points shows the 
mechanisms of the coatings in these protein solutions (Figure 7-10).  The corrosion potential 
of uncoated Mg has a low correlation with iCorr.  The large changes in corrosion rate are not 
accompanied by changes in ECorr which suggests that the proteins do not strongly interact 
with the corrosion reactions and products.  Instead, the rate changes arise due to the limited 
diffusion as a result of the forming layer [19, 21].  Biomimetic coatings follow a trend as the 
corrosion occurs on the coated samples ECorr and iCorr increase and decrease, respectively, 
with time.  Proteins in solution shift this curve down to lower corrosion rates and lower 
potentials due to the adsorption layer that both retards the corrosion current density and slows 
the formation of the layer.  ECAD coated samples corrosion rates correlate closely to iCorr.  
Where the corrosion potential becomes more noble, the corrosion decreases.  Here, the 
protein additions actually increase the measured corrosion rate for each time point, as they 
retard the repair of the coating layer.  However, this will not prevent the self healing 
mechanism of these coatings from continuing to improve as corrosion occurs, protecting the 
substrate from corrosion damage for extended periods of time.   
 
Figure 7-10: ECorr vs. iCorr for uncoated and coated samples in MEM and BSA. 
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7.4. Buffer Choice and the Presence of a CO2 Atmosphere on 
Amino Acids and Proteins in Solution 
The choice of buffering agent has been shown to have a great effect on the corrosion 
measurements of Mg, as discussed in Chapter 3.  The difference in buffer capacity and 
chemical composition is responsible for changing the corrosion layer that forms and the local 
pH the corroding surface is exposed to.  Proteins, and protein-surface interactions are highly 
sensitive to the pH [10].  The pH will affect the binding of albumin to divalent ions such as 
Ca
2+ 
[29].  The binding reaction of Mg
2+
 is similar and competes at the same sites [30].  
Albumin-Mg
2+
 binding has been shown to exhibit changes in binding behaviour between pH 
7 and 7.5 [31].  Therefore the buffer choice and passivation properties will directly influence 
the effect these proteins have on the measured corrosion rate, due to the effects of the local 
pH.  Because the binding increases at with pH [29] the greater variation in pH with a 
CO2/HCO3 buffer due to its lower capacity could affect the corrosion potential and the 
formation of the passive layer.  Additionally, the changes in surface charges with pH may 
affect the adsorption rate and therefore the protective properties [10].  
 
Figure 7-11: ECorr and iCorr of coated samples with HEPES and HCO3 buffers. 
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Figure 7-11 shows ECorr and iCorr at 30 minutes and 8 hours for both HEPES and HCO3 
buffered protein solutions.  As seen previously, in HEPES buffered solutions ECorr does not 
change much when BSA is added.  In HCO3 buffered systems, the addition of proteins lowers 
ECorr.  Uncoated Mg in HEPES buffered MEM solutions have high initial iCorr that falls as the 
corrosion progresses.  For MEM + HCO3, iCorr by 30 minutes is quite low, and by 8 hours it is 
even lower, forming a large passive layer.  This is similar to the corrosion behaviour in HBSS 
and HCO3 where the passive hydroxide and carbonate layer forms to impede corrosion [32].   
 
Figure 7-12: PDP of uncoated Mg after 30 minutes in HEPES and HCO3 buffered protein 
solutions. 
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Figure 7-13:  PDP of protein solutions and uncoated Mg after 8 hours. 
Once proteins are added, the HCO3 buffered solutions have much higher corrosion current 
densities, between 40 and 60 µA∙cm-2.  This suggests the passivation layer formed in the 
HCO3 buffer is impeded by proteins.  The polarization of uncoated Mg at 30 minutes (Figure 
7-12) shows that the carbonate buffer exhibits large decreases in cathodic kinetics and a 
smaller decrease in anodic kinetics.  With the addition of BSA, the decrease in anodic 
kinetics is lessened, possibly due to the proteins interfering with the protective passivation 
layer that forms in the HCO3 buffer.  After 8 hours, the HCO3 buffer in MEM creates a 
massive drop in both anodic and cathodic kinetics of roughly equal magnitude, leading to the 
very small change in ECorr.  When proteins are present, the cathodic kinetics are decreased, 
but the anodic kinetics remain similar to the HEPES buffered BSA solution.  The explanation 
is found in the limitation of the formation of the passive layer, perhaps by proteins taking up 
Ca
2+
 ions and preventing the calcium carbonates from forming on the surface.  The lower 
ECorr might also be explained by binding of Mg
2+
 ions, which would occur in the presence of 
the higher pH [29].  The fact that the HEPES buffered reaction kinetics drop only slightly 
with BSA addition agrees with other findings that the influence of the buffer, specifically 
CO2/HCO3 buffer, is instrumental in the reduced corrosion rate [21].   
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Figure 7-18 shows the Nyquist plots of uncoated Mg in both MEM and MEM + BSA over 
the first 7 hours.  The large EDL resistance in MEM buffered with HCO3 initially shows the 
insulation the passive layer provides in the bicarbonate buffered solution.  This effect 
increases as time passes, corrosion occurs, the pH rises and the layer becomes more passive 
(Figure 7-16).  Both solutions containing albumin show similar impedance layers, in either 
buffer initially. Instead of the low capacitance primary coating layer with a high resistance 
EDL of the MEM/HCO3 layer, the larger initial time constant appears as the result of the 
semi permeable protein layer resisting charge transfer, which causes the drop in the anodic 
and cathodic reactions.  Closer examination of the Nyquist plot (Figure 7-19) shows that the 
uncoated Mg in MEM + BSA buffered with HCO3 actually shows 3 distinct time constants.  
The first is the small passivation layer presented by the carbonate and hydroxide layer, 
followed by a layer of proteins, and finally the smaller charge transfer resistance from the 
electrolytic double layer itself.  The smaller size of the first and third time constant in this 
systems is evidence of the proteins inhibiting the passivation that provides such protection in 
MEM and HCO3 alone.   
 
Figure 7-14: PDP of biomimetic coated samples in protein solutions at 30 minutes. 
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Figure 7-15: PDP of protein solutions on biomimetic coated samples after 8 hours. 
 
Figure 7-16: Polarization resistance in MEM and MEM + BSA of uncoated Mg samples with 
buffers. 
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For biomimetic coated samples, the CO2 buffer results in decreased anodic and cathodic 
kinetics for MEM solutions at 30 minutes (Figure 7-14).  With the addition of proteins, the 
anodic kinetics decrease, but the cathodic kinetics are increased by the CO2 buffer.  This 
follows the trend seen before with uncoated Mg.  After 8 hours, the difference between these 
two buffer systems becomes more pronounced (Figure 7-15).  By this time, both layers have 
had a chance to settle, and HCO3 buffer reduces both reactions in MEM, but when albumin is 
present, the cathodic kinetics remain increased, and the anodic kinetics are slightly higher as 
well.  The inhibitory effects of the proteins on the passivation layers causes the same effect 
on these coated samples, by blocking the passivation of the pores in the coatings.  Past 8 
hours, the protective layer that formed in MEM on bare Mg did not seem to persist, as the 
corrosion resistance dropped significantly (Figure 7-17).  Thus, the layer in the presence of 
amino acids does not seem to last.  The biomimetic coatings in MEM + HCO3 also displayed 
a great increase in the passive properties of the coating.  This layer persisted over the 24 hour 
test.  However, with the addition of BSA, the protective effect of the low capacity HCO3 
buffer was much less pronounced, and the corrosion rates were more typical of what one 
would expect at pH 7.4.   
 
Figure 7-17: Polarization resistance of biomimetic coated samples in HCO3 buffered protein 
solutions. 
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The Nyquist plots show the coating resistances grow with time (Figure 7-20), and the 
bicarbonate buffered sample in MEM leads the pack due to the resistance layer that forms.  
The lower resistance of the biomimetic coated sample will be an artefact of the lower 
corrosion rate than uncoated Mg alone, where the pH rise quickly outpaces the buffer 
capacity, forming the insoluble calcium and magnesium carbonates that supplement the 
magnesium hydroxide layer.  When the coating is added, the pH change rises more slowly, 
giving the bicarbonate ion and CO2 atmosphere time to equilibrate, leading to the less 
protective layer. With proteins binding to free Ca
2+
 and Mg
2+
 ions in solution [9, 29], these 
ions are effectively less available to form the insoluble salts that prevent the corrosion.  Thus, 
the kinetics of the reactions differs depending on the buffer choice for each system.  With a 
complicated environment such as the body, it will be important to understand the effects each 
component will have on the ultimate corrosion reactions and passivation properties expected 
at the implant site.   
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Figure 7-18: Nyquist plots of uncoated Mg in protein solutions buffered with HCO3. 
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Figure 7-19: Nyquist plots of uncoated Mg in protein solutions buffered with HCO3 detail. 
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Figure 7-20: Nyquist plots of biomimetic coated samples in protein solutions buffered with 
HCO3. 
The relationship between ECorr and iCorr for uncoated and coated samples in the protein 
solutions vs. buffer type is compared in Figure 7-21.  The uncoated Mg in HEPES, displaying 
no real great passive behaviour showed no strong correlation with regard to ECorr and iCorr.  
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All other samples tested displayed the expected trend of decreasing iCorr with increasing ECorr.  
As the layers settled in the solution, the corrosion rates dropped as over time for all of these 
samples, the difference is only the impeding corrosion layer that forms, whether due to 
proteins, the buffer, or both.   
 
 
Figure 7-21: ECorr vs. iCorr plots for uncoated Mg and biomimetic coated samples for different 
buffer types on MEM and MEM + BSA. 
7.5. Conclusions 
It is clear from these results that both amino acids and proteins had an effect on the corrosion 
reactions in vitro.  It will be important to understand the individual effects in vitro if effective 
models and predictions are to be developed by in vivo testing.  The early corrosion rates of 
uncoated Mg were accelerated by the change from HBSS to MEM as the SBF, despite the 
lower amount of Cl
-
, and slightly lower solution conductivity.  The increased buffer capacity 
that the amino acids provide [3] explains this effect.  The higher rather than lower ECorr 
measured for Mg suggests the chelation of Mg
2+
 ions is not the dominant factor in the early 
corrosion mechanisms as has been proposed for the rate acceleration [2].  The increased 
buffer capacity and inhibition of passive layer formation are therefore likely to be 
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responsible.  Adsorption of amino acids did not slow the early rates of corrosion for uncoated 
Mg like they do on other metals [23, 24].  It can be concluded that the overall effect of the 
amino acids is to increase the corrosion rate in vitro, and it would be expected to contribute to 
the corrosion rate in vivo as well.   
The amino acids accelerate the corrosion rate and decrease the resistance of the coating and 
passive layer on the biomimetic coated samples as well.  The mechanism of corrosion on the 
biomimetic coated samples was similar to uncoated Mg, reduced to a smaller area by the 
insoluble CaP coating.  Amino acids accelerated the corrosion of the coated Mg through the 
defects similar to uncoated samples. Corrosion of the ECAD modified coatings was different.  
The Ca(OH)2 layer below is designed to dissolve and promote the deposition of additional 
CaP at the defect sites where corrosion is taking place.  Thus, in the more aggressive 
environment of the MEM, the corrosion rate of the ECAD coated sample decreased, and the 
coatings became more protective.   Overall, this data suggests that the use of MEM in vitro 
can accelerate the corrosion rates of Mg, and the presence of amino acids in vivo may lead to 
higher in vivo corrosion rates that one might expect by doing in vitro tests without amino 
acids.  These tests also show that the ECAD modification for corrosion protection by 
biomimetic coatings is enhanced by the amino acids.  This ECAD coating remained corrosion 
resistant even in these more aggressive solutions.   
The corrosion environment and thus the overall corrosion rate were affected by the proteins, 
It was found that the proteins reduced the corrosion of uncoated Mg in solution by the 
adsorption of proteins to the surface [18, 19].  The effect of increasing corrosion on uncoated 
Mg by chelating of metal ions with proteins was not a significant contribution to the early 
corrosion kinetics in this study [21].  The corrosion rates were dominated by the pH and Cl
-
 
ions and the relative area available for corrosion.   
The proteins affected the corrosion through biomimetic coatings as well.  With the addition 
of proteins, the extra impedance provided by the adsorption to the surface led to better 
passive properties of the exposed metal.  The reduction in corrosion rate shows that the 
proteins facilitate the barrier the biomimetic coating provides.  The corrosion through the 
defects was lessened when the proteins were present.  Therefore, in a high protein solution 
such as the body, it could be expected that this effect will reduce the corrosion rate of the 
biomimetic coated samples further than the measurements made in vitro.   
   
202 
 
The addition of proteins also reduced the diffusion of salts to the Ca(OH)2 layer of ECAD 
coated samples.  The total corrosion resistance of the ECAD coatings is improved by the 
corrosion and deposition of the salts to this layer.  Therefore, the protein additions slowed the 
formation of this layer, leading to a corrosion resistance increase at a slower rate than the 
ECAD coated samples in MEM alone.  However, the ultimate corrosion rates of these 
samples were lower than the biomimetic coated samples alone.  It can be concluded that the 
proteins slowed the self healing mechanism but did not stop it, and this method still provided 
improved protection over the other coatings.   
The behaviour of the protein solutions with different buffer systems was also found to be 
relevant to the corrosion reactions.  In NaCl and HBSS solutions the presence of the 
carbonate buffer exhibited a low capacity and rapid carbonate film formation that reduced 
corrosion rates.  This also occurred when amino acids were present.  However, once BSA 
was added, the layer formation was impeded and the total corrosion resistance dropped much 
closer to that of the HEPES buffered solutions.  The proteins appear to interfere with the 
layer formation by binding to salts [9, 29].  This is further evidence that the HCO3 buffered 
systems may not be the most physiologically relevant just because of the chemical 
equivalency.  Of course, this is only a single type of protein addition.  The actual 
physiological system has many different types of proteins, and the behaviour is complex.  
Therefore, further in vitro and in vivo tests will be needed to understand the effects of each 
different type of protein.  The different solutions and buffers all agreed on the relative 
corrosion protection provided by each coating, but for the exact rates and mechanisms, the 
effect of the proteins is not trivial, and may result in greater or lesser protection than expected 
from simple SBFs, depending on the solution and the buffering agent.   
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CHAPTER 8:  Conclusions 
8.1. Coatings and in vitro Corrosion Tests 
In order for magnesium to be used, the corrosion rate needs to be limited during the early 
implantation [1].  The coating system is also important, as the properties of Mg and the 
implant shape will limit the choices of deposition.  The ideal coating must be processable at 
low temperatures and suitable environments due to the melting temperature and reactivity of 
Mg.  The final implant shape may need to be a porous structure, which cannot be coated 
completely by techniques requiring line of sight.  The use of toxic or non-biocompatible 
precursors and intermediate chemicals during the coating process is not inconceivable, but 
these must be completely removed before the device is implanted.  If the coating process can 
avoid this concern it will be beneficial.   
One of the coating systems in the literature that meets the desired criteria is the biomimetic 
coating.  This coating type has been well documented recently for its biocompatible 
properties on titanium implants, but has received little attention for Mg.  It is biocompatible, 
imitates natural bone structure, and contains no elements or structures not found in the body 
anyway.  The process is done at body temperature, and is coated in simple solutions that 
contain no elements that are not found in physiological fluids.  The solubility of the phases is 
similar to natural bone, and thus more insoluble than Mg, and thus can be protective under 
corrosion conditions, yet less insoluble than the HA used on permanent Ti implants.  The 
biocompatibility and osteogenic properties of biomimetic coatings have already been proven 
by numerous tests on Ti, which gives us confidence that it will be just as useful in promoting 
bone growth on degradable implants.  The gap in the knowledge is the corrosion properties, 
as the protection of Ti has not been a design requirement of the coatings.  Thus, if the 
biomimetic coatings can be used to slow the corrosion rate sufficiently, they will be ideal for 
the in vivo control of the degradation rate of biodegradable Mg implants.   
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8.2. Buffer Selection for in vitro Corrosion Testing 
The corrosion rate in vitro is very sensitive to pH.  As Mg corrosion causes a pH rise, this 
will change the corrosion behaviour if it is not mitigated by a buffer system.  Electrochemical 
tests here show that while many buffers are suitable, the properties of the buffers influence 
the measured corrosion rate.  Therefore some are more suitable for in vitro tests than others.  
The in vivo buffer chemistry based on CO2/ HCO3 is commonly used in the literature.  The 
characteristics of the buffer system vary greatly depending on the in vitro SBF choice, and 
the time of immersion.  The role of carbonate in the passive layer at elevated pH coupled with 
the relatively low buffer capacity and diffusion speed with the atmosphere inside an incubator 
lead to passivation properties that may not be analogous in vivo.  Bicarbonate buffered in 
vitro solutions have slower Mg corrosion rates than in vivo [2].  With the pH changes that 
accompany fast corroding Mg, the lack of consistency in the corrosion mechanism makes it 
difficult to accurately determine the absolute corrosion protection provided.   
The zwitterionic chemical buffers provide a buffer system with higher buffer capacity than 
HCO3 without depositing to form a corrosion layer.  HEPES had the highest buffer capacity 
of the buffers tested at pH of 7.4.  The electrochemical data shows that the corrosion 
reactions and layers are consistent enough that there is no compelling reason to choose one of 
the other buffers over HEPES for these corrosion studies.  The wider use of HEPES in the 
literature for Mg corrosion studies over the other zwitterionic buffers makes comparison of 
results to the available literature easier.  When the interactions of HEPES with Mg were 
measured, the complex behaviour was very small at biological concentrations of Mg
2+
 and 
25mM HEPES.  Larger interaction was detected at high concentrations of Mg.  At the 
corrosion surface, the local ion concentration will be higher than normal.  Also, the pH at the 
surface will remain lower with HEPES than HCO3 due to the capacity.  The HEPES may 
therefore cause corrosion reaction rates faster than what would be expected in vivo [3].  With 
the individual advantages of both HEPES and HCO3, both are appropriate buffers for in vitro 
corrosion tests.  By performing tests in both buffered solutions, the properties and differences 
of these buffers can be quantified and compared.  This will bound the corrosion rate 
expectation in vivo, and allow greater understanding of the individual contributions of pH, 
carbonate ion reactions, and passive layer performance of Mg and protective coatings and 
surface treatments.  Both of these buffers were used to compare the effect of the carbonate on 
the corrosion mechanisms in vitro.  The mechanisms and effect of the buffers on the 
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measured in vitro corrosion rate allowed us to understand and quantify the corrosion response 
of protective coatings in vitro.  Therefore the properties of these coatings could be 
investigated and optimized for corrosion resistance without the need for many expensive in 
vivo studies.   
 
8.3. Biomimetic Calcium Phosphate Coatings on Magnesium 
8.3.1.  Formation on Mg 
The use of biomimetic calcium phosphates was well known on Ti.  The deposition 
mechanisms and corrosion properties on Mg were not well known.  The favourable qualities 
of these coating make them ideal for in vivo applications if the corrosion rate can be 
successfully controlled.  Thus the properties of the surface on the formation of the coating, 
the resulting corrosion protection, and the failure mechanisms of these coatings were 
examined here.   
Pretreatment to form a hydroxide layer is known to be important to biomimetic coating 
deposition on Ti, so its effect on Mg substrates was measured.  It was found not to be 
necessary to pretreat magnesium to nucleate a CaP coating on Mg. Instead, longer 
pretreatment times led to a greater amount of cracks and defects in the coating layer.  More 
defects lead to faster corrosion underneath the coating, which would eventually lead to pieces 
of coating breaking off in solution.  In a simple NaCl solution, this results in decreasing 
corrosion protection with time. When calcium and phosphate ions were added to the solution, 
the Mg(OH)2 pretreatment layer  promoted additional nucleation of CaPs. This led to 
increased corrosion resistance during the 24 hour test.  The results of the study show that 
pretreatment is not necessary for biomimetic coating of Mg and the corrosion properties are 
not necessarily improved by pretreatment.  The increase in coating polarization resistance due 
to CaP nucleation was a surprising result.  The pretreatment in this case seemed to improve 
the deposition.  If this mechanism can be leveraged to improve the corrosion properties of the 
biomimetic coatings, it may help with the ultimate goal of providing the protection needed 
for an implant.   
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The corrosion resistance of the coatings is linked to the integrity of the coating by the amount 
of defects that are there.  The severity of these defects is what will limit the total effectiveness 
of the corrosion resistance.  Optimizing the initial coating creation, as well as the deposition 
of additional CaP from physiological solutions will help to bring up the total protectiveness to 
where they can be used in vivo.   
The amount and severity of the defects in the coating do pose significant concern for the 
ultimate utility of biomimetic coatings.  If they cannot be improved to prevent localized 
corrosion, they will not be an acceptable solution, despite their other desirable properties.  
The coatings will be required to withstand corrosive environments long enough that the bone 
can heal.  The 24 hour tests show that the corrosion occurs beneath the defects, but the rise or 
fall of the corrosion resistance depends on the environment.  The short 24 hour corrosion tests 
showed some protection, but the failure mechanisms suggested this would not last.  
Therefore, longer term corrosion tests were eventually necessary to evaluate the performance.   
 
8.4. Modification and Long Term Corrosion of Biomimetic 
Coatings 
The findings from the previous studies on biomimetic coatings showed that the pretreatments 
and processes to increase the deposition of these coatings on Ti was not necessary or 
beneficial for the corrosion properties on Mg.  This was taken further to examine the 
individual contribution of both coating steps for the biomimetic coating.  The results showed 
that the high Mg amorphous carbonated CaP first step in the coating is not required for 
deposition of the biomimetic coating on Mg, in contrast to Ti [4, 5].  The composition and 
crystal structure of the substituted DCPD biomimetic coatings were found to not be affected 
by the first coating solution process.  The new biomimetic 2 coatings improved the corrosion 
protection significantly.  These coatings produced minimal H2 gas over the course of the 2 
week immersion test in HBSS.  This low level of H2 generation puts the coatings in range of 
predicted acceptable levels of H2 generation in vivo [6].  Over the 14 day test, the phase of the 
calcium phosphate coatings changed from mostly DCPD to a calcium deficient apatite 
structure.  This more stable phase is less soluble and provides more protection than the 
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amorphous phase that formed on uncoated Mg [7].  The corrosion protection provided by 
these coatings was still limited by the defects and corrosion through the coating, rather than 
the dissolution of the coating itself.  The defects and the corrosion problem they present 
remain a challenge for the use of these coatings in vivo.  The biomimetic 2 coatings did show 
some signs that the deposition of additional CaP from solution helped to repair the defects 
and extend the protection.  This mechanism can be optimized and utilized to provide a 
coating with better protection properties.   
The choice of buffer was shown to have an effect on both the measured rates of corrosion and 
the mechanism of corrosion that takes place.  The HEPES buffer proved to be more 
aggressive than the bicarbonate buffer due to the better control of the pH rise and the lack of 
carbonate phases contributing to the corrosion layer.  The measured corrosion rates in HEPES 
are thus expected to be faster than the HCO3 in vitro tests.  In vivo tests are more difficult to 
determine, but it seems likely that the HEPES buffer will provide the upper bound of the 
corrosion rate, as it‟s expected that the HCO3 buffer in vivo will present slower rather than 
faster corrosion [3].   
 
8.5. Self healing Coatings based on Calcium Hydroxide  
The defects in the biomimetic coatings present a problem for the use of biomimetic coatings.  
A defect that appears in the coating either during the deposition, implantation or while 
implanted will allow localized corrosion to take place below the coating.  Additional calcium 
and phosphate from the physiological solution can coat a Mg implant and slow the corrosion 
over time.  This phenomenon is limited by the low amounts of Ca in typical physiological 
fluids. The ECAD calcium hydroxide 2 layer biomimetic coating system was invented 
through this work to provide a self healing mechanism for defect-prone biomimetic CaP 
coatings. 
This ECAD coating increased the corrosion protection of the biomimetic coating. The 
calcium rich layer also provided a suitable nucleation substrate for the biomimetic coating, 
and this produced a better coating with less defects than the normal biomimetic coatings.  The 
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self healing mechanism increased the coating corrosion resistance over time, rather than it 
degrading. The ECAD method met the criteria for the coating methods: low temperature, not 
line of sight, fast, and non-toxic.  However, gas production during the deposition did allow 
the formation of volcano shaped defects in the ECAD layer.  This could be an issue for 
optimization of the coating, but even with these defects the coating layer was effective.  The 
biomimetic coating was deposited, and the ECAD layer did not significantly change the final 
composition or structure of the CaP.  The amount of defects in the final layer was lower, 
leading to higher initial corrosion resistance.  The Ca(OH)2 layer promotes the deposition of a 
complete and low defect biomimetic coating.   
The major benefit of the ECAD Ca(OH)2 was the self healing effect the coating produced.  
As corrosion progressed, the protectiveness of the ECAD coatings increased due to the 
calcium rich layer depositing additional protective calcium phosphates at corrosion sites.  The 
availability of a semi-soluble calcium rich layer to deposit in the defects greatly improved the 
corrosion resistance as corrosion occurred.  This led to the coating remaining intact with few 
defects to allow the corrosion reaction to progress.  The H2 generation was low, and the 
pitting below the coating was minimal.  For a biodegradable implant application where 
corrosion behaviour is critical, a self healing coating such as the one describe here may 
provide much better corrosion properties than typical biomimetic coatings by themselves. 
Therefore, the calcium hydroxide layer provides a simple, effective means of improving the 
biomimetic coating corrosion properties without using any toxic elements or processing.     
The ECAD coatings performed well with both HEPES and HCO3 buffer systems. As HEPES 
has higher buffer capacity than HCO3 in vitro, and does not accurately represent the 
carbonate ions in the body, it could be the case that the mechanisms of corrosion will not be 
quite the same when the coating system is moved from in vitro to in vivo.  The ECAD + 
biomimetic coating in HCO3 buffered HBSS was more corrosion resistant than the same 
coating in HEPES.  The additional carbonate ions and larger pH rise led to earlier deposition 
of calcium compounds, further protecting the substrate.  The good initial performance of the 
coating in HCO3 buffered solutions indicates that the mechanism of protection this coating 
provides will persist in other solutions and remain more protective in carbonated buffered 
solutions such as the body.   
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8.6. The Effect of Amino Acids and Proteins on in vitro Testing 
of Corrosion Resistant Coatings 
8.6.1.  Amino Acids 
Both amino acids and proteins had an effect on the corrosion reactions in vitro.  The early 
corrosion rates of uncoated Mg were accelerated by the change from HBSS to MEM as the 
SBF, despite the lower amount of Cl
-
, and slightly lower solution conductivity.  The 
increased buffer capacity that the amino acids provide [8] explains this.  Chelation of Mg
2+
 
ions has been proposed as a mechanism for the accelerating rate of corrosion in amino acids 
[3], but the higher rather than lower ECorr measured here does not support that theory, at least 
during the early stages of corrosion.  Adsorption of amino acids did not slow the early rates 
of corrosion for uncoated Mg like they do on other metals [9, 10].  It can be concluded that 
the overall effect of the amino acids is to increase the corrosion rate in vitro, and it would be 
expected to contribute to the corrosion rate in vivo as well.   
The amino acids had the same effect on the biomimetic coated samples, accelerating the 
corrosion rate and decreasing the resistance of the coating and passive layer.  The mechanism 
of corrosion on the biomimetic coated samples was similar to uncoated Mg, but impeded by 
the CaP layer.  Therefore, the amino acids accelerated the corrosion of the bare Mg through 
the defects in the same manner.  The ECAD modified coatings did not corrode like this, 
however.  The Ca(OH)2 layer below is designed to dissolve and promote the deposition of 
additional CaP at the defect sites where corrosion is taking place.  Thus, in the more 
aggressive environment of the MEM, the corrosion rate of the ECAD coated sample 
decreased, and the coatings became more protective.   Overall, this data suggests that the us 
of MEM in vitro can accelerate the corrosion rates of Mg, and the presence of amino acids in 
vivo may lead to higher in vivo corrosion rates that one might expect by doing in vitro tests 
without amino acids.  These tests also show that the ECAD modification for corrosion 
protection by biomimetic coatings is enhanced by the amino acids.  This demonstrates that 
the coating remains corrosion resistant even in the more aggressive solution.   
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8.6.2.  Proteins 
Although they do not directly interact with the corrosion reactions of Mg, proteins affect the 
environment and thus the overall corrosion rates measured.  It was found that the proteins 
reduced the corrosion of uncoated Mg in solution by the adsorption of proteins to the surface 
[11, 12].  The effect of increasing corrosion on uncoated Mg by chelating of metal ions with 
proteins was not a significant contribution to the early corrosion kinetics in this study [2].  
The corrosion rates were dominated by the pH and Cl
-
 ions and the relative area available for 
corrosion.   
Biomimetic coated samples corrosion properties were dependant on the cracks and pores in 
the coating.  With the addition of proteins, the extra impedance provided by the adsorption of 
proteins to the surface led to better passive properties of the exposed metal.  The reduction in 
corrosion rate shows that the proteins facilitate the barrier the biomimetic coating provides.  
The corrosion through the defects was lessened when the proteins were present.  Therefore, in 
a high protein solution such as the body, it could be expected that this effect will reduce the 
corrosion rate of the biomimetic coated samples further than the measurements made in vitro.   
When modified with the ECAD layer of Ca(OH)2, the addition of proteins also reduced the 
diffusion of salts to the layer.  The total corrosion resistance of the ECAD coatings is 
improved by the corrosion and deposition of the salts to this layer.  Therefore, the protein 
additions slowed the formation of this layer, leading to a corrosion resistance increase at a 
slower rate than the ECAD coated samples in MEM alone.  However, the ultimate corrosion 
rates of these samples were lower than the biomimetic coated samples alone.  Therefore, it 
can be concluded that the BSA slowed the CaP deposition and protection mechanism of these 
ECAD coatings, but did not stop it, and this method still provided improved protection over 
the other coatings.   
The choice of buffer system was also found to be important in the formation of the corrosion 
layers and ultimate corrosion protection.  In simple ionic NaCl and HBSS solutions the 
presence of the carbonate buffer exhibited a low capacity and therefore rapid pH rise and film 
formation that reduced the corrosion rate.  In MEM, this was also observed to occur.  
However, once BSA was added, the layer formation was impeded and the total corrosion 
resistance dropped to much closer to that of the HEPES buffered solutions.  The proteins 
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interfere with the layer formation by binding to salts [13, 14].  This is further evidence that 
the HCO3 buffered systems may not be the most physiologically relevant just because of the 
chemical equivalency.  Of course, this is only a single type of protein addition.  The actual 
physiological system has many different types of proteins, and the behaviour is complex.  
Therefore, further in vitro and in vivo tests will be needed to understand the effects of each 
different type of protein.  However, this work shows that the relative protection provided by 
the coatings remained the same across these solution, and that for the exact rates and 
mechanisms, the effect of the proteins is not trivial, and may result in greater or lesser 
protection than expected from simple SBFs, depending on the solution and the buffering 
agent.   
 
8.7. Concluding Remarks and Future Work 
Biomimetic coatings have already proven their value on Ti implants for biocompatibility.  
These properties, and the processing abilities make them attractive for degradable Mg 
implants.  The need for the coating of Mg implants is to slow the corrosion rate.  The results 
presented here show that the biomimetic coatings can be applied to Mg.  The coatings have 
been shown to provide improved corrosion protection.  However, the protection is not 
complete due to the amount of defects in the coating.  By changing the deposition process, 
and improving the healing mechanism of the coating, the defects can be minimized and 
sealed.  This leads to better corrosion protection, brining the corrosion rates closer to levels 
that would be acceptable for degradable implants.  Overall, these changes bring biomimetic 
coated degradable Mg implants into the realm of practical applications.   
The research does not end here though.  The research here has been conducted to accurately 
model and identify the dominant corrosion behaviour and environments that may be faced in 
vivio.  However, the complexity of the physiological environment means the measurements 
of exact corrosion rates are not yet possible in vitro.  While the coatings can be optimized for 
protection against specific elements, they must be tested in vivo, using animal models, before 
clinical trials can begin.  The research should continue moving up in complexity, to plasma, 
cell culture, then animal models.  This will also allow the effects of long term 
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biocompatibility and dissolution behaviour.  The data collected here shows the corrosion rate 
is slowed, which is one goal, but it will also be necessary to measure and optimize the final 
dissolution properties of these coatings.  After all, the implant should not last forever, and 
must degrade after an appropriate interval.  Further optimization of the biomimetic 
composition, the thickness and morphology of the calcium hydroxide layer, and the adhesion 
to the substrate will need to be performed.  The system could further be improved by linking 
it with a better alloy as a substrate, or the addition of another element of a composite coating, 
such as a biodegradable polymer.   
Furthermore, the implant and coating remnants must not cause problems as or after they 
degrade.  The use of only biologically present elements gives us confidence that these 
coatings may be used, but this must be proven in vivo.  These biodegradable implants must be 
formulated to provide maximum benefit with minimal harm, so this must be studied and 
measured.  Overall, if this research is done and these obstacles can be overcome, the use of 
biodegradable Mg metal for temporary orthopaedics can move from the realm of research to 
the clinic.   
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APPENDIX A :  Selected coating in vitro corrosion studies 
Coating Process 
Alloys Polis
h 
Coat Process Coat Process Sub type Pretreatment Coat solution Ca:P 
coat 
soln 
Coat 
soln 
pH 
Coat 
Tem
p 
coat 
time 
post treat coating 
created 
Ca:P 
coat 
coat 
thick
ness 
Ref 
Pure Mg, 
AZ91D 
1000 Anodization 50V 5mA/cm2   0.25 M NaOH and 0.1 M Na 2 
SiO 3 
na     up 
to 
3hrs 
      10 
um 
[1] 
Pure Mg, 
AZ91D 
1000 Anodization 50V 5mA/cm2   0.25 M NaOH and 0.1 M Na 2 
SiO 3 
na     up 
to 
3hrs 
      10 
um 
[1] 
Pure Mg, 
AZ91D 
1000 Anodization 50V 5mA/cm2   0.25 M NaOH and 0.1 M Na 2 
SiO 3 
na     up 
to 
3hrs 
      10 
um 
[1] 
Pure Mg, 
AZ91D 
1000 Anodization 50V 5mA/cm2   0.25 M NaOH and 0.1 M Na 2 
SiO 3 
na     up 
to 
3hrs 
      10 
um 
[1] 
CP Mg, 
AZ91D, 
AM60, 
MEZ, 
ZE41 
1200 Anodization 20-5mA/cm2   K2SiO3 (1.6%wt) + KOH 
(1%wt) 
na   ambi
ent 
30mi
n 
  anodized     [2] 
AZ91D ??? Anodization Plasma 
Electrolytic 
Oxidation 
  NaOH, Na PO4, Ca acetate, Na 
Silicate 
need
s calc 
??? 
(basi
c) 
  10 
min 
  MgO, 
Mg2SiO4 
    [3] 
Pure Mg 
(99.95%) 
2000 Anodization MAO   NaOH (30 g/L), Na2SiO3·9H2O 
(160 g/L) and Na2B4O7·10H2O 
(160 g/L) 
    25C 1-
22mi
n 
  oxide MAO     [4] 
Pure Mg 1200 Anodization TiO2 and F 
and MgO 
anodization 
NaOH (2 g/l), Na4SiO4 
(8 g/l) and NaF (2 g/l) 
(Ti(OC4H9)4) and isobutanol 
(C4H9OH) in a volume ratio of 
1:3. 
          MAO     [5] 
AZ31   Anodization Microarc 
Oxidation 
  30–50 g/L Na2SiO3 and 5 g/L 
NaOH 
na basic ? ? Ion beam HIPIB Mao film   25u
m 
[6] 
Mg 6Zn 
1-1.5Ca 
  Anodization Electrodeposit
ion 
  KOH 10M       2H Aneal 450C 6hrs 
in air 
MgOH2   ?? [7] 
5.5–6.5% 
Zn, 1.0–
1.5% Ca 
.05m
m 
alumi
Anodization Electrodeposit
ion 
              MgO     [8] 
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Alloys Polis
h 
Coat Process Coat Process Sub type Pretreatment Coat solution Ca:P 
coat 
soln 
Coat 
soln 
pH 
Coat 
Tem
p 
coat 
time 
post treat coating 
created 
Ca:P 
coat 
coat 
thick
ness 
Ref 
na 
Pure Mg 600 
grit 
Anodization   Anodization 2-100V Hanks modified 1.3mM Ca, 
.8mM PO4, blood plasma Cl- 
1.62
5 
7 
(neut
ral) 
not 
meti
oned 
buffe
r 
310 K up 
to 40 
h 
  amorphous? .75-.95 not 
repo
rted 
[9] 
AZ91 ??? Anodization 30-90V   NaOH 4M           anodized     [10] 
Pure Mg 
(99.9%) 
1200 biomimetic     SBF for 5 days 60 mL per 
9.5mm dia sample, TRIS buffer 
2.5 7.4??
? 
Initia
l? 
RT 5 
days 
NaOH, air, h2o, 
NaOH only 
effective to seal 
cracks 
some kind of 
CaP, Mg in it 
.5 to 2   [11] 
Pure Mg 1200 Biomimetic   H2O at 100C for up to 
30 min 
5x SBF   5 to 
8 
37 48hr
s 
  Calcium 
phsophate 
DCPD + HA 
  10-
20 
um 
[12] 
AZ91D 1500 Biomimetic   Ca(NO3)2 .17M and 
K2HPO4 0 to .1m 
titrated in 
mSBF 0 to 
1.7 
pretr
eat, 
then  
7.4 37 C 3h   DCPD ? 20 
um 
after 
5 
days 
[13] 
AZ80 ? Composite 
MAO + ED 
  MAO in 50 g/L NaOH, 
40 g/L Na 2 SiO 3 , 20 
g/L Na 2 B 4 O 7 and 
40 g/L Na 3 C 6 H 5 O 7 
90V for 40 min 
 10 g/L Ca (NO 3 ) 2 and 10 g/L 
NH 4 H 2 PO 4 . Also 10 mL/L 
H2O2 done at 7V for 10 min 
  4.4   10 
min 
  DCPD plus 
MAO 
  8-
10u
m 
MAO 
2-4 
ED 
[14] 
AZ81 Die 
cast 
2000 Composite 
MAO + EN + 
Polymer 
Electroless 
nickel and 
plga 
MAO in NaOH and 
NaSiO3 
2NiCO3
.3Ni(OH)2
.4H2O, then 
PLGA 
          PLGA EN     [15] 
WE42 2000 Composite 
MAO + PLLA 
coat 
      na         MAO/PLLA     [16] 
AZ31 1000 Conversion HF   HF 10 to 40% na acidi
c 
RT 72 
hrs 
none No xtalline 
MgF2 
detected, too 
thin? 
Amorphous?  
Paper not 
clear 
na 8 to 
23 
um 
[17] 
AZ31 2000 Conversion Hydrothermal    5.66% mass fraction NaOH na basic 160 C 1 to   Mg(OH)2 na   [18] 
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Alloys Polis
h 
Coat Process Coat Process Sub type Pretreatment Coat solution Ca:P 
coat 
soln 
Coat 
soln 
pH 
Coat 
Tem
p 
coat 
time 
post treat coating 
created 
Ca:P 
coat 
coat 
thick
ness 
Ref 
14 4 
hour
s 
MgZnCa 
extruded 
2000 Conversion Conversion/so
lution coat 
H3PO4 then NH4F NaSiO3 (30g/L) and Ca(NO3)2 
(30g/L) 
          CaSiO3 and 
brushite 
  6um [19] 
AZ31 3.5 
um 
diam
ond 
conversion cerium 
conversion 
coat 
  Ce(NO3)3, with concentrations 
of 10 g/L, at 60 °C for 
immersing 5 min and 20 mL/L 
of hydrogen dioxide solution, 
H2O2 (Fisher Scientific, 30%) 
    60 C 5 
min 
  Ce conversion     [20] 
Powder 
Met Pure 
Mg, Cast 
Pure Mg, 
AZ31 
1200 Conversion HF   48 wt% HF     RT 24h         [21] 
pure Mg 4000 Conversion MgF in HF none HF 48% wt na acidi
c 
RT 6 to 
24 h  
(24 
repo
rted) 
  MgF2 na 1.5 
um 
[22] 
AZ31   Conversion Fluride   HF           HF     [23] 
AZ91D   Conversion phytic acid               phytic acid     [24] 
Pure Mg 
powder 
met 
1500 Conversion F conversion 
coating 
  .01-.3 M KF Cl added in some 
up to 8gL 
na not 
said, 
weak 
basic 
my 
gues
s 
  1hr   Mg F posibly, 
only EDX and 
theory 
    [25] 
AZ91D 1000 Conversion HF   70% HF no acid       MgF     [26] 
AZ81E   conversion Rare Earth has Ce SO4, Al as well look into this more?           Rare Earth 
conversion 
    [27] 
AM60,  1200 conversion Molybdate 
phosphate 
ultrasonic acetone Na2MoO4 30 g L
−1 + Ca(NO3)2 
4 g L−1 + Mn(Ac)2 
6 g L−1 +additive 1 g L−1 NaNO3 
1 g L−1 + HNO3, also Mo + H3PO4 + 
NaH2PO440 g L−1 
to 
calc 
? 50 C 120s   Molybdate 
phosphate 
    [28] 
Pure Mg 
(99.99%) 
2000 Conversion 
and Aerosol 
Deposition 
HF and then 
HA coat 
48% HF at RT for 24 
hrs 
HA powder heated to 1200 1 
hrs then sprayed 
          MgF2 HA     [29] 
Mg–
1.0Ca 
1000 
grit 
Electrodepositi
on 
Potentiostatic none 0.042 M Ca(NO3)2·4H2O and 
0.025 M NH4H2PO4 
  5 40 C 4h   DCPD NR thick
er 
[30] 
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Alloys Polis
h 
Coat Process Coat Process Sub type Pretreatment Coat solution Ca:P 
coat 
soln 
Coat 
soln 
pH 
Coat 
Tem
p 
coat 
time 
post treat coating 
created 
Ca:P 
coat 
coat 
thick
ness 
Ref 
than 
EDS 
AZ31 1000 
grit 
Electrodepositi
on 
Potentiostatic none 0.042 M Ca(NO3)2·4H2O and 
0.025 M NH4H2PO4 
  5 40 C 4h   DCPD NR thick
er 
than 
EDS 
[30] 
Mg 6 
wt.% Zn 
1000 
grit 
Electrodepositi
on 
Galvanostat   CaNO3 .042 M, NH4H2PO4 
.025 M 
  4.4     Sat Ca(OH)2 
then .1M NaOH 
80C for 4h 
Formed DCPD, 
HA, FHA 
tested 
    [31] 
AZ91 Mach
ined 
Electrodepositi
on 
Potentiostatic 1 M NaOH 80 C for 1 
hrs 
.1 M CaNO3 and NH4H2PO4 1.66
6667 
      1 M NaOH 80 C 
for 1 hrs 
HA     [32] 
Mg 1.0  
Ca 
1200 Electrodepositi
on 
Potentiostatic   42mM CaNO32 and 
NH4H2PO4 
1.68 5   20, 
60,1
20, 
240 
min 
  Brushite   20-
25u
m 
[33] 
Mg–Zn–
Ca 
1000 Electrodepositi
on 
F substituted 
apatite/ 
pulsed 
reverse 
current PRC in 
addition to 
traditional ed 
TED 
40% HF 0.15 mol/L NaNO3, 
0.025 mol/L NH4H2PO4, 
0.042 mol/L Ca(NO3)2 and 
20 mL/L H2O2 
1.68 5 65 C     FHA 1.44 
PRC/1.
3 TED 
  [34] 
AZ91D   Electrodepositi
on 
Electrophoreti
c deposition 
MAO HA particle and chitosan stoic 
ha 
and 
chito
san 
acidi
c? 
25C 30 
min 
  HA-chitosan 
Ha particles  
    [35] 
Pure, 
AZ91 
  Electroplating 
ionic liquids 
                      [36] 
Pure Mg 
(99.99%) 
1200 
then 
electr
opoli
shed 
Polymer Dip   PLC and PLA in 
trichloromethane 
    RT     PLC PLA     [37] 
99.98% 
Mg, SS, 
and Ti 
na PVD                 Mg   100u
m 
[38] 
Mg 2% 
Zn 
Diam
ond 
W1.5 
PVD Magnetron 
Sputtering 
TiO2 
ultrasonic acetone 
ethanol 
n/a magnetron sputter na na 325
Watt 
powe
2h   TiO2 na 200 
nm 
[39] 
   
220 
 
Alloys Polis
h 
Coat Process Coat Process Sub type Pretreatment Coat solution Ca:P 
coat 
soln 
Coat 
soln 
pH 
Coat 
Tem
p 
coat 
time 
post treat coating 
created 
Ca:P 
coat 
coat 
thick
ness 
Ref 
r 
AZ31 2000 PVD Aerosol 
Deposition 
              HA/ Chitosan     [40] 
AZ31 1000 PVD Ion Beam 
Assisted 
Deposition 
Ar beam 
bombardment to 
pretreat 
Ion beam 20min HA + 
37% 
CaO 
pow
der 
na less 
than 
100C 
20mi
n 
some anealed 
250C 2h, some 
in H2O 100C 
30min for 
Amorphous -> 
Xtal HA 
CaP     [41] 
AZ31 .05 
alumi
na 
Sol Gel Titania   Ti(OC4H9)4:EtOH: 
H2O:NH(C2H4OH)2 = 14:112:2:3 
      3–5 
cm 
min−
1 
anneal 200–400 
°C for 1–2 h in 
the vacuum 
furnace 
TiO2 na   [42] 
Mg 1% 
Ca 
??? Sol Gel Titania   organic sol gel na ??   12 
cm/
min 
500 C for 2 hrs, 
repeated several 
times for thicker 
coating 
TiO2 na up to 
thick 
enou
gh 
xrd 
did 
not 
pene
trate 
[43] 
ZE41 800 Sol Gel Silica dip, 
conventional, 
dense light 
  SiO2 TEOS/ethanol/acidulated 
water 1:1:1 or 4:4:1 or 1:11:1 
na     dip 
35c
m/m
in 
sinter 400 or 
500 C 1 or 2 hrs 
silica, some 
others zn, mg 
only EDS and 
sem 
na 4um [44] 
AZ31 600 Solution 
Chemistry 
  Acid Etch Ca-EDTA: C10H12N2O8Na2Ca), 
potassium 
dihydrogenphosphate 
(KH2PO4) and sodium 
hydroxide (NaOH) 
    363K 10mi
n-
6hr 
  HA, HA OCP .61-.67 5um [45] 
AZ31 1200 Solution 
Chemistry 
immersion 
long term 
Na2HPO4 60C NaH2PO4 and CaNO3)2 need
s calc 
8.9 70C 48h   beta TCP and 
CaPO3OH 
NR 15-
20u
m 
[46] 
Pure Mg 2000 Solution 
Chemistry 
  none .01 M CaNO3 + Na3PO4 + 
H3PO4 
? 4.5 65 2min NaOH 10g/L 80C 
60 min 
HA 1.45 200-
300 
nm 
[47] 
mg-1.2 
Mn - 1.0 
Zn 
1000 Solution 
Chemistry 
  alkaline 63 C for 15 
min, 2% H3PO4 and 
H2SO4 for -10 sec 
phosphating bath MCP and Zn 
and NO3 - see paper 
need
s calc 
??? ??? 6min   CaHPO4 dot 
2H2O 
not 
accura
tely 
measu
red 
  [48] 
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Alloys Polis
h 
Coat Process Coat Process Sub type Pretreatment Coat solution Ca:P 
coat 
soln 
Coat 
soln 
pH 
Coat 
Tem
p 
coat 
time 
post treat coating 
created 
Ca:P 
coat 
coat 
thick
ness 
Ref 
Ulness 
XPS? 
Pure Mg 600 Solution 
Chemistry 
Hydrothermal  HNO3 and H2SO4 etch C10H12CaN2Na2O8 (Ca-EDTA) 
and KH2PO4 
1 5.9, 
8.9, 
11.9 
RT to 
363K 
tem
p 
ram
p 
then 
7.2 
ks 
  HA and/or 
OCP 
  3um [49] 
Pure Mg 
(99.98) 
600 Solution 
Chemistry 
Ca-EDTA Acid Etch C10H12CaN2Na2O8 (Ca-EDTA) 
and KH2PO4 
  5.9, 
8.9, 
11.9 
      HA/OCP     [49] 
Pure Mg .1 um 
Alumi
na 
Solution 
Chemistry 
Hydrothermal    Ca EDTA, K2HPO4, NaOH chec
k it 
6.3-
11.3 
368 K 8 or 
24 
hrs 
  HA     [50] 
Pure Mg 1500 Solution 
Chemistry 
PO4 slowly 
added 
MAO (for corrosion) .17 M Ca(NO3)2 dribbled in 
.1M K2HPO4 
1.7 ? 27 C 5h   DCPD and HA 1.43 10u
m 
[51] 
AZ31   Solution 
Chemistry 
  Na2CO3 50C 30min, 
then NaOH 24h room 
temp, heat treat 140C 
for 24h 
3mM CaCl2 1.8mM Na2HPO4 1.67 5   few 
min 
to 1 
wee
k 
  Ca deficient 
HA 
1.1 muc
h 
great
er 10 
nm 
[52] 
Pure Mg 600 Solution 
Chemistry 
  HNO3 and H2SO4 etch C10H12CaN2Na2O8 (Ca-EDTA) 
and KH2PO4 
1 8.9 313K 
to 
363K 
8h or 
2h 
  HA   3um [53] 
Pure, 
AZ31, 
AZ61, 
AZ91 
.1um 
Alumi
na 
Solution 
Chemistry 
Chelate 
solution chem 
none Ca EDTA, K2HPO4, NaOH 1 to 
1.67 
5.4-
11.3 
7.3 
for 
corro
sion 
368 K 8-16-
24 
hrs 
  HA not 
report
ed 
  [54] 
AZ31 1200 Solution 
Chemistry 
Immersion Acid Etch Ca(NO3)2 and NH4H2PO4   4 60 C 24hr
s 
  CaP mixed, 
TCP??? 
Mg 
Phosp
hates, 
  [55] 
Pure Mg 600 Solution 
Chemistry 
Hydrothermal  nitric sulfuric acid etch 0.25 mol/l Ca-EDTA and 
0.25 mol/l KH2PO4 
  8.9 363K 600-
2880
0 s 
  HA (Mg(OH)2 
seen as well) 
  1.3-
9.2 
um 
[56] 
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Corrosion Results 
 
Corrosion Solution Cor 
Soln 
Temp 
Corrosion Soln Buffer Corr Soln pH Solution 
Refreshed 
mass loss 
max time 
Mass loss coat mass loss 
control 
Ref 
0.15M NaCl and SBF ??? ??? (none prob) 7 initial daily       [1] 
0.15M NaCl and SBF ??? ??? (none prob) 7 initial daily       [1] 
0.15M NaCl and SBF ??? ??? (none prob) 7 initial daily       [1] 
0.15M NaCl and SBF ??? ??? (none prob) 7 initial daily       [1] 
5wt% 25+/-
1 
none 7.0 initial         [2] 
.9% NaCl ??? none not stated not       [3] 
SBF 8.035 g/L NaCl, 0.355 g/L NaHCO3, 0.225 g/L KCl, 0.231 g/L 
K2HPO4·3H2O, 0.311 g/L MgCl2·6H2O, 0.292 g/L CaCl2 and 0.072 g/L 
Na2SO4 
37C tris + HCl 7.4         [4] 
Hanks   TRIS and HCl 7.4         [5] 
3.5 NaCl               [6] 
Hanks         3 days     [7] 
                [8] 
none               [9] 
                [10] 
Dulbeccos Mod Eagle and FBS 37 CO2 5% 7.4 start? no       [11] 
Hanks + NaCl 37 HEPES 6g/l 7.4 no 24 hours     [12] 
SBF (similar to hanks)               [13] 
Kokubo's solution 37 ??? 200ml per sample, 
replaced 2 day interval 
7.4         [14] 
Hanks 37 C NaOH 7.4 initial         [15] 
Hanks 37 ??? Adjst with NaOH 
and HCl 
7.4         [16] 
Hanks 28-32 
C 
none 7.4         [17] 
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Corrosion Solution Cor 
Soln 
Temp 
Corrosion Soln Buffer Corr Soln pH Solution 
Refreshed 
mass loss 
max time 
Mass loss coat mass loss 
control 
Ref 
Hanks 37C None   0.4 mL /mm2 or 
40mL per cm2 
31 Days 
(1,3,5,7,15,
31) 
0.3 0.35 [18] 
Hanks 310 K none, CO3 in solution           [19] 
Hanks 37 C none/carbonate present ??? not stated       [20] 
DMEM 37 not said, think CO2 7.4 48 hours       [21] 
Hanks 37 refreshed every 2 days 7.4   18 days 1.01mmpy 3.7mmpy [22] 
                [23] 
                [24] 
8g/L NaCl               [25] 
not relevant to bio               [26] 
                [27] 
0.93 g/l H3BO4 and 9.86 g/l Na2B4O7 room   9.2         [28] 
SBF Kokubo   none? 7.4 initial nope 3 days     [29] 
Hanks   ??? 7.4     none none [30] 
Hanks   ??? 7.4     none none [30] 
mod SBF 37 HEPES 7.4 up to 8.2 no       [31] 
SBF like hanks 37 HEPES 17.8 g/L 7.4   5 days     [32] 
Hanks   none 7.4   3 days ?? ?? [33] 
SBF (hanksish) 37 TRIS + HCL 7.4 start up to 
7.7 at 128h 
no       [34] 
                [35] 
                [36] 
mSBF (reported elsewhere, human plasma) 37 HEPES 7.4 200 mL/cm2 250 hrs maintained for 8 
days then degraded 
none [37] 
DMEM +10% FCS 37 CO2 5% 7.36   1-12 hrs survived after 12 
hours 
didn't 
survive 
after 12 
hours 
[38] 
SBF like hanks   TRIS + HCL 4         [39] 
SBF Kokubo 37             [40] 
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Corrosion Solution Cor 
Soln 
Temp 
Corrosion Soln Buffer Corr Soln pH Solution 
Refreshed 
mass loss 
max time 
Mass loss coat mass loss 
control 
Ref 
                [41] 
Hanks ??? ??? ??? ???       [42] 
Kokubo's solution 37C ???? 7.4         [43] 
3.5 wt% NaCl 24+- 
3C 
none nont stated         [44] 
3.5% NaCl room ??? NR         [45] 
Hanks 37 ??? ???     none   [46] 
MEM 37 co2 5% incubator 7.4 I think   48 hours 0.03 2 
mg/cm2/d
ay 
[47] 
cell culture and in vivo   CO2 in cell culture 7.4     none none [48] 
3.5 wt% NaCl   none ??     none none [49] 
3.5% NaCl room none ??? no       [49] 
mHanks Cl down to blood 310 K none? 8 rotated 120 rpm 
for flow 
      [50] 
SBF: 8.035 g/L NaCl, 0.355 g/L NaHCO3, 0.225 g/L KCl, 0.231 
g/LK2HPO4·3H2O, 0.311 g/L MgCl2·6H2O, and 0.292 g/L CaCl2 
  TRIS and HCl 7.4 initially, up 
to 7.56 at 147h 
        [51] 
none           none none [52] 
none           none none [53] 
3.5 wt% NaCl  (shore simulation)           none none [54] 
Hanks, PBS, saline 37   7.4 initial   26 days 
max 
    [55] 
3.5 NaCl room             [56] 
 
Corrosion Values Continuted 
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H2 evo coat H2 Evo 
Control 
H2 time PDP timepoint PDP 
icorr 
coat 
(µA/c
m2) 
PDP icor 
control(µA/cm2) 
EIS timepoint EIS Rp Coat 
(ohms) 
EIS Rp 
Uncoat 
(ohms) 
Mg ion 
Coat 
Mg 
ion 
contr
ol 
Ref 
      48hr immersion 3h pure mg 
in NaCl 
2.70E-
05 
3.00E-04 2h pure mg 2hr 1037 109     [1] 
      48hr immersion 2h pure mg 
in NaCl 
2.70E-
05 
3.00E-04 20min pure mg 2hr 
NaCl 
2000 363     [1] 
      48hr immersion 3h AZ91D 
in NaCl 
6.25E-
08 
3.04E-05 10h Az91D 3hr 1198 1100     [1] 
      48hr immersion 2h AZ91D 
in NaCl 
8.51E-
07 
3.04E-05 1h Az91D 3hr 
NaCl 
2029 1500     [1] 
                      [2] 
      not mentioned 1.05E-
07 
1.76E-05           [3] 
      40 min 1.73E-
07 
1.35E-05           [4] 
        1.25E-
05 
4.00E-04 12h to 15 days 4000 800     [5] 
        4.00E-
09 
3.00E-07 5 and 48 hrs see doc       [6] 
      3 days? Unclear               [7] 
                      [8] 
                      [9] 
                      [10] 
            24 h I think 500 350     [11] 
      24 hrs 1.09E-
05 
6.26E-05 24 hrs 3657 885     [12] 
      10 min 2.6 70 10 min 4210 331     [13] 
.004 MAOED, .006 
MAO only? 
0.07 
mL/cm2/day H2 
5 days                 [14] 
      ??? 1.00E-
07 
1.00E-06           [15] 
            0 and 4 weeks 120000 1500 200-600 2400
-
1000 
[16] 
13.1, 9.7, 4 mL 43 mL 16 days immediate               [17] 
                      [18] 
      steady state ocp 1.45E-
05 
1.35E-04           [19] 
            10 min 15000 2000     [20] 
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H2 evo coat H2 Evo 
Control 
H2 time PDP timepoint PDP 
icorr 
coat 
(µA/c
m2) 
PDP icor 
control(µA/cm2) 
EIS timepoint EIS Rp Coat 
(ohms) 
EIS Rp 
Uncoat 
(ohms) 
Mg ion 
Coat 
Mg 
ion 
contr
ol 
Ref 
            1,7,11 Days 380,28,19 
kOhms 
6.8,7.8,8.7 
kOhms 
    [21] 
      10 - 15 min, cathodic shift       5200 180     [22] 
                      [23] 
                      [24] 
            1 hr 250-2000 
ohms 
no control?     [25] 
                      [26] 
                      [27] 
      2               [28] 
                  100 at 70 
hrs 
350 [29] 
145 248 70 h immediate 6.27 556 none none none     [30] 
6 28 240 h immediate 2.75E-
06 
2.74E-04 none none none     [30] 
.5,1.25,1.5 ml/cm2 3 up to 500 
hrs 
                [31] 
                      [32] 
        7.46E-
06 
5.90E-04           [33] 
      ??? Less than 5 days 2.50E-
06 
1.27E-04           [34] 
                      [35] 
                      [36] 
      Right away 1.29E-
05 
2.03E-04           [37] 
      not said, think the fig is 
wrong.   
1.43E-
03 
1.43E-03           [38] 
1.95mmpy 4.13mmpy 10 days 120 S       none none     [39] 
      not sure 4.70E-
06 
3.89E-04           [40] 
                      [41] 
      ??? 1.26E-
07 
3.16E-05           [42] 
      5 min - measure in A 1.59E- 3.33E-02           [43] 
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H2 evo coat H2 Evo 
Control 
H2 time PDP timepoint PDP 
icorr 
coat 
(µA/c
m2) 
PDP icor 
control(µA/cm2) 
EIS timepoint EIS Rp Coat 
(ohms) 
EIS Rp 
Uncoat 
(ohms) 
Mg ion 
Coat 
Mg 
ion 
contr
ol 
Ref 
05 
      168 hrs (1hrs different) 26.1 84.4           [44] 
      600 s 2.00E-
06 
1.00E-04       2 and 5 25 [45] 
none     ??? 2.34E-
06 
2.93E-06 ? 8399 1494     [46] 
      48 hrs   2 orders of mag 
different 
      none   [47] 
none                     [48] 
none none none 360 s 1E-07 0.0001 none none none     [49] 
      360 s 5.00E-
07 
1.00E-03           [49] 
            0 to 6 hrs 1.00E+05 4.00E+03 2.75 ave, 4 
days 
3.25 [50] 
1 9 137 h ? ? ?           [51] 
none none none none none none           [52] 
none none none none none none           [53] 
none none none 1 hour 1.00E-
06 
1.00E-03           [54] 
      ??? 1.18E-
06 
2.93E-04           [55] 
      360s 1.00E-
07 
2.00E-04           [56] 
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APPENDIX B :  Biomimetic Coating 
Methodology 
 Ultrasonically clean all glassware and apparatus in ethanoic acid and distilled 
water to remove all CaP from the surface.  Rinse with distilled water and 
allow to dry 
 Prepare Mg samples for coating by applying the correct polish, surface 
treatments, and cleaning processes. 
 Set hot water bath at 37oC 
 Prepare solution 1 in 1 L of distilled H2O at 37
o
C (this step 1 is to form 
amorphous calcium phosphate or ACP, no NaCl used to avoid corrosion of 
samples (literature method uses 40 g/L), Na+ bumped up by adding more 
NaHCO3 so that more Na+ ions present for ensuring ACP forms and no 
crystalline HA forms, ACP is a necessary precursor layer to nucleate 
crystalline HA in second step).  The solution can nucleate CaP phases when 
mixed that will not be soluble again.  Therefore, the salts should be mixed 
only directly before the coating process is to be started. 
 
  Literature value = 0.55 
 
 Attach aeration stone to tube, to CO2 tank via rubber stopper. Gently bubble 
CO2 through solution for 15 minutes. Measure pH of solution, should be ~5-6.   
Solution Step 1
Salt: g/L
CaCl2 1.65
KH2PO4 0.3
MgSO47H20 1.8
Na2HPO42H20 0.4
NaHCO3 2.27
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 Place samples on a nonconductive mesh holder.  Do not use metal apparatus, 
or allow the individual samples to come into contact with each other, as this 
can lead to galvanic corrosion in the solution. When the samples into 1L 
beaker, pour solution 1 into beaker. Place beaker + samples + solution into hot 
water bath.  
 
 Attach aeration stone to air pump. Diffuse air through solution (Air gets rid of 
precipitation and CO2 encourages precipitation of HA crystals) 
 
 Cover and let incubate for 24 hours, in hot water bath with air diffusion. 
 
 Measure pH of solution after incubation. Should be ~8. Pour off liquid through 
funnel with Whatman filter paper to collect precipitate. Precipitate should 
primarily consist of CaCO3. 
 
 Wash samples very well with distilled water, clean apparatus as directed above 
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 Prepare solution 2 (aim of this step is to form OCP/HA crystals, need to 
minimise Mg and HCO3 as these inhibit OCP/HA formation, note low amount 
of NaCl compared to literature): 
 
 
 
 Set hot water bath at 37oC 
 Repeat procedure above with CO2 diffusion, incubation of samples in basket with 
air diffusion for 24 hours. After CO2 diffusion, initial solution pH ~5 (solution 
should be crystal clear at this point). Final solution pH ~6.5. Wash samples very 
well in distilled water.  
 
Solution Step 2
Salt: g/L
NaCl 7
CaCl2 1.65
KH2PO4 0.3
Na2HPO42H20 0.4
NaHCO3 0.35
